Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MFGE8,Lactadherin,42063,-0.180604939039296,0.00474069017312413,-0.18989669177862,-0.171313186299973,1.09945542245299e-301
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGSF9,Protein turtle homolog A,39895,-0.321736940922653,0.00897882227751226,-0.339335432586577,-0.304138449258729,1.97407713861342e-266
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRSS8,Prostasin,42007,-0.147714912999503,0.00440687987160753,-0.156352397547854,-0.139077428451152,1.27823789069558e-236
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GCG,Pro-glucagon,41771,-0.436442568116451,0.0131388308246614,-0.462194676532788,-0.410690459700115,2.00516092205215e-232
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,39904,-0.135591865084391,0.00410458191271192,-0.143636845633307,-0.127546884535476,1.54602761751519e-228
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42108,0.109492405954103,0.00353177967717742,0.102570117786835,0.116414694121371,6.44893571919454e-204
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C9,Complement component C9,39927,0.187499857136486,0.0061008563586143,0.175542178673602,0.19945753559937,2.69871137888552e-199
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,39858,-0.18209323892175,0.00598820324203097,-0.19383011727613,-0.170356360567369,2.90530243477644e-195
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CES1,Liver carboxylesterase 1,42091,-0.269628568452296,0.00905306023234033,-0.287372566507683,-0.251884570396909,7.79366048170629e-189
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42213,0.400432405119028,0.0135232545588037,0.373926826183772,0.426937984054283,8.53294857181946e-187
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NPY,Pro-neuropeptide Y,42187,-0.195317366912153,0.00676395660083591,-0.208574721849792,-0.182060011974515,5.33936683778781e-178
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42063,0.0930049472229783,0.00343921221417486,0.0862640912831956,0.099745803162761,6.98797315997588e-157
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACY1,Aminoacylase-1,42072,-0.177685576039894,0.00674367856716052,-0.190903186031529,-0.164467966048259,3.12345461899844e-149
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,INHBC,Inhibin beta C chain,42063,-0.111385320988347,0.00425389013609911,-0.119722945655102,-0.103047696321593,1.9079388650899e-147
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OXT,Oxytocin-neurophysin 1,42174,-0.403457079011823,0.0155636713569194,-0.433961874871385,-0.372952283152261,1.17987888125559e-144
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FURIN,Furin,42108,-0.0919198708951875,0.003554849500349,-0.0988873759158716,-0.0849523658745035,6.16736988945758e-144
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CPM,Carboxypeptidase M,42121,-0.0944182734633285,0.00365167051850779,-0.101575547679604,-0.0872609992470532,6.33845686622513e-144
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGF21,Fibroblast growth factor 21,42172,-0.324263398065703,0.0129035826587692,-0.34955442007689,-0.298972376054515,2.99584686442779e-136
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PYY,Peptide YY,39512,-0.26948202462245,0.0107286962836268,-0.290510269338358,-0.248453779906542,2.12726763031691e-135
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UPB1,Beta-ureidopropionase,39895,-0.240192127527756,0.00971834328619829,-0.259240080368704,-0.221144174686807,2.17895462987296e-131
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41828,-0.21434863211811,0.00879570482089953,-0.231588213567073,-0.197109050669147,2.37196983118071e-128
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MVK,Mevalonate kinase,41842,-0.211071638119513,0.00890402127087736,-0.228523519810432,-0.193619756428593,1.0725843603937e-121
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,41943,-0.0773303219061467,0.00326420724051142,-0.0837281680975491,-0.0709324757147443,1.44027561018543e-121
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TMPRSS15,Enteropeptidase,41995,-0.221784531115132,0.00947921217603965,-0.240363786980169,-0.203205275250094,1.08491332563009e-118
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42213,0.150521056473119,0.00651783879365765,0.13774609243755,0.163296020508688,8.87427865147859e-116
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,42111,0.072923375017321,0.00316609429568016,0.0667178301977879,0.0791289198368542,3.58477542800462e-115
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL17RB,Interleukin-17 receptor B,41864,0.133729652340061,0.00582903668179922,0.122304740443735,0.145154564236388,2.92563247417138e-114
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SHBG,Sex hormone-binding globulin,39927,0.115228635816157,0.00504478465163177,0.105340857898959,0.125116413733355,6.2258131140997e-113
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,42048,-0.129460640032916,0.0057264690394725,-0.140684519350282,-0.11823676071555,4.25666286713311e-111
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APOF,Apolipoprotein F,39927,0.0625071530837861,0.00278949514619172,0.0570397425972503,0.0679745635703219,7.47353517417008e-109
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AGRP,Agouti-related protein,42222,-0.123762543009547,0.00555389776023914,-0.134648182619616,-0.112876903399479,4.47081897342675e-108
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,41828,-0.1303271773042,0.00589571016914058,-0.141882769235716,-0.118771585372685,2.3354210818074e-106
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AFM,Afamin,39917,-0.0480845552034744,0.00217675187444109,-0.0523509888773789,-0.0438181215295698,6.69029575941269e-106
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TTR,Transthyretin,39800,-0.0587201445545551,0.00266654250227389,-0.0639465678590119,-0.0534937212500983,3.03749437756306e-105
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,39675,0.0722206901448843,0.00331816329844715,0.0657170900799278,0.0787242902098407,6.96955757676291e-103
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADIPOQ,Adiponectin,39917,0.159754387917347,0.00739651884125614,0.145257210988485,0.174251564846209,2.03478167192558e-101
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DSG2,Desmoglein-2,42063,0.0625921806752189,0.00291792676058656,0.0568730442244692,0.0683113171259685,2.12800804785926e-100
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CKB,Creatine kinase B-type,39904,0.131943419776947,0.00618833547648897,0.119814282243029,0.144072557310865,6.29866932436614e-99
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GH1,Somatotropin,42056,0.406060348557881,0.0192298603311676,0.368369822308793,0.44375087480697,2.13319146241978e-97
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTSD,Cathepsin D,41154,-0.0939989305445793,0.00446366060098466,-0.102747705322509,-0.0852501557666494,8.88757286026786e-97
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,39849,-0.195691574661646,0.00934731355612947,-0.21401230923166,-0.177370840091632,1.66069006178274e-95
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CNTN3,Contactin-3,42063,-0.063916485483668,0.00306336324397977,-0.0699206774418684,-0.0579122935254677,3.56248103650791e-95
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LDLR,Low-density lipoprotein receptor,42097,-0.114134786755296,0.00549665417329118,-0.124908228934946,-0.103361344575645,2.6877751614436e-94
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MME,Neprilysin,41995,-0.17447579378051,0.00843281232444973,-0.191004105936432,-0.157947481624589,1.23009235066941e-93
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GSTA1,Glutathione S-transferase A1,42046,-0.189082064336935,0.00918186188420746,-0.207078513629981,-0.171085615043888,8.5168887865838e-93
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,F9,Coagulation factor IX,42124,-0.0406646723500627,0.00198767019391152,-0.0445605059301293,-0.0367688387699961,1.22466390359143e-91
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,F7,Coagulation factor VII,42119,-0.0678475341985434,0.00336469963931643,-0.0744423454916036,-0.0612527229054832,4.08082112753995e-89
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,39422,-0.070504796789746,0.00349992990418142,-0.0773646594019416,-0.0636449341775504,1.25027464020539e-88
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GHR,Growth hormone receptor,39675,-0.0614965667897852,0.00305415090038281,-0.0674827025545355,-0.0555104310250349,1.37691788918917e-88
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CA14,Carbonic anhydrase 14,42187,0.0799784178921167,0.00398063013857244,0.0721763828205147,0.0877804529637186,1.66815110675081e-88
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42155,-0.104345519684207,0.00523678473536112,-0.114609617765515,-0.0940814216028992,4.29754889775208e-87
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LPL,Lipoprotein lipase,42072,0.102932593953311,0.00520956790729354,0.0927218408550153,0.113143347051606,1.10532748881851e-85
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCLY,Selenocysteine lyase,42149,-0.103215289888604,0.00527735942990191,-0.113558914371211,-0.0928716654059959,5.04863759634244e-84
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLAT,Tissue-type plasminogen activator,42198,-0.108020763295377,0.00555075465890744,-0.118900242426836,-0.0971412841639185,3.2020128283187e-83
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA4,Kallistatin,39740,-0.0492635891324489,0.00253049051554739,-0.0542233505429217,-0.044303827721976,4.87864532787815e-83
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RTN4R,Reticulon-4 receptor,42187,-0.0704496908953367,0.00365981932078046,-0.0776229367640664,-0.063276445026607,1.72735725232377e-81
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS4,Galectin-4,42050,-0.117874321549046,0.0061231316008039,-0.129875659486622,-0.10587298361147,1.7328411238914e-81
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,39927,-0.0451651633053385,0.00234617431676909,-0.0497636649662059,-0.0405666616444711,2.75669259568868e-81
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD300LG,CMRF35-like molecule 9,42063,0.0767939151205896,0.00403471712955553,0.0688858695466607,0.0847019606945184,1.00395797457832e-79
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KHK,Ketohexokinase,39575,-0.129897974733668,0.00683066899548798,-0.143286085964824,-0.116509863502511,2.31884126289656e-79
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GIP,Gastric inhibitory polypeptide,39575,-0.104300794914715,0.00549274818761192,-0.115066581362435,-0.0935350084669961,3.89097792224793e-79
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FAM20A,Pseudokinase FAM20A,39895,-0.0576254698088742,0.0030503084100482,-0.0636040742925687,-0.0516468653251797,2.14517626594409e-78
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPIND1,Heparin cofactor 2,39897,-0.0592873509578554,0.00315661890436223,-0.0654743240104054,-0.0531003779053055,1.60084038833329e-77
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GLA,Alpha-galactosidase A,39652,-0.0791184384816725,0.00425795210464433,-0.0874640246067754,-0.0707728523565696,6.48597608418649e-76
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPY,Pancreatic prohormone,42017,-0.207740328820727,0.0112000046707132,-0.229692337975325,-0.18578831966613,7.46314534263623e-76
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42236,-0.0799339514546195,0.00432173987164625,-0.0884045616030462,-0.0714633413061929,1.86530250439801e-75
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL16,C-C motif chemokine 16,42236,-0.101586702774137,0.00557680418894936,-0.112517238984477,-0.090656166563796,2.84615738923349e-73
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NFASC,Neurofascin,42222,-0.0576035972311482,0.00316864823402207,-0.0638141477698314,-0.0513930466924649,5.48474243535238e-73
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42108,-0.0693510177840517,0.00381742019315214,-0.0768331613626299,-0.0618688742054735,6.93361715589624e-73
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GSTA3,Glutathione S-transferase A3,41771,-0.152594604640743,0.00840337144892128,-0.169065212680629,-0.136123996600857,8.44205396262507e-73
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RBP5,Retinol-binding protein 5,41995,-0.111031158406205,0.00611913609178419,-0.123024665146102,-0.0990376516663079,1.04369079081861e-72
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42236,0.0658249287395906,0.00363704216438177,0.0586963260974024,0.0729535313817789,2.29791420408753e-72
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MEP1A,Meprin A subunit alpha,39869,-0.147184835893883,0.0082539274901662,-0.163362533774608,-0.131007138013157,3.65081471680564e-70
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41771,-0.125966057138898,0.00710660999137805,-0.139895012721999,-0.112037101555797,1.71476447524043e-69
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,39754,-0.0502589812254658,0.00284276979018839,-0.0558308100142351,-0.0446871524366966,5.24188391608568e-69
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GPR37,Prosaposin receptor GPR37,41828,-0.124826270588827,0.00709191782012707,-0.138726429516276,-0.110926111661378,1.45545567564069e-68
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42236,0.0479928652864796,0.00273064457157907,0.0426408019261846,0.0533449286467745,2.14491014961935e-68
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,42088,-0.0614537672547147,0.00350094311049847,-0.0683156157512917,-0.0545919187581377,3.20171897316859e-68
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,42187,-0.235668997874961,0.013452551533291,-0.262035998880212,-0.209301996869711,5.76894220864036e-68
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SORD,Sorbitol dehydrogenase,42129,-0.130973057199756,0.0074827665825432,-0.145639279701541,-0.116306834697971,7.55024244502065e-68
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MET,Hepatocyte growth factor receptor,42085,0.0361776552597595,0.00208961859137612,0.0320820028206623,0.0402733076988567,1.9575214041669e-66
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,41834,-0.156238146439952,0.00905986849621197,-0.173995488692528,-0.138480804187377,6.3904956938665e-66
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42165,-0.0593837184223674,0.00345601872827834,-0.066157515129793,-0.0526099217149419,1.7625989372715e-65
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39667,-0.0906305843497779,0.00527688479116496,-0.100973278540461,-0.0802878901590945,2.85572499437291e-65
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42039,-0.0964166496914114,0.0056334666470356,-0.107458244319601,-0.0853750550632216,5.59457705341026e-65
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BCHE,Cholinesterase,39744,-0.0498772517910193,0.00291726678377346,-0.0555950946872152,-0.0441594088948233,1.03692997733622e-64
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLTP,Phospholipid transfer protein,42194,0.0698514074246515,0.00410790513368953,0.06179991336262,0.077902901486683,3.52139957315465e-64
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LEP,Leptin,42072,-0.128154596187135,0.00756870614662192,-0.142989260234514,-0.113319932139756,1.18504107379173e-63
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,41771,-0.110406143915316,0.00653863272335304,-0.123221864053088,-0.0975904237775445,2.67464286639953e-63
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCN1,CCN family member 1,41972,-0.131060894992002,0.00777629508895299,-0.14630243336635,-0.115819356617655,4.39293965389512e-63
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,41995,-0.145012742287009,0.00871431804156236,-0.162092805648471,-0.127932678925547,1.46407389491496e-61
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SELE,E-selectin,42236,-0.0913362067452016,0.00550046405019027,-0.102117116283575,-0.0805552972068286,2.55467231310699e-61
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,41771,-0.150712998569089,0.00916805059452702,-0.168682377734362,-0.132743619403816,3.9920910947644e-60
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42142,0.0690478178143427,0.00420209519982639,0.060811711222683,0.0772839244060024,4.319480740773e-60
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HJV,Hemojuvelin,39872,-0.0747754906127569,0.00459067732408752,-0.0837732181679685,-0.0657777630575454,5.600346677768e-59
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NRP1,Neuropilin-1,42155,0.0478375223098409,0.00296831403403878,0.0420196268031249,0.0536554178165569,6.78563423959835e-58
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42124,0.0511108824470563,0.00317202591695368,0.0448937116498271,0.0573280532442855,7.14209624645186e-58
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,F11R,Junctional adhesion molecule A,42063,-0.0961421482605465,0.00607621403374642,-0.10805152776669,-0.0842327687544035,6.91323972740928e-56
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,41847,-0.25174556414299,0.0159199665150797,-0.282948698512547,-0.220542429773434,8.1687268846604e-56
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MUC13,Mucin-13,41766,-0.0905674902332,0.00575810585031568,-0.101853377699819,-0.0792816027665812,3.05887640887601e-55
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KYNU,Kynureninase,42222,-0.0773531912406178,0.00495335689366565,-0.0870617707522025,-0.0676446117290332,1.6723416811245e-54
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCG2,Secretogranin-2,42118,-0.0562318283429633,0.00360151890958323,-0.0632908054057464,-0.0491728512801802,1.76466028569518e-54
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,39858,-0.0904064575351492,0.0058002130275747,-0.101774875069196,-0.0790380400011028,3.29611512333428e-54
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,42142,0.054202848744682,0.00348546303568785,0.0473713411947338,0.0610343562946302,4.58497119239916e-54
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL27,C-C motif chemokine 27,42072,-0.105798326668601,0.00681239760914177,-0.119150625982519,-0.0924460273546835,6.34721656700957e-54
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,39773,-0.0508124874796446,0.00327486180538022,-0.0572312166181898,-0.0443937583410993,9.82662034639226e-54
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",41995,-0.14278611628639,0.00926772431853115,-0.160950855950711,-0.124621376622069,4.20116191796599e-53
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GUSB,Beta-glucuronidase,42138,-0.102104354052111,0.00664490137466689,-0.115128360746458,-0.0890803473577634,7.7442391398732e-53
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,42092,0.0744819327842017,0.00485664968902822,0.0649628993937064,0.084000966174697,1.21958598367935e-52
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,41995,-0.142303547395149,0.00930451890488436,-0.160540404448722,-0.124066690341576,2.31956096286775e-52
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,39675,-0.126571736132874,0.00832109284088853,-0.142881078101015,-0.110262394164732,9.9542636934903e-52
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,39904,-0.057278817967731,0.00377761827964879,-0.0646829497958426,-0.0498746861396194,1.99950211171706e-51
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42048,-0.0456807976665207,0.00303147485632907,-0.0516224883849257,-0.0397391069481157,6.75560086207443e-51
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,39868,-0.12642185993044,0.00838813479403467,-0.142862604126748,-0.109981115734132,7.79321113882809e-51
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APOD,Apolipoprotein D,39410,0.0689898366903374,0.00459107562805507,0.0599913284593495,0.0779883449213253,1.58104410724944e-50
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,41943,-0.055284210108176,0.00368834629344498,-0.0625133688433282,-0.0480550513730239,2.22985816535027e-50
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,42072,-0.050405338835905,0.00338318953618611,-0.0570363903268298,-0.0437742873449802,8.36231918519346e-50
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,39895,-0.0932230863223906,0.00625516319190268,-0.10548320617852,-0.0809629664662614,9.29577205356109e-50
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLUL1,Clusterin-like protein 1,42051,0.0722693134513998,0.00486765158992024,0.0627287163351562,0.0818099105676435,1.79589023949524e-49
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42236,-0.107055101125474,0.00724725144738592,-0.121259713962351,-0.092850488288598,5.32250895556748e-49
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OMD,Osteomodulin,42111,0.0658933518257065,0.00447508328919904,0.0571221885788764,0.0746645150725366,1.06966694429908e-48
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTSF,Cathepsin F,42108,-0.0648117926948393,0.00440397125079221,-0.073443576346392,-0.0561800090432866,1.19896217700373e-48
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD2AP,CD2-associated protein,42072,-0.101188442141373,0.00688719105030554,-0.114687336599972,-0.0876895476827741,1.71352305671977e-48
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39675,-0.0801214316988584,0.0054521512981419,-0.0908076482432165,-0.0694352151545002,1.96988758597528e-48
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,41995,-0.170244391445677,0.0116585569878778,-0.193095163141918,-0.147393619749437,6.31645854444385e-48
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MTSS1,Protein MTSS 1,39869,-0.17766770403451,0.0121610587747615,-0.201503379233043,-0.153832028835978,6.68464459828491e-48
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTSB,Cathepsin B,42080,0.0807112217777288,0.00553702380609982,0.0698586551177732,0.0915637884376845,9.12810111862168e-48
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,39895,-0.104913837777376,0.00720955374929429,-0.119044563125992,-0.0907831124287588,1.52455839988077e-47
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NOMO1,Nodal modulator 1,42063,-0.0367723904746254,0.00253983595717566,-0.0417504689506897,-0.0317943119985611,3.75732722099977e-47
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DCXR,L-xylulose reductase,42108,-0.0853112672879755,0.00592896813244399,-0.0969320448275657,-0.0736904897483853,1.34276916487084e-46
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,41662,-0.0324105796631532,0.00225471126599797,-0.0368298137445092,-0.0279913455817971,1.69004393719257e-46
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",41828,-0.143581942883583,0.0100074075698821,-0.163196461720552,-0.123967424046614,2.45657480634163e-46
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NTRK3,NT-3 growth factor receptor,42174,0.0332222138766638,0.00231899918554762,0.0286769754729904,0.0377674522803371,3.26480545063051e-46
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42172,-0.0656857335169324,0.00460669237798492,-0.0747148505777829,-0.056656616456082,8.46593544335385e-46
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,39883,0.0766543769155202,0.00540151435594767,0.0660674087778628,0.0872413450531776,2.54416529203653e-45
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PVR,Poliovirus receptor,42174,-0.05772845302178,0.00408720977864697,-0.065739384187928,-0.0497175218556319,5.61097764044616e-45
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ENO3,Beta-enolase,39575,-0.0970143331123004,0.0068694383516114,-0.110478432281459,-0.0835502339431421,6.80853722282586e-45
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,39575,0.0869277476812216,0.00616714578095294,0.0748401419505539,0.0990153534118894,9.95851279998025e-45
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,F10,Coagulation factor X,39927,-0.0445442739752993,0.00317084086378923,-0.0507591220683262,-0.0383294258822724,1.86699455052721e-44
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41710,-0.0838507830564196,0.00599107930581568,-0.0955932984958184,-0.0721082676170209,3.43114524702566e-44
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FUOM,Fucose mutarotase,39675,-0.0984174779895981,0.00702731612861784,-0.112191017601689,-0.0846439383775071,3.45807377277691e-44
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ISM1,Isthmin-1,42048,-0.0604027015015553,0.00431734757184718,-0.0688647027423758,-0.0519407002607348,3.62316065381488e-44
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTGR1,Prostaglandin reductase 1,39895,-0.127562273046959,0.00913231510956361,-0.145461610661704,-0.109662935432214,5.65164776201143e-44
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTH,Parathyroid hormone,39590,-0.126489471301551,0.00908376003013939,-0.144293640960625,-0.108685301642478,1.05204643653792e-43
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANG,Angiogenin,42077,-0.04978351052358,0.00357938717112291,-0.0567991093789809,-0.0427679116681791,1.12841175446744e-43
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PROC,Vitamin K-dependent protein C,42124,-0.0388805661481719,0.00279950452930591,-0.0443675950256115,-0.0333935372707323,1.48303074814901e-43
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42010,-0.0292874481743508,0.00211515921075195,-0.0334331602274246,-0.025141736121277,2.65376881149501e-43
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,42222,-0.0498092100764529,0.00360800852553174,-0.0568809067864951,-0.0427375133664107,4.62286563578862e-43
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,42050,0.0522583839299463,0.0037853831674158,0.0448390329218113,0.0596777349380812,4.65395424410872e-43
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41771,-0.123334436787422,0.00900906490891821,-0.140992204008902,-0.105676669565942,2.27001578513151e-42
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39575,-0.0857453567079266,0.00628001444942657,-0.0980541850288027,-0.0734365283870505,4.23373772186798e-42
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AMBP,Protein AMBP,42164,-0.0300068403887043,0.00220288920406285,-0.0343245032286675,-0.0256891775487412,5.62727647109802e-42
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,POSTN,Periostin,39904,0.0560883317729742,0.0041293419167582,0.0479948216161281,0.0641818419298203,1.07419990962275e-41
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CPA2,Carboxypeptidase A2,42130,-0.0982232013299736,0.00726710290234696,-0.112466723018574,-0.0839796796413736,2.32964502229125e-41
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDHR2,Cadherin-related family member 2,41995,-0.0972761865794909,0.00720010453683519,-0.111388391471688,-0.0831639816872939,2.53212888089578e-41
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CES3,Carboxylesterase 3,41995,-0.104545799909722,0.00776219545908015,-0.119759703009519,-0.0893318968099253,4.42988522314179e-41
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,39675,-0.0551756937552298,0.00409486719253941,-0.0632016334526071,-0.0471497540578526,4.66004574151661e-41
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,42027,-0.029280252936248,0.00218669328350925,-0.0335661717719261,-0.0249943341005699,1.25709831610273e-40
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MYH9,Myosin-9,39904,-0.165444552619231,0.0124103818719502,-0.189768901088253,-0.141120204150208,3.06901698617563e-40
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,41766,-0.0768036357737727,0.00578255024365574,-0.088137434251338,-0.0654698372962075,5.32623406091875e-40
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,42063,0.0390904810233917,0.00294600502494704,0.0333163111744955,0.0448646508722879,6.23897292333286e-40
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CFI,Complement factor I,39917,-0.0279782112043664,0.00212069569251141,-0.0321347747616887,-0.023821647647044,1.88306825385031e-39
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FYB1,FYN-binding protein 1,42041,-0.132972405200535,0.0101087088322622,-0.152785474511769,-0.113159335889302,2.81250919180211e-39
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,39852,-0.158100470985882,0.0120289163039825,-0.181677146941688,-0.134523795030077,3.6084121423226e-39
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BTD,Biotinidase,39917,-0.0291240717603759,0.00223753549167095,-0.033509641324051,-0.0247385021967009,1.86960096535665e-38
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,39868,0.0523280145221535,0.00402677045614237,0.0444355444281145,0.0602204846161926,2.460761872942e-38
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42142,0.0609027936636789,0.00469203525611506,0.0517064045616934,0.0700991827656644,2.68689703385933e-38
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,41995,-0.0974306291047131,0.00751121208313517,-0.112152604787658,-0.0827086534217681,3.02216723218061e-38
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,INSL5,Insulin-like peptide INSL5,39869,-0.144924831197851,0.0111979175658018,-0.166872749626822,-0.122976912768879,4.85718263100657e-38
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42187,-0.0455494822022563,0.00353258900655832,-0.0524733566551106,-0.038625607749402,8.09836827043586e-38
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42174,0.0655312376743236,0.0050935342305089,0.0555479105825261,0.075514564766121,1.16700576871602e-37
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,41995,-0.160246384002617,0.0124880359137565,-0.18472293439358,-0.135769833611654,1.80385208806891e-37
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HGF,Hepatocyte growth factor,42222,-0.0483608223638404,0.0037718559556573,-0.0557536600369287,-0.0409679846907521,2.04500733642581e-37
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,41972,-0.0363815912049936,0.00284388824010374,-0.0419556121555969,-0.0308075702543903,2.96983576268206e-37
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,42108,-0.127852874039639,0.0100260924281392,-0.147504015198792,-0.108201732880486,4.96616988355793e-37
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42222,0.035525844065751,0.00278849881045076,0.0300603863972675,0.0409913017342345,5.74966034771378e-37
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HEG1,Protein HEG homolog 1,39675,-0.0384407737516827,0.00301832165447122,-0.0443566841944463,-0.0325248633089191,6.78235978718383e-37
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,42063,-0.0736467387840842,0.005814574576156,-0.0850433049533499,-0.0622501726148184,1.47688090319247e-36
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GRP,Gastrin-releasing peptide,39575,-0.0737416882302626,0.00583818295166831,-0.0851845268155325,-0.0622988496449927,2.55019862577074e-36
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AMOT,Angiomotin,39675,-0.0527251247772233,0.00419394672303468,-0.0609452603543712,-0.0445049892000753,5.31821742083672e-36
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42048,-0.145435073169796,0.0116451537258844,-0.16825957447253,-0.122610571867063,1.35235589334077e-35
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,WIF1,Wnt inhibitory factor 1,42187,0.0459834271018558,0.00368446617585902,0.0387618733971722,0.0532049808065395,1.49681999475451e-35
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NRP2,Neuropilin-2,42063,0.0382385344150466,0.00307665944204766,0.0322082819086331,0.04426878692146,2.85427490790907e-35
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,41943,-0.071731813095758,0.00577254707547468,-0.0830460053636884,-0.0604176208278276,2.94529101102062e-35
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39512,-0.0757271071049265,0.0061207032804479,-0.0877236855346044,-0.0637305286752487,6.32709031568958e-35
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39512,-0.0927826391299817,0.00749992118040701,-0.107482484643579,-0.0780827936163839,6.41628097603332e-35
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42048,-0.13533503186123,0.0109507623948271,-0.156798526155092,-0.113871537567369,6.77763564796988e-35
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,42222,-0.101965809849685,0.00825102103174349,-0.118137811071902,-0.0857938086274679,6.78523049154064e-35
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,41943,-0.0780090088746049,0.00631471834587432,-0.0903858568325186,-0.0656321609166913,7.23032880728427e-35
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,39858,-0.0958878869435276,0.00777768674805782,-0.111132152969721,-0.0806436209173343,1.06375972877031e-34
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,42072,-0.117084490344333,0.0095049781035247,-0.135714247427242,-0.098454733261425,1.11052393795491e-34
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",41995,-0.131530628233653,0.0106963705106799,-0.152495514434585,-0.11056574203272,1.44822091457201e-34
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42174,-0.069980099263159,0.005702993779817,-0.0811579670716003,-0.0588022314547177,1.97881967870686e-34
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42128,0.0427964410810074,0.00350487395194661,0.035926888135192,0.0496659940268228,4.12767557720797e-34
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,42072,-0.102374032027802,0.00839166901997199,-0.118821703306947,-0.0859263607486569,4.72986588879107e-34
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,39858,-0.0750654402887228,0.00615278207031361,-0.0871248931465375,-0.0630059874309081,5.07995711998263e-34
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39675,-0.0294412422014411,0.0024158830081201,-0.0341763728973565,-0.0247061115055257,6.04623456283159e-34
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42142,-0.0568669656672734,0.0046862214125896,-0.066051959635949,-0.0476819716985978,1.03182087888682e-33
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,41842,-0.0721258562358482,0.00597383703988416,-0.0838345768340212,-0.0604171356376753,2.17989169243476e-33
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,42108,-0.0296439727470092,0.00246277045198696,-0.0344710028329036,-0.0248169426611148,3.36380563236906e-33
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42108,-0.0321822925794582,0.00267430937130169,-0.0374239389472095,-0.0269406462117069,3.48569819135546e-33
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,41667,-0.132099331090057,0.0109951291548644,-0.153649784233592,-0.110548877946523,4.46151303036229e-33
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,41995,-0.165936356144519,0.0138194940452881,-0.193022564473284,-0.138850147815754,4.80061755755891e-33
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TXLNA,Alpha-taxilin,41943,-0.115265404493948,0.00962716868535051,-0.134134655117235,-0.0963961538706607,7.258064580663e-33
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLXNA4,Plexin-A4,42048,-0.10546546036476,0.00881320744997655,-0.122739346966714,-0.0881915737628062,7.78950108771176e-33
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,41771,-0.146393676828448,0.012241639965914,-0.170387291161639,-0.122400062495256,8.64635643128562e-33
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42019,-0.0688346655628769,0.00576034609264645,-0.080124943904464,-0.0575443872212899,9.54684384028296e-33
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,42174,-0.124123978706909,0.0104631398256195,-0.144631732765123,-0.103616224648695,2.66131689896122e-32
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD209,CD209 antigen,42098,0.0505250926059088,0.00426491292442296,0.0421658632740398,0.0588843219377778,3.23271060101563e-32
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42236,0.0415116488583648,0.00350495160502527,0.0346419437125152,0.0483813540042143,3.33584474346401e-32
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41771,-0.0885463141027466,0.00748519953103997,-0.103217305183585,-0.0738753230219083,3.99441269686478e-32
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NUMB,Protein numb homolog,39597,-0.108526291533173,0.00917478024947906,-0.126508860822152,-0.0905437222441937,4.33705033366349e-32
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,41995,-0.10411658314067,0.00881361682801739,-0.121391272123585,-0.0868418941577564,4.81403331030216e-32
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,41943,-0.0944381363168696,0.00799854393388171,-0.110115282427278,-0.0787609902064614,5.18794088174812e-32
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IDUA,Alpha-L-iduronidase,42187,-0.0609478965227766,0.00516451364728185,-0.071070343271449,-0.0508254497741041,5.50720116557054e-32
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42198,-0.0253002394027014,0.0021475964700449,-0.0295095284839894,-0.0210909503214134,7.01085011456943e-32
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42121,-0.0303332766232081,0.00258762018446924,-0.0354050121847678,-0.0252615410616484,1.39024646433889e-31
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CFHR4,Complement factor H-related protein 4,39883,0.0936796793997902,0.00799456892753196,0.0780103243018275,0.109349034497753,1.57102055080176e-31
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39800,-0.0373852230401057,0.00319531338332136,-0.0436480372714156,-0.0311224088087958,1.94124562487605e-31
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ASAH2,Neutral ceramidase,41943,-0.0678259518443052,0.00580235924632116,-0.0791985759670947,-0.0564533277215157,2.05498363044935e-31
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42187,-0.042790959182508,0.00366474628909296,-0.0499738619091302,-0.0356080564558858,2.37597098467432e-31
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,39868,-0.0616822611284818,0.00528227929035954,-0.0720355285375865,-0.0513289937193771,2.52479021386447e-31
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42063,-0.030651537282405,0.00262684550653426,-0.0358001544752122,-0.0255029200895979,2.61012247069218e-31
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AGR3,Anterior gradient protein 3,41755,-0.0756796867653712,0.00649637472856786,-0.0884125812333642,-0.0629467922973782,3.28330690042074e-31
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,42048,-0.116585048842818,0.0100098035741333,-0.13620426384812,-0.096965833837517,3.35198735182371e-31
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C19orf12,Protein C19orf12,41766,-0.0853383851326597,0.00732927520190107,-0.0997037645283858,-0.0709730057369336,3.52041477167455e-31
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MTSS2,Protein MTSS 2,39858,-0.127731619016252,0.0110052152644731,-0.14930184093462,-0.106161397097885,5.73290816865728e-31
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HYAL1,Hyaluronidase-1,42003,-0.0292156514502428,0.00252525568066367,-0.0341651525843436,-0.024266150316142,8.25031839066368e-31
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39872,-0.126567523786796,0.01094502660418,-0.148019775930989,-0.105115271642603,9.3581336648055e-31
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DCTN1,Dynactin subunit 1,42187,-0.0809557015699061,0.0070046111917781,-0.0946847395057912,-0.067226663634021,9.42106972697335e-31
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VSNL1,Visinin-like protein 1,39868,-0.0488525193972105,0.00423040400161707,-0.0571441112403799,-0.040560927554041,1.12477415195558e-30
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EEF1D,Elongation factor 1-delta,39895,-0.115251097254579,0.0099921661350519,-0.13483574287928,-0.095666451629877,1.31697373287113e-30
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARF6,ADP-ribosylation factor 6,39869,-0.137225228246534,0.0119047532635238,-0.160558544643041,-0.113891911850028,1.43204689922033e-30
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,S100A4,Protein S100-A4,42108,-0.0705638496343748,0.00613852846253626,-0.0825953654209458,-0.0585323338478037,1.93104898130517e-30
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,39675,-0.0516229455267155,0.00449097409089551,-0.0604252547448707,-0.0428206363085603,2.083136829374e-30
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CPE,Carboxypeptidase E,42059,0.0491914435875192,0.00428374533178839,0.040795302737214,0.0575875844378245,2.21738539205081e-30
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39848,-0.098656328573707,0.00858809294350444,-0.115488990742976,-0.0818236664044383,2.24966324119678e-30
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NPPC,C-type natriuretic peptide,42048,-0.0661626426359863,0.00576257435671081,-0.0774572883751394,-0.0548679968968331,2.26524050136637e-30
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",39872,-0.0797773573881305,0.00695447778814161,-0.093408133852888,-0.0661465809233729,2.70529925366402e-30
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,41842,-0.0888093330715028,0.00775930579675144,-0.104017572433136,-0.07360109370987,3.43292618771551e-30
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NCS1,Neuronal calcium sensor 1,42187,-0.0351911271403798,0.00309540688286922,-0.0412581246308034,-0.0291241296499561,8.15319705587232e-30
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TREH,Trehalase,39904,-0.093609294521005,0.00823036610351983,-0.109740812083904,-0.0774777769581061,8.21441004016704e-30
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42072,0.0335950284226914,0.00295973027849326,0.0277939570768446,0.0393960997685382,1.0038493352307e-29
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA9,Serpin A9,41950,-0.0898945237941174,0.00793343539300945,-0.105444057164416,-0.0743449904238189,1.25686007157939e-29
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42210,-0.0481875701493354,0.00425689989673858,-0.056531093946943,-0.0398440463517278,1.41848070182825e-29
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",41766,-0.0627118699539598,0.00554613696490818,-0.0735822984051799,-0.0518414415027398,1.65150053501634e-29
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRSS2,Trypsin-2,42142,-0.0705717500368551,0.00625092224467743,-0.0828235576364229,-0.0583199424372873,1.99440189294545e-29
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41842,-0.0762546645437316,0.00675399969193242,-0.0894925039399192,-0.0630168251475441,1.99713476407708e-29
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42092,-0.104683571908678,0.00927839284929134,-0.122869221893289,-0.0864979219240672,2.16785939878956e-29
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AXIN1,Axin-1,42048,-0.118943583286877,0.0105759907883501,-0.139672525232043,-0.0982146413417107,3.25097604158936e-29
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39868,-0.0859925391289035,0.0076483615353219,-0.100983327738134,-0.0710017505196725,3.57381265159285e-29
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TJAP1,Tight junction-associated protein 1,42108,-0.102427789374918,0.0091175584238073,-0.120298203885581,-0.0845573748642559,3.73318638329799e-29
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTSO,Cathepsin O,42222,-0.0375881721615689,0.00334697365368918,-0.0441482405227997,-0.0310281038003381,3.87868002612411e-29
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLXNB2,Plexin-B2,42181,-0.0300030668306173,0.00267744358833823,-0.0352508562637603,-0.0247552773974744,5.11568521982272e-29
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APOA4,Apolipoprotein A-IV,39917,-0.0421194815678567,0.00375934923434662,-0.0494878060671761,-0.0347511570685374,5.54068128872734e-29
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,41771,-0.0782047134437317,0.00698570148597117,-0.0918966883562352,-0.0645127385312282,5.83102021355787e-29
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ASS1,Argininosuccinate synthase,39512,-0.0945323860605466,0.00846318109940092,-0.111120221015372,-0.0779445511057208,8.20733573922635e-29
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDH2,Cadherin-2,42072,-0.0430691177546265,0.00386394080069342,-0.0506424417239856,-0.0354957937852674,9.95493828776678e-29
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39696,-0.139149227305832,0.0125043901123089,-0.163657831925957,-0.114640622685706,1.29843326637709e-28
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42048,-0.059428105392535,0.00534352727940034,-0.0699014188601597,-0.0489547919249104,1.31389491578049e-28
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,39675,-0.101066442588513,0.00910074856888401,-0.118903909783525,-0.0832289753934999,1.67166357704098e-28
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SORT1,Sortilin,42056,-0.0463947373786432,0.00418224074250248,-0.054591929233948,-0.0381975455233383,1.79701271762345e-28
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD248,Endosialin,39904,0.0491857323600413,0.00443236104209632,0.0404983047175325,0.0578731600025501,1.82038859108269e-28
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLK14,Kallikrein-14,42187,0.0563261818949454,0.00507878484652786,0.0463717635957508,0.06628060019414,1.84836753826376e-28
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BECN1,Beclin-1,39575,-0.0721122869089637,0.00651737459753386,-0.0848863411201301,-0.0593382326977974,2.62825838173765e-28
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,39512,-0.0736308002674769,0.00665865470069638,-0.0866817634808418,-0.060579837054112,2.83577013910618e-28
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41696,-0.101620808501661,0.00920131889719603,-0.119655393540165,-0.0835862234631567,3.1168666300726e-28
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39512,-0.090563636128695,0.00820080760318562,-0.106637219030939,-0.0744900532264512,3.33247639024071e-28
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,42187,-0.0444296404085858,0.00403144926186176,-0.0523312809618349,-0.0365279998553368,3.99246098719904e-28
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CPB1,Carboxypeptidase B,42236,-0.0747754060909507,0.00679483095485893,-0.0880932747624742,-0.0614575374194272,4.75709520628689e-28
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39895,-0.0358946728214255,0.00326036897886345,-0.0422849960199978,-0.0295043496228531,4.78076381118813e-28
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,41771,-0.0883169102127972,0.0080359428430326,-0.104067358185141,-0.0725664622404533,5.63279251753302e-28
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BCAN,Brevican core protein,41943,0.0415124898481511,0.00377880458547824,0.0341060328606137,0.0489189468356884,5.90476730371998e-28
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DTYMK,Thymidylate kinase,39895,-0.0809226504815167,0.00736349617352212,-0.09535510298162,-0.0664901979814133,5.93324603425432e-28
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39597,-0.0554500682538179,0.00505529368543579,-0.0653584438772721,-0.0455416926303638,7.53206436114029e-28
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CNST,Consortin,42072,-0.1307539545755,0.0119403129129156,-0.154156967884814,-0.107350941266185,8.64133376283028e-28
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,41929,-0.0434840171278284,0.00397433334985122,-0.0512737104935368,-0.03569432376212,9.60674888628597e-28
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD93,Complement component C1q receptor,41580,0.0376230237498129,0.00344441434781566,0.0308719716280943,0.0443740758715316,1.18177826216373e-27
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GAST,Gastrin,39868,-0.156431582325522,0.0143236602080488,-0.184505956333297,-0.128357208317746,1.25536102782584e-27
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PROS1,Vitamin K-dependent protein S,39917,-0.0303458713769407,0.00277945682999347,-0.0357936067637279,-0.0248981359901535,1.29935663525693e-27
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,42222,-0.090474539302289,0.00830090202190109,-0.106744307265215,-0.0742047713393629,1.50807585486808e-27
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42111,0.024223179367641,0.00222749622707372,0.0198572867625766,0.0285890719727055,1.9782165316149e-27
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BACH1,Transcription regulator protein BACH1,42048,-0.0892901486682802,0.00822300779697837,-0.105407243950358,-0.0731730533862026,2.35775434889463e-27
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,41995,0.028746801095189,0.00265025142377358,0.0235523083045927,0.0339412938857852,2.68117062837915e-27
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BCR,Breakpoint cluster region protein,42048,-0.1096283729581,0.0101228199273227,-0.129469100015652,-0.0897876459005474,3.21993128341472e-27
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39895,-0.0742444752935449,0.00686327829640017,-0.0876965007544892,-0.0607924498326006,3.85720199220872e-27
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDH1,Cadherin-1,41624,-0.0474233273762215,0.00440473068925039,-0.0560565995271523,-0.0387900552252907,6.43451912943515e-27
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,39858,-0.0938334778266478,0.00871624399044344,-0.110917316047917,-0.0767496396053786,6.78079831582466e-27
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,41995,-0.0436058444659945,0.00405285406751538,-0.0515494384383247,-0.0356622504936644,6.90018281947365e-27
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,42063,0.033637174708377,0.00312766419783841,0.0275069528806137,0.0397673965361402,7.23831912210803e-27
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,39597,-0.147405678211502,0.0137240755925838,-0.174304866372966,-0.120506490050038,8.90129745614356e-27
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,39512,-0.0796288310819246,0.00741428167785789,-0.094160823170526,-0.0650968389933231,8.9932516724551e-27
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39895,-0.089303249626533,0.00832834620733083,-0.105626808192901,-0.0729796910601646,1.0692080136353e-26
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42072,-0.0507866745599405,0.00474413591998328,-0.0600851809631077,-0.0414881681567732,1.23197618421039e-26
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,41995,0.0229296266745784,0.00214325997843141,0.0187288371168528,0.0271304162323039,1.32494613945143e-26
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,39889,0.0173242507380341,0.00162454518683179,0.0141401421718438,0.0205083593042244,2.00232099743139e-26
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,41771,-0.0761115915978751,0.00714569621827503,-0.0901171561856941,-0.062106027010056,2.19953560345628e-26
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,39872,-0.0680897053955737,0.00639682025675734,-0.0806274730988181,-0.0555519376923293,2.4717912056792e-26
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CPA1,Carboxypeptidase A1,42236,-0.0752348903770288,0.00708520654124548,-0.0891218951978699,-0.0613478855561876,3.09206376906623e-26
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,42051,-0.0891995980825263,0.00840406841874701,-0.10567157218327,-0.0727276239817822,3.26182659293218e-26
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL15,C-C motif chemokine 15,42236,-0.0505314211024087,0.00477000511619636,-0.0598806311301536,-0.0411822110746639,4.03185820718585e-26
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,REN,Renin,42072,-0.0941661330859851,0.0088923980603439,-0.111595233284259,-0.0767370328877111,4.22140320858907e-26
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42048,-0.120507845120546,0.0114091022412841,-0.142869685513463,-0.0981460047276295,5.6243753065419e-26
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41893,-0.0567209801409504,0.00537791445758993,-0.0672616924778267,-0.0461802678040742,6.636131884951e-26
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",41995,-0.0512230451566609,0.00485936318728148,-0.0607473970037326,-0.0416986933095892,7.0511509746802e-26
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42149,-0.0841969021977763,0.00799757708858805,-0.0998721532914089,-0.0685216511041438,8.09111506042854e-26
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39597,-0.079618291391892,0.00756799844315858,-0.0944515683404828,-0.0647850144433012,9.22188335848883e-26
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HEXIM1,Protein HEXIM1,42048,-0.0928900658403179,0.00885473949225808,-0.110245355245144,-0.075534776435492,1.20063712314053e-25
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,41919,-0.103113421952032,0.00984311794550924,-0.12240593312523,-0.0838209107788338,1.40460363635484e-25
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,41995,0.0466313079661184,0.00445990558712814,0.0378898930153473,0.0553727229168896,1.72996728967272e-25
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,THOP1,Thimet oligopeptidase,42010,-0.035822764427726,0.003427135932855,-0.0425399508561218,-0.0291055779993302,1.78447328730662e-25
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,42048,-0.099448895250905,0.00952218453172359,-0.118112376933083,-0.0807854135687268,1.95456362360509e-25
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PGF,Placenta growth factor,42222,-0.0299223641635629,0.00286599284427372,-0.0355397101383394,-0.0243050181887864,2.02010829124134e-25
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UMOD,Uromodulin,42200,0.0615567346005427,0.00589892272198797,0.0499948460654463,0.0731186231356391,2.1345019216157e-25
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42108,-0.0425973919047678,0.00408519762074562,-0.0506043792414292,-0.0345904045681063,2.32384571311495e-25
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ELN,Elastin,39895,-0.039607142877249,0.00380638595471397,-0.0470676593484884,-0.0321466264060097,3.0446993717761e-25
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KAZN,Kazrin,39869,-0.119458936585213,0.0114895278758595,-0.141978411221898,-0.0969394619485288,3.31915982185303e-25
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",41981,-0.119989781321913,0.0115743628970284,-0.142675532600088,-0.0973040300437369,4.36612503334304e-25
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39868,-0.0987411828475571,0.00952222912886418,-0.117404751940131,-0.0800776137549834,4.42279897875184e-25
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,42108,0.0315060726248865,0.00304336262135163,0.0255410818870373,0.0374710633627357,5.06276004322807e-25
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,41995,-0.0765767732363061,0.00740038188319432,-0.091081521727367,-0.0620720247452452,5.32559740156275e-25
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,42179,-0.0641168378353109,0.00621235862279866,-0.0762930607359963,-0.0519406149346256,7.00899821248928e-25
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,39590,-0.139142548572595,0.0135076537956898,-0.165617550012147,-0.112667547133043,9.03586081006033e-25
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITGA11,Integrin alpha-11,42048,0.0382283095856244,0.00371475442539135,0.0309473909118574,0.0455092282593915,9.56345726860602e-25
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39858,-0.0418641216753659,0.00407075995253256,-0.0498428111823297,-0.0338854321684021,1.06877260638137e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39868,-0.0463962045316311,0.00452578556343395,-0.0552667442359616,-0.0375256648273005,1.49301159736739e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,41995,-0.0463373742140998,0.00452600060169805,-0.055208335393428,-0.0374664130347717,1.64865088333917e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDH15,Cadherin-15,42155,-0.0776393658894788,0.0075913741585785,-0.0925184592402927,-0.0627602725386649,1.83574639011387e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,41995,-0.0938310019561795,0.00918175578879481,-0.111827243302217,-0.0758347606101416,1.99784152763659e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,39597,-0.0970746582733524,0.00950915786227702,-0.115712607683415,-0.0784367088632895,2.33149329073484e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,39895,-0.0923660503200868,0.009053000793672,-0.110109931875684,-0.0746221687644897,2.45587056055089e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,39858,-0.126976121338128,0.0125140276343252,-0.151503615501406,-0.102448627174851,4.35060352627016e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,41995,-0.0312736441005611,0.00308709189886925,-0.0373243442223448,-0.0252229439787774,4.94067262845929e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NIT2,Omega-amidase NIT2,39840,-0.0811908770332099,0.00801286557484089,-0.096896093559898,-0.0654856605065217,5.02341415258942e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42050,-0.0303148753044067,0.00299771609264992,-0.0361903988460005,-0.0244393517628128,5.91314188515509e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,39597,-0.0493897745229481,0.00488647368555947,-0.0589672629466447,-0.0398122860992516,6.51157716809347e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BRAP,BRCA1-associated protein,39752,-0.121716233236817,0.012081523151682,-0.145396018614114,-0.0980364478595208,9.04417422993838e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42072,-0.0374410010598947,0.00371826570520162,-0.0447288018420899,-0.0301532002776995,9.14733053804238e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,42142,-0.050847557986884,0.00505926558291047,-0.0607637185293885,-0.0409313974443795,1.10784201541988e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BOC,Brother of CDO,41828,0.0256165566591667,0.002549734250972,0.0206190775272616,0.0306140357910718,1.15425679707313e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,41924,-0.0794272580067177,0.00790692554533638,-0.094924832075577,-0.0639296839378583,1.1699255289234e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42111,-0.114247873621137,0.0113930328143482,-0.136578217937259,-0.091917529305014,1.39007057411239e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39869,-0.154001385238559,0.0153708735574518,-0.184128297411165,-0.123874473065954,1.57698764360592e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GLB1,Beta-galactosidase,41943,-0.0471956083764873,0.00472115996903283,-0.0564490819157916,-0.0379421348371829,1.90677280085198e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42236,0.0268211845772456,0.00268596790969351,0.0215566874742463,0.0320856816802449,2.11905882096733e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLA2,Src-like-adapter 2,39872,-0.117047982715585,0.0117199538680034,-0.140019092296872,-0.0940768731342986,2.17179521814276e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SELP,P-selectin,42142,-0.0610554622318565,0.00611609197792412,-0.0730430025085878,-0.0490679219551253,2.18449553499814e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STC1,Stanniocalcin-1,42174,-0.0501367319136011,0.00502300519704733,-0.0599818220998138,-0.0402916417273883,2.21292790088058e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SBSN,Suprabasin,39892,0.0388691284983248,0.0038934861449248,0.0312378956542722,0.0465003613423774,2.25839450305572e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VASN,Vasorin,41901,0.0298645812987419,0.00300103207309603,0.0239825584354736,0.0357466041620101,2.99714080335193e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42142,-0.0466165337046707,0.00468829403327685,-0.0558055900098933,-0.0374274773994481,3.24374590854579e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ERBIN,Erbin,41995,-0.111651925843931,0.0112357975807628,-0.133674089102227,-0.0896297625856365,3.45104184107328e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,39917,0.0289285317964362,0.00291115822623009,0.0232226616730253,0.0346344019198472,3.57083456808587e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42063,-0.0503873886232956,0.00507489043978957,-0.0603341738852832,-0.0404406033613081,3.74855016221465e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACAN,Aggrecan core protein,41922,0.0297504092666324,0.00300230467990138,0.0238658920940257,0.0356349264392391,4.56282835051647e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42046,-0.0666234718871929,0.00672893618632948,-0.0798121868123987,-0.0534347569619872,4.93916904056962e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CX3CL1,Fractalkine,41943,0.0361661223171183,0.00365853084555752,0.0289954018598255,0.043336842774411,5.77489493991452e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,42029,-0.0314273801543732,0.00318144320800616,-0.0376630088420653,-0.0251917514666811,6.18751147152759e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RBKS,Ribokinase,41757,-0.0532668975388891,0.00539502506686338,-0.0638411466699414,-0.0426926484078369,6.52595861955942e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATRN,"Attractin, Isoform 2",39917,-0.0179876012487929,0.00182305703838543,-0.0215607930440284,-0.0144144094535575,7.17631024657296e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,39538,-0.0552620218766297,0.00561850222787637,-0.0662742862432674,-0.0442497575099921,9.8148135005416e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DPY30,Protein dpy-30 homolog,42141,-0.0648496711646335,0.00659710739994757,-0.0777800016685308,-0.0519193406607363,9.96057219633656e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HEPH,Hephaestin,39895,-0.029784025257989,0.0030315021614933,-0.0357257694945159,-0.0238422810214622,1.08503884844225e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,39597,-0.0864375361582049,0.00882354031933101,-0.103731675184094,-0.0691433971323162,1.44515933846231e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,41842,-0.0917936399091322,0.00938086546716958,-0.110180136224785,-0.0734071435934798,1.55395512540417e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SELL,L-selectin,39917,0.024915531715634,0.00254685306465686,0.0199236997089065,0.0299073637223614,1.63784578311321e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PAXX,Protein PAXX,39675,-0.049687148847205,0.00508176288677524,-0.0596474041052845,-0.0397268935891256,1.73331522770139e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,39868,-0.116817875496166,0.0119488952066813,-0.140237710101261,-0.0933980408910707,1.74556970131713e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,41771,-0.0711659976123618,0.00728462885180257,-0.0854438701618948,-0.0568881250628288,1.81719609997491e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39895,-0.0776107774872365,0.00796697162286031,-0.0932260418680427,-0.0619955131064303,2.45404070314199e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,39869,-0.0920952030249035,0.00945391993086504,-0.110624886089399,-0.073565519960408,2.45715602425669e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINH1,Serpin H1,39696,-0.137670627152465,0.0141437523584532,-0.165392381775033,-0.109948872529897,2.66009101421422e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,39869,0.0323540866334657,0.00332924808311022,0.0258287603905697,0.0388794128763617,3.08516545897429e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,39868,-0.0955436397684817,0.00984442100360286,-0.114838704935543,-0.07624857460142,3.49369968494065e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TF,Serotransferrin,39917,-0.0227586437393964,0.00234652708369434,-0.0273578368234374,-0.0181594506553555,3.71827476959294e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD63,CD63 antigen,41919,-0.0534249898281767,0.00552538378478482,-0.064254742046355,-0.0425952376099985,4.82412519902731e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,41943,-0.0556300438557675,0.00575868698443972,-0.0669170703452693,-0.0443430173662656,5.25305211601814e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CMIP,C-Maf-inducing protein,39858,-0.0889854620606302,0.00920971489739545,-0.107036503259525,-0.0709344208617351,5.31554404431959e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SH2B3,SH2B adapter protein 3,41771,-0.104476995899903,0.0108165237064699,-0.125677382364584,-0.0832766094352218,5.32483739980286e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FCN1,Ficolin-1,39915,-0.0590752652340848,0.00611702981475715,-0.0710646436710088,-0.0470858867971607,5.55331930715535e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39895,-0.0817307574908478,0.00846498009222245,-0.0983221184716038,-0.0651393965100917,5.6827850043126e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EHBP1,EH domain-binding protein 1,39895,-0.0794273901355453,0.00822773737052824,-0.0955537553817806,-0.0633010248893099,5.76863859960399e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,39850,-0.0610197374483927,0.00632598910369629,-0.0734186760916374,-0.0486207988051479,6.22136208812495e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42108,-0.100001553079906,0.0104245397979711,-0.12043365108393,-0.079569455075883,1.00444259399346e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42185,-0.0853310560316035,0.00893539280385024,-0.10284442592715,-0.067817686136057,1.51866382977942e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42055,-0.0529381692496415,0.00554463870827714,-0.0638056611178647,-0.0420706773814183,1.55261893639199e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FOXO1,Forkhead box protein O1,42048,-0.0907617970115677,0.00950725481194764,-0.109396016442985,-0.0721275775801503,1.56843420465824e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42070,0.0344396736442586,0.00360757369685968,0.0273688291984136,0.0415105180901035,1.56940075194247e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39575,-0.0888005575058139,0.00930765263095899,-0.107043556662493,-0.0705575583491342,1.72038832852202e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42156,-0.0317367707319531,0.0033416783389736,-0.0382864602763413,-0.0251870811875648,2.51041394889303e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DAG1,Dystroglycan,42111,-0.0493866137953252,0.00520494626319513,-0.0595883084711877,-0.0391849191194628,2.73288615915317e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,41995,-0.142671854138116,0.015038842556683,-0.172147985549215,-0.113195722727017,2.77612707287123e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39426,-0.0319755561619304,0.00337274559278441,-0.0385861375237879,-0.025364974800073,3.05702664149203e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MLN,Promotilin,42048,-0.0924138437080649,0.00978801743770357,-0.111598357885964,-0.0732293295301659,4.26990138537248e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,39575,-0.0768822578317181,0.00814867733335077,-0.0928536654050857,-0.0609108502583506,4.70053802433817e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EZR,Ezrin,42174,-0.0251434775330142,0.00266640301625443,-0.0303696274448729,-0.0199173276211555,4.76813512150558e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS8,Galectin-8,42174,-0.0629960352669752,0.00668288407099687,-0.0760944880461291,-0.0498975824878213,4.91772657910881e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R9B,Neurabin-2,42222,-0.0978856783290286,0.0103946523817615,-0.118259196997281,-0.0775121596607762,5.37998676559938e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42092,-0.0785051893332563,0.00834587604914998,-0.0948631063895902,-0.0621472722769223,5.94765386936901e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,41995,-0.0379203474925472,0.00403552627081776,-0.04582997898335,-0.0300107160017444,6.53344316284911e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEP43,Centrosomal protein 43,41725,-0.0725995440185127,0.00772836661819292,-0.0877471425901708,-0.0574519454468546,6.72397095897105e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,41995,-0.0798273281569771,0.00851315586091377,-0.096513113644368,-0.0631415426695861,7.86653406271698e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39845,-0.113263900939386,0.0120830074769039,-0.136946595594118,-0.0895812062846544,8.3304079210405e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GSN,Gelsolin,39880,0.0194601885998296,0.00207834186792314,0.0153866385387003,0.023533738660959,9.18897680439922e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FAM3C,Protein FAM3C,42056,-0.031185844140936,0.00333251515738939,-0.0377175738494192,-0.0246541144324528,9.39043767756175e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,39868,-0.0907586231860703,0.00969611415246942,-0.10976300692491,-0.0717542394472302,9.45469642868575e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDH5,Cadherin-5,42236,0.0311061305043518,0.00332484095472968,0.0245894422330816,0.037622818775622,9.58420686933989e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,39895,-0.0746734711253107,0.00799087282261358,-0.0903355818576333,-0.0590113603929881,1.09267746278371e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,41766,-0.0812129602090916,0.00869381389919609,-0.0982528354515159,-0.0641730849666672,1.10081977276543e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRG2,Bone marrow proteoglycan,39904,0.052468051718578,0.00561758682304306,0.0414575815454136,0.0634785218917424,1.14369974322421e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,42048,-0.0601294292495436,0.00645293213498126,-0.0727771762341068,-0.0474816822649803,1.36544360256999e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FAM13A,Protein FAM13A,39869,-0.0694203566684141,0.00745144495839541,-0.0840251887868691,-0.0548155245499591,1.42720861345282e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CNTN1,Contactin-1,42236,0.027254741733317,0.00292661074449102,0.0215185846741146,0.0329908987925194,1.43375023222781e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APLP1,Amyloid-like protein 1,42072,0.0519452739345323,0.00557944323429545,0.0410095651953132,0.0628809826737514,1.47175528165311e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,F12,Coagulation factor XII,39917,-0.0419560265615824,0.00451854577234111,-0.050812376275371,-0.0330996768477939,1.90600043176213e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TCTN3,Tectonic-3,39895,-0.0309410434043851,0.0033338605415569,-0.0374754100658366,-0.0244066767429336,1.98731343351633e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DOK2,Docking protein 2,42072,-0.124991408979548,0.0134826253101357,-0.151417354587414,-0.0985654633716822,2.12934242619529e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,41771,-0.0501856072252987,0.00542329445747905,-0.0608152643619577,-0.0395559500886398,2.49862113216495e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42138,-0.0335509833801175,0.0036284239493251,-0.0406626943207947,-0.0264392724394403,2.6565146142082e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPP1,Osteopontin,42213,0.0444918891303794,0.00481873022168104,0.0350471778958846,0.0539366003648743,3.01175830479972e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DDHD2,Phospholipase DDHD2,39872,-0.0673261885165645,0.00729173961119851,-0.0816179981545136,-0.0530343788786154,3.09478034440237e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DKK1,Dickkopf-related protein 1,42174,-0.0597154589827513,0.00647005769717859,-0.0723967720692213,-0.0470341458962813,3.11542731280017e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CBS,Cystathionine beta-synthase,39575,-0.0522375507950449,0.00566084762224555,-0.0633328121346461,-0.0411422894554436,3.26632528953805e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,39512,-0.0364437001533024,0.00394966861940405,-0.0441850506473343,-0.0287023496592704,3.29501634468338e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42222,-0.0987074862232725,0.0107227378433509,-0.11972405239624,-0.0776909200503048,3.89206241325289e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39872,-0.0819686648949827,0.00891050473629781,-0.0994332541781264,-0.064504075611839,4.24316712007409e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41771,-0.0492830443468204,0.00536075175220053,-0.0597901177811334,-0.0387759709125073,4.37392771140205e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39869,-0.0518896531423337,0.00564458914659501,-0.0629530478696599,-0.0408262584150074,4.49713998880921e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OPHN1,Oligophrenin-1,39868,-0.109287845982819,0.0119025833410618,-0.1326169093313,-0.085958782634338,4.97537324950513e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42072,-0.0739604355107123,0.0080685634069706,-0.0897748197883746,-0.0581460512330499,5.58481144831452e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD69,Early activation antigen CD69,42009,-0.0880844122960279,0.00961942119163184,-0.106938477831626,-0.0692303467604295,6.10263291665637e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39869,-0.10861368125994,0.0118733128919536,-0.13188537452817,-0.0853419879917113,6.81217716831152e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL32,Interleukin-32,42048,0.0443573141136986,0.0048627169503017,0.0348263888911073,0.0538882393362899,8.41567733060625e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42137,-0.102611206839918,0.0112504894539979,-0.124662166169754,-0.0805602475100824,8.51090426320484e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CFH,Complement factor H,39356,-0.0234700136960606,0.00257318653393377,-0.0285134593025708,-0.0184265680895504,8.7694657086056e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRIP2,Cysteine-rich protein 2,41943,-0.0363207062064375,0.00398528931546537,-0.0441318732647496,-0.0285095391481254,9.08423590131239e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,39904,-0.0235330828816556,0.0025833253880501,-0.0285964006422337,-0.0184697651210774,9.65608441949854e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARSA,Arylsulfatase A,42063,-0.0449623127028458,0.00493996968639691,-0.0546446532881838,-0.0352799721175079,1.01235299480267e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,METAP2,Methionine aminopeptidase 2,42172,-0.055643169310147,0.00612060029735621,-0.0676395458929652,-0.0436467927273288,1.11437229333307e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEP20,Centrosomal protein 20,41771,-0.0750909504623569,0.00826066655422471,-0.0912818569086373,-0.0589000440160765,1.12846192529743e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,42063,-0.0497768739951856,0.00547623388724718,-0.0605102924141901,-0.0390434555761811,1.13104630379593e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTBS,Di-N-acetylchitobiase,39798,-0.0274833092696236,0.00302791077664771,-0.0334180143918531,-0.021548604147394,1.30657646551384e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41828,-0.0945485743670256,0.0104445299237535,-0.115019853017582,-0.0740772957164688,1.59119528564248e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,39597,-0.032122064455891,0.00355581103962713,-0.0390914540935601,-0.0251526748182218,1.93691423372299e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,39872,-0.0725107653975949,0.00802776642955053,-0.088245187599514,-0.0567763431956759,1.95054959211608e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,39675,-0.076430178449013,0.00846404799437337,-0.0930197125179848,-0.0598406443800412,2.00091558834336e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",41995,0.0423313479360845,0.0046926474627434,0.0331337589091075,0.0515289369630616,2.11850784217316e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,QDPR,Dihydropteridine reductase,42010,-0.0416911970845986,0.00462769465441372,-0.0507614786072495,-0.0326209155619477,2.35568319195965e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FAM3B,Protein FAM3B,41995,-0.0345472756329996,0.00385778688741512,-0.0421085379323333,-0.026986013333666,3.83302853589574e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,42187,0.0585377248045716,0.0065442344385825,0.0457110253049499,0.0713644243041933,4.19740830914604e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,39917,-0.0161995034502388,0.0018126255656629,-0.0197522495589381,-0.0126467573415395,4.61543990819602e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,41924,-0.0225423381341068,0.0025260065726588,-0.0274933110165181,-0.0175913652516956,5.07379675720348e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42048,-0.0644606103643995,0.00722636351178537,-0.0786242828474988,-0.0502969378813002,5.24878369485766e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,42056,-0.0746689646412246,0.00837267986248353,-0.0910794171716923,-0.0582585121107569,5.34503342706553e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42236,0.0277248708810861,0.0031126813458318,0.0216240154432558,0.0338257263189164,5.8951855841222e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42048,0.0385952841507683,0.00433387925235012,0.030100880816162,0.0470896874853745,5.98951165826999e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CNTN5,Contactin-5,42095,0.0361269677737245,0.0040645603273352,0.0281604295321475,0.0440935060153015,6.98375009788899e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,41915,-0.0360952804258423,0.00406371607074125,-0.0440601639244951,-0.0281303969271895,7.37717675567865e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADD1,Alpha-adducin,39675,-0.067930666303532,0.00766141826777269,-0.0829470461083665,-0.0529142864986975,8.69587441501162e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FETUB,Fetuin-B,42124,-0.0311760840946229,0.00352411608564199,-0.0380833516224812,-0.0242688165667646,1.0138137197367e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41924,-0.108327890404755,0.0122462491046471,-0.132330538649863,-0.0843252421596465,1.02188033875805e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39858,-0.0700808866092756,0.00792523480105885,-0.0856143468193509,-0.0545474263992002,1.07272205815873e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,41771,-0.0591950081612403,0.00669781269104093,-0.0723227210356805,-0.0460672952868001,1.09721837185924e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,41995,-0.0822864549905381,0.00931453110451173,-0.100542935955381,-0.0640299740256951,1.13228580365396e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39575,-0.0665839476856926,0.007536961283269,-0.0813563918008998,-0.0518115035704853,1.16027590609104e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42108,0.0225762636485566,0.0025720891935344,0.0175349688292291,0.027617558467884,1.87168316558486e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,41943,-0.0911184538463941,0.0104013358275609,-0.111505072068413,-0.0707318356243748,2.18046957808261e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,41828,-0.0467553428632388,0.00534048843956182,-0.05722270020478,-0.0362879855216977,2.28870217563482e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,41766,-0.0818152036943731,0.00935620618420871,-0.100153367815422,-0.0634770395733241,2.50956524549939e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,41766,-0.058942335758775,0.00674730985853802,-0.0721670630815096,-0.0457176084360405,2.71177449336898e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,41766,-0.0637349275573893,0.00730140788359729,-0.07804568700924,-0.0494241681055386,2.87256802610092e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39858,-0.0467569055585257,0.00536942838988323,-0.0572809852026968,-0.0362328259143546,3.52424970574784e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,39603,-0.0259898889903058,0.00299005010270857,-0.0318503871916146,-0.020129390788997,4.06124409411777e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,39904,0.0314001069812967,0.00361564796263031,0.0243134369745413,0.0384867769880522,4.32583421293361e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL5,C-C motif chemokine 5,42142,-0.0960622461872947,0.0110653531868285,-0.117750338433479,-0.0743741539411109,4.35352587581184e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39564,-0.0752385599367304,0.00868597726720119,-0.0922630753804447,-0.0582140444930161,5.28200662751181e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OGA,Protein O-GlcNAcase,39869,-0.0678663378709168,0.00783629015465706,-0.0832254665740447,-0.052507209167789,5.33510504037091e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,39868,-0.0589357574969626,0.00681478496895546,-0.0722927360361153,-0.0455787789578099,5.93836515008266e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,41842,-0.0662768716325501,0.00767077176422182,-0.0813115842904249,-0.0512421589746753,6.24997153294786e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,39597,-0.048877517150095,0.00566200200450429,-0.0599750410789234,-0.0377799932212666,6.82626709941866e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MGLL,Monoglyceride lipase,42092,-0.0825128355218363,0.00956978034050952,-0.101269604989235,-0.0637560660544376,7.29159130538968e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA4C,Semaphorin-4C,41995,0.026308591175654,0.00305383760428552,0.0203230694712544,0.0322941128800536,7.77469203121266e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNC,Tenascin,42142,0.0455622068982404,0.00529405606621626,0.0351858570084566,0.0559385567880243,8.36989394316456e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42114,0.0282908078100256,0.00328846805862563,0.0218454104151193,0.0347362052049318,8.61162631030656e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,39872,-0.0525499080931538,0.00611745698271308,-0.0645401237792715,-0.0405596924070362,9.82665593352886e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SRPK2,SRSF protein kinase 2,42048,-0.0802805815121613,0.00935233536150088,-0.098611158820703,-0.0619500042036196,1.01587126426411e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,41943,-0.0527077893887919,0.00615175655631335,-0.064765232239166,-0.0406503465384177,1.1683581492978e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTSZ,Cathepsin Z,42093,-0.030334782940464,0.0035421641277348,-0.0372774246308243,-0.0233921412501038,1.2081572411571e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42048,-0.0956206251214653,0.0111754740953302,-0.117524554348312,-0.0737166958946182,1.29068321878032e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADM,Pro-adrenomedullin,42187,-0.0244906757470758,0.00287394956511969,-0.0301236168947104,-0.0188577345994412,1.73784154198984e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,39868,-0.0599029358992915,0.00703176704171008,-0.0736851993010433,-0.0461206724975397,1.81525567406258e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AAMDC,Mth938 domain-containing protein,39575,-0.0495451228887645,0.00582197221487165,-0.060956188429913,-0.0381340573476161,1.96503597531022e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NIT1,Deaminated glutathione amidase,39575,-0.0414602697905884,0.00487770788266921,-0.0510205772406201,-0.0318999623405568,2.14208594606051e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,42111,-0.116787521310725,0.0137552805848839,-0.143747871257097,-0.0898271713643522,2.27277949700737e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,39869,-0.0717436077392894,0.00846251453041454,-0.0883301362189019,-0.0551570792596769,2.58020734385794e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL11,Eotaxin,42222,-0.0346583453366966,0.00409673219475956,-0.0426879404384253,-0.0266287502349678,2.94408276301663e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,42174,-0.063244633146243,0.0074814259508713,-0.0779082280099507,-0.0485810382825352,3.11144923337617e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,REG4,Regenerating islet-derived protein 4,42070,-0.0472719835817389,0.00559282261876875,-0.0582339159145257,-0.0363100512489521,3.14830351938568e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,39512,-0.0397102310194271,0.00470103818477508,-0.0489242658615863,-0.030496196177268,3.36436802355199e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STAB2,Stabilin-2,39904,-0.0260142101784691,0.00308233807043518,-0.032055592796522,-0.0199728275604161,3.566784433598e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,42111,-0.0988410140562317,0.0117222248688573,-0.121816574799192,-0.0758654533132714,3.74190054513843e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPT1,Angiopoietin-1,42011,-0.0772290263507591,0.00916621521449835,-0.0951948081711758,-0.0592632445303423,3.95837306182376e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLG,Plasminogen,39680,-0.0201648931246388,0.00239591232770972,-0.0248608812869499,-0.0154689049623278,4.36035596811907e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,39575,-0.0673630811722643,0.00801068307488077,-0.0830640199990306,-0.051662142345498,4.64049300214986e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39872,-0.0779775361441338,0.00927788227221445,-0.0961621853976741,-0.0597928868905935,4.80547171422328e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FOLR2,Folate receptor beta,42174,0.0268071225489101,0.00319183534985911,0.0205511252631862,0.0330631198346339,4.96083368489685e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",41972,-0.0697560633347525,0.00830755254357978,-0.0860388663201689,-0.0534732603493361,5.0505784221051e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,39512,-0.0579137345718012,0.00689641963851207,-0.0714307170632848,-0.0443967520803175,5.11849511993133e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL23,C-C motif chemokine 23,42111,-0.0388858503285874,0.00463251923764027,-0.0479655880343623,-0.0298061126228125,5.15795974194228e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,42111,-0.0787688578069227,0.00939754786855633,-0.0971880516292931,-0.0603496639845522,5.72128868780728e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",42050,-0.0871864078418897,0.0104238365197491,-0.107617127420598,-0.0667556882631815,6.64734160365383e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,39872,-0.0581489573781353,0.00695266223236536,-0.0717761753535714,-0.0445217394026991,6.80114619815037e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,S100A14,Protein S100-A14,39872,-0.0475862348959304,0.00569117418421558,-0.0587409362969929,-0.0364315334948678,6.92512348326268e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,39597,-0.0889503446487006,0.0106429659238585,-0.109810557859463,-0.0680901314379379,7.16675853445134e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,42048,0.0326997636983346,0.00391699377335615,0.0250224559025565,0.0403770714941126,7.60457833455165e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,41995,-0.0546943568194199,0.00656373680726773,-0.0675592809616647,-0.0418294326771751,8.6576020325035e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EGF,Pro-epidermal growth factor,42007,-0.0949424645946076,0.0114180258424172,-0.117321795245745,-0.0725631339434699,1.00415678918301e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,39869,-0.0436181958677049,0.00524569177845374,-0.0538997517534743,-0.0333366399819356,1.02239472220577e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLKB1,Plasma kallikrein,39698,-0.0222837775055836,0.00268492743710718,-0.0275462352823137,-0.0170213197288535,1.16570064850114e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42141,-0.0524681392379829,0.0063337172327961,-0.0648822250142633,-0.0400540534617026,1.30277784003589e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,41856,-0.0413095634892712,0.00499821592683734,-0.0511060667058724,-0.03151306027267,1.53065823150562e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDH17,Cadherin-17,42072,-0.0617926259356318,0.00747887508291859,-0.0764512210981522,-0.0471340307731113,1.56160036424831e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RNASE4,Ribonuclease 4,39584,-0.025183796657818,0.00305303390865757,-0.0311677431187869,-0.0191998501968492,1.78275356875471e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HPSE,Heparanase,39804,-0.0864837958209804,0.0104863406640847,-0.107037023522586,-0.0659305681193745,1.80126745431894e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39872,-0.0600348966230062,0.00728160063143301,-0.0743068338606149,-0.0457629593853975,1.83856728136159e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39575,0.0305489068888158,0.00371033734361992,0.0232766456953207,0.0378211680823108,2.0248883182593e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39869,-0.068493861543915,0.00832159895562075,-0.0848041954969317,-0.0521835275908984,2.06337929237143e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42048,-0.102168004114397,0.012418273463125,-0.126507820102122,-0.0778281881266718,2.09085415877222e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39675,-0.0521062503604434,0.00633181220012044,-0.0645166022726795,-0.0396958984482074,2.09431966230143e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42142,-0.0289091550600731,0.00352753038999174,-0.0358231146244569,-0.0219951954956893,2.72279590990474e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTSE,Cathepsin E,39675,-0.0477310270800397,0.00582923060626448,-0.0591563190683181,-0.0363057350917614,2.94191849713388e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGA,Fibrinogen alpha chain,39673,0.0278224294570404,0.00340500302857472,0.021148623521034,0.0344962353930468,3.38978151265717e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,39895,-0.0532524041099673,0.00653781363446623,-0.0660665188335211,-0.0404382893864135,4.18141023182153e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATXN2L,Ataxin-2-like protein,39872,-0.0431192949920932,0.00529446891662334,-0.0534964540686749,-0.0327421359155114,4.21943406583407e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,39872,-0.0844599830378871,0.0103835256195468,-0.104811693252199,-0.0641082728235754,4.58718583365271e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,42201,0.034022664698073,0.0041839189906531,0.0258221834763929,0.0422231459197531,4.59462258803097e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,39895,-0.0962285376646609,0.0118317988250974,-0.119418863361852,-0.0730382119674699,4.62379250236015e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AREG,Amphiregulin,41995,-0.0348678917624564,0.00429902424697923,-0.0432939792865357,-0.0264418042383771,5.47023005884474e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,41873,0.0343093662232963,0.00423123076517366,0.0260161539235559,0.0426025785230367,5.56708609581287e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,USO1,General vesicular transport factor p115,41995,-0.0792276656298073,0.00977448994593563,-0.0983856659238412,-0.0600696653357735,5.70337373222047e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPARCL1,SPARC-like protein 1,42095,0.0242798538076376,0.00299866599493944,0.0184024684575563,0.0301572391577189,6.11887759369841e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDCD5,Programmed cell death protein 5,42174,-0.0508712216470559,0.00629170058247511,-0.0632029547887072,-0.0385394885054047,6.71511321307635e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,39872,-0.105530754880326,0.0130537687860877,-0.131116141701058,-0.0799453680595938,6.88999960414891e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,39872,-0.0689639242743875,0.00853080257250442,-0.0856842973164962,-0.0522435512322788,6.90157342894313e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PXN,Paxillin,41766,-0.0455969620305602,0.00564315751040585,-0.0566575507509557,-0.0345363733101647,7.03551535387889e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42111,-0.0968122621265453,0.0119914479841859,-0.12031550017555,-0.073309024077541,7.4091197300183e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,42048,-0.0615102959795498,0.00761905591011381,-0.0764436455633728,-0.0465769463957267,7.42550277537605e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SNCA,Alpha-synuclein,39675,-0.104580575742241,0.0129543062621034,-0.129971016015964,-0.0791901354685188,7.56638913547502e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MTDH,Protein LYRIC,39597,-0.0843818013003461,0.010466222983989,-0.104895598348965,-0.0638680042517277,8.26326532934083e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,42048,-0.0379054045698121,0.00470442699556082,-0.0471260814811113,-0.0286847276585129,8.44736156870283e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,42063,-0.0233451466828777,0.00289941281475953,-0.0290279957998064,-0.017662297565949,8.84822073461736e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,P4HB,Protein disulfide-isomerase,42002,-0.0340749142339776,0.00424011273814179,-0.0423855352007355,-0.0257642932672196,1.00279170451501e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",41995,-0.0538217425429866,0.00669916253918473,-0.0669521011197886,-0.0406913839661845,1.0210892933002e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39904,0.0239980195039417,0.00298740713453358,0.0181427015202558,0.0298533374876275,1.04501407479058e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,41943,-0.0378632866058025,0.00471504771323632,-0.0471047801237457,-0.0286217930878593,1.05331988270365e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD200,OX-2 membrane glycoprotein,42048,0.0239353659320681,0.0029852853298016,0.0180842066856569,0.0297865251784792,1.16517073455628e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,39575,-0.0906338323683395,0.0113024212586954,-0.112786578035383,-0.0684810867012965,1.17460580525005e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FN1,Fibronectin,39917,-0.0239516004489194,0.00298715909249649,-0.0298064322702125,-0.0180967686276263,1.17868194956381e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DOK1,Docking protein 1,39868,-0.120722148861155,0.0150712882138839,-0.150261873760367,-0.091182423961942,1.25913269202199e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NCAN,Neurocan core protein,42174,0.0329659496542627,0.0041181174508469,0.0248944394506028,0.0410374598579227,1.29016720741459e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCN2,CCN family member 2,42072,-0.0495243711990628,0.00619907957525088,-0.0616745671665545,-0.0373741752315711,1.47043941985118e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41771,-0.0678764950703366,0.00850684708754362,-0.0845499153619221,-0.0512030747787512,1.59608727201031e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OPLAH,5-oxoprolinase,39575,-0.0607631163405834,0.00761833062712107,-0.0756950443697407,-0.0458311883114261,1.66287252253845e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39869,-0.0898784095903372,0.0112717760773703,-0.111971090701983,-0.0677857284786914,1.68777558363405e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,42236,-0.0628547149314232,0.00788871103470318,-0.0783165885594414,-0.0473928413034049,1.74443615132505e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42072,-0.0242736772685155,0.00305271123234039,-0.0302569912839026,-0.0182903632531283,1.98848747355615e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,39674,-0.0576825458900915,0.00725822542303667,-0.0719086677192433,-0.0434564240609396,2.09275360967122e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,41995,-0.0285349286629232,0.00359487512094053,-0.0355808838999666,-0.0214889734258797,2.22326100172966e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42048,-0.090845994756672,0.0114494827326099,-0.113286980912587,-0.0684050086007566,2.27969446709374e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,41771,-0.0550991113084306,0.00695251785684584,-0.0687260463078485,-0.0414721763090128,2.46291160932396e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42111,-0.0258496008375021,0.00326472160610896,-0.0322484551854757,-0.0194507464895286,2.60405256070869e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,41943,-0.0500752971695266,0.00633324809243844,-0.062488463430706,-0.0376621309083473,2.84903804706302e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PF4,Platelet factor 4,39852,-0.0845918726705528,0.010698893959346,-0.105561704830871,-0.0636220405102346,2.8921068513723e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GTPBP2,GTP-binding protein 2,39590,-0.0713416580662615,0.00902453470963318,-0.0890297460971426,-0.0536535700353805,2.92846488145847e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATXN3,Ataxin-3,39868,-0.0529505720204236,0.00670253538968475,-0.0660875413842057,-0.0398136026566415,3.04618938259536e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SIAE,Sialate O-acetylesterase,42074,-0.0404011790002174,0.00511545760422169,-0.0504274759044919,-0.0303748820959428,3.0559984625566e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COCH,Cochlin,39895,-0.0397621857536534,0.00504169282563165,-0.0496439036918914,-0.0298804678154154,3.38910860947054e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MITD1,MIT domain-containing protein 1,41943,-0.0834294130934341,0.01059501888261,-0.10419565010335,-0.0626631760835185,3.6872306219379e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41752,-0.0511661111403665,0.00649771206109812,-0.0639016267801188,-0.0384305955006141,3.68879563402454e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,41828,-0.0822646827352434,0.0104526513412328,-0.10275187936406,-0.061777486106427,3.81434026666676e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,39597,-0.0781609681158529,0.00997054475547353,-0.097703235836581,-0.0586187003951248,4.9533399511416e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,39869,-0.0718671171294395,0.00917060929523107,-0.0898415113480924,-0.0538927229107866,5.04200686722597e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COMT,Catechol O-methyltransferase,41668,-0.0717468792319136,0.00915753690108508,-0.0896956515580403,-0.0537981069057868,5.06009820606125e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,42063,0.0340956845446452,0.00435544389305551,0.0255590145142564,0.042632354575034,5.31348064181929e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42072,-0.0539393960544816,0.00689403823965929,-0.0674517110042138,-0.0404270811047494,5.49400096477436e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GOLM2,Protein GOLM2,42174,-0.0195157610635911,0.00249877588318215,-0.0244133617946282,-0.0146181603325541,6.13056326373682e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39869,-0.0257381789010767,0.00329720617089089,-0.0322007029960229,-0.0192756548061306,6.42238658292865e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDGFC,Platelet-derived growth factor C,41771,-0.0239440318809072,0.00307218015469957,-0.0299655049841184,-0.017922558777696,6.98718105066626e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42011,-0.01713460321605,0.00219893835330607,-0.0214445223885299,-0.0128246840435701,7.06719388740483e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,42174,-0.0491396846605822,0.00630781122356479,-0.0615029946587692,-0.0367763746623952,7.16916124027633e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,39895,-0.0782451868045959,0.0100486959399909,-0.0979406308469781,-0.0585497427622137,7.48479216041199e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42108,-0.0519730406661488,0.00668204213340463,-0.0650698432476219,-0.0388762380846757,7.89920512380536e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCN4,CCN family member 4,42187,-0.0333796288148005,0.00430244477618638,-0.0418124205761258,-0.0249468370534752,9.21977186179649e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SEC31A,Protein transport protein Sec31A,39575,-0.0660015161334256,0.00850820953220656,-0.0826776068165504,-0.0493254254503007,9.43757494476534e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MYDGF,Myeloid-derived growth factor,39895,-0.0848300538837105,0.0109391070997539,-0.106270703799228,-0.0633894039681928,9.61191663046751e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",41766,-0.0454552414571344,0.00586921628018598,-0.056958905366299,-0.0339515775479699,1.02802553563002e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,39590,-0.0596199023361496,0.00769805569654182,-0.0747080915013716,-0.0445317131709276,1.04147118707105e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTRB1,Chymotrypsinogen B,42063,-0.0495772771888245,0.00640552506423019,-0.0621321063147156,-0.0370224480629333,1.06675279355967e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AGT,Angiotensinogen,39927,-0.0184817587894883,0.00239372471767259,-0.0231734592361265,-0.01379005834285,1.25207067615287e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,39597,0.0274794002700721,0.00356359593808051,0.0204947522314343,0.0344640483087099,1.35454882183201e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,39675,-0.0569739295039168,0.00739589153541177,-0.0714698769133238,-0.0424779820945097,1.43731820910441e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LPP,Lipoma-preferred partner,39512,-0.055898555735802,0.00726429725892083,-0.0701365783632868,-0.0416605331083171,1.53731883875133e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39868,-0.0704398945196471,0.00915795789772507,-0.0883894919991882,-0.0524902970401059,1.57332587172889e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GMPR,GMP reductase 1,42222,-0.0401613597658604,0.00522281109964866,-0.0503980695211718,-0.029924650010549,1.57679081199983e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CA4,Carbonic anhydrase 4,42236,0.0204716586343341,0.00266225976595514,0.015253629493062,0.0256896877756062,1.57700732794462e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRKL,Crk-like protein,42069,-0.0887858054775544,0.0115696702389818,-0.111462359145959,-0.06610925180915,1.78131982341513e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,42048,-0.0504040952368857,0.00657277372553549,-0.0632867317389353,-0.0375214587348362,1.85770359027014e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,JAM3,Junctional adhesion molecule C,39675,-0.042915187754261,0.00559805602510176,-0.0538873775634604,-0.0319429979450615,1.92151324073126e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ESYT2,Extended synaptotagmin-2,39868,-0.0702596302526706,0.00916633424262693,-0.0882256453682194,-0.0522936151371218,1.93565242818198e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,41771,-0.0764081394914558,0.00997075884443775,-0.0959508268265538,-0.0568654521563578,1.93982018740001e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CHAD,Chondroadherin,39675,0.0394682964238205,0.00514928895540954,0.0293756900712178,0.0495609027764232,1.94070789269124e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,39675,-0.057146065066725,0.00745652791887823,-0.0717608597877264,-0.0425312703457237,1.95440779963016e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,39512,-0.0559568215985865,0.00731671565826212,-0.0702975842887803,-0.0416160589083927,2.21630497207461e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MBL2,Mannose-binding protein C,39764,0.0923962794488954,0.0120836342892667,0.0687123562419327,0.116080202655858,2.23649843279297e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,42174,-0.0526809875494109,0.00690167190175091,-0.0662082644768427,-0.0391537106219791,2.44481386995345e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42174,0.0233868380136944,0.00306561500000122,0.017378232613692,0.0293954434136968,2.52772047037786e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42048,-0.0801940479788281,0.0105265482394573,-0.100826082528164,-0.0595620134294918,2.74256161944296e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,39597,-0.0463318760826981,0.00608623740892775,-0.0582609014041965,-0.0344028507611997,2.90707801184768e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLXNB3,Plexin-B3,42026,-0.0401440437225819,0.00528386315806842,-0.050500415512396,-0.0297876719327678,3.21907330387361e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,42072,0.0327258734464816,0.00430973042972189,0.0242788018042267,0.0411729450887365,3.31877454838924e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,42032,-0.0531961973902842,0.00701142392764073,-0.06693858828846,-0.0394538064921084,3.48701631307129e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,39575,-0.051661859305243,0.00680878384744339,-0.065007075646232,-0.0383166429642539,3.52449591236376e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD36,Platelet glycoprotein 4,39597,-0.038761726596754,0.00511021474712795,-0.0487777475011248,-0.0287457056923832,3.58903209099987e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GZMA,Granzyme A,42222,-0.0282546341219737,0.00372638464012261,-0.035558348016614,-0.0209509202273334,3.61355135355375e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GMPR2,GMP reductase 2,39675,-0.0553535642726102,0.00730818529013462,-0.0696776074412741,-0.0410295211039464,3.90152296769858e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EGLN1,Egl nine homolog 1,42048,-0.0463780584084452,0.00614700745170485,-0.0584261930137867,-0.0343299238031037,4.8196541830891e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DNMBP,Dynamin-binding protein,41943,-0.0502016578901258,0.00666006333319596,-0.0632553820231899,-0.0371479337570618,5.09084901160252e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DLG4,Disks large homolog 4,39868,-0.0595321926416182,0.00792066080696139,-0.0750566878232626,-0.0440076974599739,6.07279281041755e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,39575,-0.0518544315799526,0.00689944854035292,-0.0653773507190443,-0.0383315124408609,6.09981421129651e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,39675,-0.0596268788039167,0.00793871848016758,-0.0751867670250452,-0.0440669905827883,6.32424544681915e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42057,-0.046756595031098,0.00623163691397467,-0.0589706033824884,-0.0345425866797077,6.62319946806134e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STAMBP,STAM-binding protein,41924,-0.0518072341587043,0.00690913330378394,-0.0653491354341208,-0.0382653328832877,6.86972763346212e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TADA3,Transcriptional adapter 3,39858,-0.0333569636108225,0.00444886487092135,-0.0420767387578283,-0.0246371884638167,6.97404976852453e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINE2,Glia-derived nexin,39895,-0.0534166919795001,0.00713006204089286,-0.0673916135796501,-0.0394417703793501,7.30277117885968e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39872,-0.087706336296971,0.0117167295193177,-0.110671126154834,-0.0647415464391082,7.65484270345074e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,39696,-0.0443653942565489,0.00593459261536896,-0.0559971957826721,-0.0327335927304258,8.25618402490553e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42063,-0.0247989906138486,0.00332130393302613,-0.0313087463225798,-0.0182892349051174,8.73194052854465e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C4BPB,C4b-binding protein beta chain,42108,0.0313273004566291,0.00419696366592637,0.0231012516714134,0.0395533492418447,8.88783189362999e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,42048,0.0430460935046456,0.00576994539459134,0.0317370005312466,0.0543551864780447,9.15473152691732e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39575,-0.0620899163820103,0.00832125063611042,-0.0783995676287867,-0.0457802651352338,9.19344187114519e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,42108,-0.0205435489225932,0.00275605767016356,-0.0259454219561138,-0.0151416758890726,9.60844474885592e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,42108,-0.0224058424333986,0.00301377159874416,-0.0283128347669371,-0.01649885009986,1.11289811864085e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ASPN,Asporin,39895,0.02267612749118,0.00306078987523352,0.0166769793357223,0.0286752756466377,1.36753460453225e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EBI3_IL27,Interleukin-27,42172,0.024878103980306,0.00336091341427059,0.0182907136883356,0.0314654942722763,1.4184044466617e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OPTC,Opticin,41995,0.0369360561361025,0.00499292280061901,0.0271499274468893,0.0467221848253158,1.4682314812043e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,WASHC3,WASH complex subunit 3,39868,-0.0616839092806912,0.00834821292281659,-0.0780464066094118,-0.0453214119519707,1.58544710327169e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,S100G,Protein S100-G,39872,0.0396551857114141,0.00537794194723163,0.0291144194948401,0.0501959519279881,1.77624047665296e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BIN2,Bridging integrator 2,42063,-0.0721850840678444,0.00979894033774917,-0.0913910071298327,-0.052979161005856,1.85185363994697e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EREG,Proepiregulin,41924,-0.064704708485624,0.00880417743565191,-0.0819608962595018,-0.0474485207117463,2.10819735702142e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,39917,-0.02517399199471,0.00342779227900744,-0.0318924648615646,-0.0184555191278555,2.21401272788146e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TBCC,Tubulin-specific chaperone C,41943,-0.0647736535507544,0.00882298960478326,-0.0820667131761296,-0.0474805939253792,2.23502657649651e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39575,-0.0304762191129653,0.00415232442532817,-0.0386147749866085,-0.0223376632393221,2.29454752051907e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APOM,Apolipoprotein M,42124,0.0227723947222089,0.0031053207525107,0.0166859660472879,0.0288588233971299,2.37235094808887e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,41766,-0.0444914899960268,0.00607605184922023,-0.0564005516204985,-0.0325824283715552,2.57656228005853e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FABP5,Fatty acid-binding protein 5,42145,-0.0535032421839151,0.00730963858773518,-0.067830133815876,-0.0391763505519542,2.6282410599707e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,42174,0.0228364145550417,0.00312167871346729,0.0167179242766458,0.0289549048334375,2.7094992708513e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42155,0.0154384646632166,0.00211104688607698,0.0113008127665057,0.0195761165599274,2.7552680662865e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,39453,-0.0426017381918958,0.00584487275292656,-0.0540576887876319,-0.0311457875961597,3.34630398608649e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,41995,0.0214005493726386,0.002938617665825,0.0156408587476216,0.0271602399976556,3.45923606057362e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",39652,-0.0689434107705272,0.00947665534824076,-0.0875176552530791,-0.0503691662879753,3.69667854435391e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,39858,-0.0495604908218417,0.00681261359059315,-0.0629132134594043,-0.0362077681842792,3.69949093517429e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,39679,-0.0366120815750412,0.00504774582280839,-0.0465056633877457,-0.0267184997623368,4.34347896388861e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,39512,-0.0536347274914528,0.00739604470863268,-0.0681309751203729,-0.0391384798625328,4.39087639191869e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RRAS,Ras-related protein R-Ras,39590,-0.104785694318462,0.0144641006014269,-0.133135331497259,-0.0764360571396657,4.62982618121641e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39575,-0.0771121033307675,0.0106447270680207,-0.0979757683840881,-0.0562484382774468,4.64303683423273e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,42222,-0.0531137644916724,0.00733823520974856,-0.0674967055027796,-0.0387308234805653,4.79906876068423e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DBNL,Drebrin-like protein,42111,-0.0736083195670192,0.0101725034778789,-0.0935464263836619,-0.0536702127503765,4.86997991955149e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPBP,Platelet basic protein,39846,-0.0680673751386211,0.00940597354149051,-0.0865030832799425,-0.0496316669972997,4.89987826747834e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,39927,-0.0380293359270136,0.00525986615708509,-0.0483386735949003,-0.0277199982591268,5.13735781757072e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,41995,-0.0425891078696081,0.00589334081154698,-0.0541400558602402,-0.0310381598789761,5.21845470996851e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39872,-0.0622149400288428,0.00860932737317262,-0.0790892216802611,-0.0453406583774245,5.27775787294834e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NPL,N-acetylneuraminate lyase,39895,-0.0368583782586508,0.0051009663036466,-0.0468562722137982,-0.0268604843035035,5.30397602689675e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DDT,D-dopachrome decarboxylase,39904,-0.032215571659605,0.00446306778604549,-0.0409631845202541,-0.0234679587989558,5.60337523057472e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,41995,0.0311841316383536,0.00432346804803658,0.0227101342642019,0.0396581290125053,5.777369990372e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42111,-0.0311938574882097,0.00432688628453942,-0.039674554605907,-0.0227131603705125,5.92242080596821e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OCLN,Occludin,39872,-0.0349714659805725,0.00486259518643325,-0.0445021525459817,-0.0254407794151633,6.79265461855801e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39869,-0.115342078637971,0.0160425437345867,-0.146785464357761,-0.0838986929181815,6.90120108384823e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RAB10,Ras-related protein Rab-10,39895,-0.0422826209777305,0.00588230232045597,-0.0538119335258242,-0.0307533084296368,6.98398292137489e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39868,-0.0502410854866813,0.00699501703574171,-0.0639513188767351,-0.0365308520966276,7.28102817589464e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BCAM,Basal cell adhesion molecule,42063,0.019326122422118,0.00269681044588073,0.0140403739481918,0.0246118708960443,8.10688481445814e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,41995,-0.091917674852355,0.0128320119956979,-0.117068418363923,-0.0667669313407871,8.29594401779211e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,42025,0.0508927278738505,0.00710510670945913,0.0369667187233106,0.0648187370243904,8.31406922599397e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FUS,RNA-binding protein FUS,41759,-0.0312860687807298,0.00436914260900805,-0.0398495882943855,-0.022722549267074,8.45363162047999e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,41828,-0.0573936111583788,0.00801891420099246,-0.073110682992324,-0.0416765393244335,8.66328017229503e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39675,-0.0824636901677868,0.0115250198760282,-0.105052729124802,-0.0598746512107716,8.88378614350658e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NUCB2,Nucleobindin-2,42156,-0.0294592619167595,0.00411879686082329,-0.0375321037639731,-0.0213864200695458,8.96498494613245e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41828,-0.0450145575102776,0.00629460702442632,-0.0573519872781531,-0.032677127742402,9.0483908258248e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42174,-0.0272288296440649,0.00380883938959944,-0.0346941548476798,-0.01976350444045,9.19789296853333e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42088,-0.0551522455245835,0.00771966667272041,-0.0702827922031155,-0.0400216988460515,9.50406959275922e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TALDO1,Transaldolase,39886,-0.0347009522231085,0.00485632961109692,-0.0442193582608585,-0.0251825461853586,9.5188784569407e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41828,-0.0437161054754993,0.00611997724431461,-0.0557112608743559,-0.0317209500766426,9.59658179776698e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,39872,-0.0601885647054376,0.00842624480391164,-0.0767040045211044,-0.0436731248897708,9.69516964252759e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,42072,-0.101052829835476,0.0141861419053015,-0.128857667969867,-0.0732479917010849,1.10684168776618e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CR1,Complement receptor type 1,39907,0.0277227741952927,0.00389506879085508,0.0200884393652168,0.0353571090253687,1.16638629086837e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,39597,-0.0614515804181848,0.00863731130934797,-0.0783807105845069,-0.0445224502518628,1.19163042368583e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MMP1,Interstitial collagenase,41620,-0.0705808571664875,0.00992322184694388,-0.0900303719864975,-0.0511313423464775,1.19744959176054e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COMMD1,COMM domain-containing protein 1,39575,-0.0477386692641266,0.00671218779976933,-0.0608945573516745,-0.0345827811765788,1.21284307239608e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39872,-0.0611696653897961,0.00861633199592473,-0.0780576761018086,-0.0442816546777837,1.32957760089664e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,42063,0.0220520785217187,0.00310977107905256,0.0159569272067757,0.0281472298366617,1.39564614510833e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42092,0.0611146214063266,0.00863062488261259,0.044198596636406,0.0780306461762473,1.50055475913274e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,39904,0.0170593923326732,0.0024100786666917,0.0123356381459575,0.021783146519389,1.5451664322728e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,39635,0.0267837084543072,0.00378517001775942,0.0193647752194988,0.0342026416891157,1.57417908345668e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41771,-0.0760980445487396,0.0107596353875271,-0.0971869299082927,-0.0550091591891866,1.59793038690244e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DAB2,Disabled homolog 2,42187,-0.0861137646679829,0.0121839649176549,-0.109994335906587,-0.0622331934293792,1.65092725462232e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42072,0.0620930274860705,0.00879176753162875,0.0448611631240781,0.0793248918480628,1.71391267677873e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39869,-0.0218878081056335,0.00309870174472395,-0.0279612635252925,-0.0158143526859746,1.71875877162335e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LEPR,Leptin receptor,42072,0.0243186017405514,0.00344490448528216,0.0175665889493984,0.0310706145317045,1.75541501893455e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FEN1,Flap endonuclease 1,41771,-0.0499472968747371,0.00708083385548019,-0.0638257312314783,-0.036068862517996,1.82698085737372e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,41842,-0.0460311419288279,0.00652789759842017,-0.0588258212217314,-0.0332364626359244,1.85847121315344e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42222,-0.0427666772762371,0.00606970238628332,-0.0546632939533524,-0.0308700605991218,1.93082727264678e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,39872,-0.0511714356637671,0.00727017609245692,-0.0654209808049827,-0.0369218905225516,2.05543795413919e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DPEP1,Dipeptidase 1,41924,0.0354559878062269,0.00504038032266272,0.025576842373808,0.0453351332386459,2.09909158042285e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,42108,-0.0428202851392962,0.0060908653048756,-0.0547583811368524,-0.0308821891417401,2.16070603880116e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42063,-0.0592684443014068,0.00843613839439485,-0.0758032755544207,-0.0427336130483929,2.23485556265311e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,42066,-0.0304431846295955,0.00433425421147401,-0.0389383228840845,-0.0219480463751064,2.26185383167166e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,39858,-0.0663838174176457,0.00946966240987537,-0.0849443557410015,-0.04782327909429,2.51669656530093e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IMPACT,Protein IMPACT,39868,-0.0417653235673243,0.00595948984706527,-0.0534459236675722,-0.0300847234670764,2.55177411057952e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CFC1,Cryptic protein,41771,-0.0368353841966151,0.00526561435993215,-0.0471559883420821,-0.026514780051148,2.771671095602e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,THBS2,Thrombospondin-2,42063,-0.0295920576124442,0.00423483885294607,-0.0378923417642185,-0.0212917734606699,2.92436909338381e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41765,-0.0609789025241966,0.00873287137013088,-0.0780953304096531,-0.0438624746387401,3.03483132682345e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APCS,Serum amyloid P-component,39808,-0.0248733655478393,0.00356430951260313,-0.0318594121925414,-0.0178873189031372,3.15289905876302e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,42236,-0.0309186519296768,0.0044356469325534,-0.0396125199174815,-0.0222247839418722,3.30347017728094e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TBC1D23,TBC1 domain family member 23,41995,-0.0689119130946151,0.00990301753763961,-0.0883218274683887,-0.0495019987208414,3.59449716703126e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,39675,0.0227646618282508,0.003275475961322,0.0163447289440597,0.0291845947124419,3.85726249547915e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42072,-0.0615088751325075,0.00885572245973716,-0.0788660911535923,-0.0441516591114226,3.93965018152437e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPARC,SPARC,42108,-0.0533827844809832,0.00768823254205435,-0.0684517202634097,-0.0383138486985567,4.00149694596418e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL4,C-C motif chemokine 4,42074,-0.0473816784757269,0.00683438449619638,-0.0607770720882718,-0.033986284863182,4.31262682185906e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD226,CD226 antigen,39597,-0.0323412005327173,0.00467888039436626,-0.0415118061056751,-0.0231705949597594,5.03736277969726e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,39579,-0.0646353700398616,0.00936456380449297,-0.0829899150966678,-0.0462808249830554,5.40560375727662e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RWDD1,RWD domain-containing protein 1,42174,-0.0472216852617239,0.0068449196702211,-0.0606377278153572,-0.0338056427080905,5.47699744747586e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,42236,0.0177543239730926,0.00257656306711277,0.0127042603615516,0.0228043875846336,5.79554569686557e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EHD3,EH domain-containing protein 3,39575,-0.0894814168205957,0.0129879100845771,-0.114937720586367,-0.0640251130548245,5.90161225105413e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATOX1,Copper transport protein ATOX1,42108,-0.0537998077741652,0.00781939072465952,-0.0691258135944978,-0.0384738019538325,6.23548272080172e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CASP10,Caspase-10,41766,-0.0539692586589879,0.00784834819155847,-0.0693520211144426,-0.0385864962035333,6.41034226433082e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,39904,-0.0297322456217261,0.00432631758409341,-0.0382118280865492,-0.021252663156903,6.64447342084657e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IMMT,MICOS complex subunit MIC60,39858,-0.0336239286438531,0.00489513949590233,-0.0432184020558217,-0.0240294552318846,6.8137829050765e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42164,-0.0488293377521061,0.00711022478690212,-0.0627653783344343,-0.034893297169778,6.81904702515544e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LARP1,La-related protein 1,39858,-0.0470030762851141,0.00685122095089585,-0.06043146934887,-0.0335746832213583,7.2199031253126e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VNN1,Pantetheinase,39927,-0.0551482493473515,0.00804248466376623,-0.0709115192883333,-0.0393849794063697,7.39199789331649e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITGAV,Integrin alpha-V,42187,0.0125394794863354,0.00182916523500296,0.00895431562572962,0.0161246433469412,7.42335328073243e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCGN,Secretagogin,41842,-0.0334072989766425,0.00487430318565896,-0.042960933220534,-0.0238536647327509,7.51185266494351e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATG4A,Cysteine protease ATG4A,41771,-0.0437993044382764,0.00640181762654402,-0.0563468669863027,-0.0312517418902501,8.17186543370528e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APP,Amyloid-beta precursor protein,42038,-0.0496878962848821,0.00726700347199141,-0.0639312230899853,-0.0354445694797789,8.4087438087715e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EPO,Erythropoietin,42048,-0.0547982281461761,0.00801840088183112,-0.0705142938745651,-0.0390821624177871,8.61005487760547e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ZNRD2,Protein ZNRD2,39869,-0.0523391142940325,0.0076649212551506,-0.0673623599541276,-0.0373158686339373,9.02852027141035e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,39872,-0.0467786938905925,0.00686777722554014,-0.0602395372526512,-0.0333178505285338,1.01622452055652e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,41890,-0.0878019410578979,0.0129015689967999,-0.113089016291626,-0.06251486582417,1.04998659260418e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42072,0.0240532949239791,0.00353955980340343,0.0171157577093084,0.0309908321386498,1.12427385696739e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,41766,-0.0465103606040752,0.00684454611429306,-0.0599256709880896,-0.0330950502200608,1.12781769852881e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42092,-0.0389192897621749,0.00573124585960772,-0.0501525316470061,-0.0276860478773438,1.16244810894558e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,YJU2,Splicing factor YJU2,39858,-0.0246880938833077,0.00363830695144187,-0.0318191755081338,-0.0175570122584816,1.21407946084498e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42056,-0.0921641149878458,0.0136088964458917,-0.118837552021794,-0.0654906779538979,1.3197413294041e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AMN,Protein amnionless,41842,-0.0351081823231104,0.00518479685988439,-0.0452703841684838,-0.024945980477737,1.32948253629656e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TWF2,Twinfilin-2,39904,-0.0633901669400935,0.00936057192403529,-0.0817368879112027,-0.0450434459689843,1.33275267907088e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DBI,Acyl-CoA-binding protein,42011,-0.0578087905408068,0.00855300319353424,-0.0745726768001339,-0.0410449042814797,1.44802020168444e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LAMB1,Laminin subunit beta-1,39575,-0.023316975784513,0.00345273063378176,-0.0300843278267252,-0.0165496237423007,1.51929336950429e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,39868,-0.0739555377350836,0.0109586981326564,-0.0954345860750901,-0.052476489395077,1.56634711610299e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,39590,-0.0588964582591822,0.00872796723610839,-0.0760032740419547,-0.0417896424764098,1.57421557732474e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGF23,Fibroblast growth factor 23,42175,-0.0374765713493116,0.00556077870078722,-0.0483756976028546,-0.0265774450957687,1.65407111887376e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,41943,-0.0583515551375254,0.0086721428840749,-0.0753489551903122,-0.0413541550847386,1.78268968263174e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42093,-0.088268818873289,0.0131361668515852,-0.114015705902396,-0.0625219318441819,1.8963228143461e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,39597,-0.0430832671726255,0.00641370530522072,-0.0556541295708581,-0.0305124047743929,1.94161338346888e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NUDC,Nuclear migration protein nudC,42222,-0.0468065026908336,0.00697498912705724,-0.0604774813798658,-0.0331355240018015,2.01460219367273e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,39869,-0.0299686903297714,0.00446840262592847,-0.0387267594765912,-0.0212106211829516,2.08455416918373e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,41842,0.0290579811921303,0.00433337557835409,0.0205645650585563,0.0375513973257044,2.08684877594695e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FCN2,Ficolin-2,42041,-0.0298516530182639,0.00445295870998323,-0.038579452089831,-0.0211238539466967,2.11202524700707e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CASP7,Caspase-7,39868,-0.0622317735081548,0.00929425537480331,-0.0804485140427693,-0.0440150329735404,2.24807783835497e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,THTPA,Thiamine-triphosphatase,39836,-0.0645725776231221,0.0096546063440758,-0.0834956060575107,-0.0456495491887335,2.36549000412105e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39696,-0.0366258496043683,0.00547842357304311,-0.0473635598075328,-0.0258881394012038,2.41228636076246e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,39827,0.0199913915688972,0.00299720132112106,0.0141168769794999,0.0258659061582945,2.67787140523306e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,41766,-0.0215778660346778,0.00323602900632759,-0.0279204828870799,-0.0152352491822757,2.69645038155261e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FBLN2,Fibulin-2,39904,0.0235139803979408,0.00352811741835511,0.0165988702579647,0.0304290905379168,2.77469124081116e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RFC4,Replication factor C subunit 4,39858,-0.0162481773722773,0.00243980598713133,-0.0210301971070547,-0.0114661576374999,2.87322585872747e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PALM2,Paralemmin-2,39868,-0.0282695869550605,0.00424494247482813,-0.0365896742057236,-0.0199494997043974,2.87361918533991e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TSPAN8,Tetraspanin-8,39869,-0.0695808414126634,0.0104651525617236,-0.0900925404336416,-0.0490691423916853,3.09121593997437e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41828,0.0161210254329394,0.00242907474089593,0.0113600389407833,0.0208820119250954,3.33298456731746e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,39872,-0.0558531439955852,0.0084147543823184,-0.0723460625849293,-0.0393602254062412,3.33632359960556e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42111,-0.0284569893950886,0.00428871068418347,-0.0368628623360882,-0.020051116454089,3.36127478564495e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,39872,-0.0486528004850671,0.00733144149577659,-0.0630224258167892,-0.034283175153345,3.36666858153652e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39858,-0.0611672120652883,0.00921962054197321,-0.0792376683275558,-0.0430967558030208,3.40628197029251e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SH3GLB2,Endophilin-B2,39868,-0.0479182655065579,0.00722742557613055,-0.0620840196357737,-0.033752511377342,3.50885449342841e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,41967,0.0157875714685885,0.00238760351610984,0.0111078685770132,0.0204672743601638,3.92748888225131e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NECTIN2,Nectin-2,42056,-0.0224475488914154,0.00339567907277843,-0.0291030798740611,-0.0157920179087696,3.97139335881123e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39858,-0.0783912708233405,0.0118695755924258,-0.101655638984495,-0.0551269026621859,4.17143517990017e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42136,0.0173926360426283,0.00263544429164418,0.0122271652310057,0.0225581068542509,4.27880876328835e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,42030,-0.0815624482675217,0.0123641982996533,-0.105796276934842,-0.0573286196002011,4.36268155373524e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DLL1,Delta-like protein 1,42108,0.0222469875978605,0.0033734659018013,0.01563499443033,0.0288589807653911,4.41973769723436e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARSB,Arylsulfatase B,41995,-0.0402077036619365,0.00610518233779769,-0.0521738610440199,-0.028241546279853,4.69225194157713e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42063,0.0323453820303601,0.00491579878325433,0.0227104164151816,0.0419803476455386,4.8823354237083e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42063,-0.0278948705561085,0.00424295264628388,-0.0362110577428249,-0.0195786833693921,5.06505142100676e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42222,-0.0280051927098713,0.00425994374005689,-0.0363546824403828,-0.0196557029793598,5.07394731444398e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,39868,-0.0387523892164318,0.00589645631264238,-0.0503094435892109,-0.0271953348436528,5.17826671451603e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42048,-0.042502667055084,0.00647609896898543,-0.0551958210342955,-0.0298095130758726,5.46672401867397e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39858,-0.0255374249255514,0.00389056513730714,-0.0331629325946734,-0.0179119172564294,5.47083786710066e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATP6AP2,Renin receptor,41771,-0.0282894566294013,0.00432088839874598,-0.0367583978909434,-0.0198205153678591,6.08245435566867e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MINK1,Misshapen-like kinase 1,39868,-0.066912843836348,0.010239576061122,-0.0869824129161471,-0.046843274756549,6.64739256028982e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,42048,-0.0290612148843724,0.00444992094393735,-0.0377830599344896,-0.0203393698342552,6.78041640154321e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,39513,0.0453396229739615,0.00694439070309208,0.031728617195901,0.058950628752022,6.91706028978043e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,39590,-0.0522938446489511,0.00801485186916604,-0.0680029543125165,-0.0365847349853856,7.11730001236252e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,39575,-0.0655313060271938,0.010045886155329,-0.0852212428916385,-0.045841369162749,7.18517665277123e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SAA4,Serum amyloid A-4 protein,39917,-0.0235433776618268,0.00361123561874826,-0.0306213994745734,-0.0164653558490802,7.35532115519813e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DNM3,Dynamin-3,39872,-0.0395410144047973,0.00607195145057537,-0.0514420392479251,-0.0276399895616696,7.72706239594992e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39895,-0.0635277987146644,0.00976012986362582,-0.082657653247371,-0.0443979441819578,7.89045880480224e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GLO1,Lactoylglutathione lyase,41828,-0.0402954337307928,0.00620586966997501,-0.0524589382839438,-0.0281319291776418,8.70820822351792e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MIF,Macrophage migration inhibitory factor,42032,-0.0476104183030368,0.00734846713239312,-0.0620134138825273,-0.0332074227235462,9.55776779376692e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,41943,0.036434566205252,0.00562475379349701,0.0254100487699978,0.0474590836405061,9.64999891102872e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,42236,0.0192389448452591,0.00297319879490085,0.0134114752072535,0.0250664144832648,1.0082272918564e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACHE,Acetylcholinesterase,39675,-0.0243832477863053,0.00377060208317273,-0.0317736278693238,-0.0169928677032867,1.04402738755994e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42063,0.0369700115021062,0.00572216733969556,0.0257545635163028,0.0481854594879095,1.07704727497721e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42174,-0.0328970124762599,0.00509524844128561,-0.0428836994211797,-0.0229103255313401,1.10863633837249e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,41943,-0.0662864955948413,0.0102697646665851,-0.0864152343413482,-0.0461577568483344,1.12309675730794e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TSNAX,Translin-associated protein X,39512,-0.0278893635442668,0.00432800288815275,-0.0363722492050462,-0.0194064778834874,1.21322663720449e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39597,-0.0392608715285618,0.00609325983207847,-0.0512036607994356,-0.027318082257688,1.21767456533722e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,39869,-0.0455116071646819,0.00708085166114162,-0.0593900764205195,-0.0316331379088443,1.35028011705103e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,39895,-0.0342005651344671,0.00532475049021768,-0.0446370760952937,-0.0237640541736404,1.3903425739404e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,41984,-0.0333533860856088,0.00519461290078628,-0.0435348273711499,-0.0231719448000677,1.40169418030315e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,39512,-0.0468309500613366,0.00731195328236382,-0.0611623784947697,-0.0324995216279035,1.5685129579269e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39869,-0.0624561256224986,0.0097563259637285,-0.0815785245114065,-0.0433337267335908,1.59863066067857e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TTF2,Transcription termination factor 2,39590,-0.0350626133723559,0.00547796387491286,-0.0457994225671851,-0.0243258041775267,1.61003141055832e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39868,-0.0695675049803704,0.0108818736496201,-0.0908959773336258,-0.0482390326271151,1.69123063354999e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AP2B1,AP-2 complex subunit beta,39590,-0.034207697390867,0.00535132187134523,-0.0446962882587037,-0.0237191065230303,1.69939183445238e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,42027,0.0122026607301139,0.00191068757777168,0.00845771307768141,0.0159476083825464,1.75284370746364e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CETN3,Centrin-3,39869,-0.0552071002167132,0.00864441920266487,-0.0721501618539363,-0.03826403857949,1.76470167294085e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FOXO3,Forkhead box protein O3,41771,-0.0675381249019674,0.0105773203548718,-0.0882696727975162,-0.0468065770064187,1.76939128412948e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,41943,-0.0555693833849588,0.00870618442326267,-0.0726335048545537,-0.038505261915364,1.79691192491612e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42104,0.0341023548557441,0.00534917065380034,0.0236179803742954,0.0445867293371928,1.88593506681676e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42056,-0.0332177355694791,0.005212356040413,-0.0434339534086885,-0.0230015177302696,1.91554000455371e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RPL14,60S ribosomal protein L14,39575,-0.0273883973233383,0.00430101122685888,-0.0358183793279817,-0.0189584153186949,1.99296425223879e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ST13,Hsc70-interacting protein,39675,-0.0380728748674971,0.0059809637901123,-0.0497955638961172,-0.026350185838877,2.02120855172545e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TMED8,Protein TMED8,39869,-0.072276006156068,0.0113579837975196,-0.0945376543992063,-0.0500143579129296,2.04920332662857e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CFHR5,Complement factor H-related protein 5,39802,0.0291392181472173,0.00458556424943243,0.0201515122183298,0.0381269240761049,2.17145653620819e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BID,BH3-interacting domain death agonist,42048,-0.0461798545756342,0.00728246870387316,-0.0604534932352256,-0.0319062159160428,2.35217268315749e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SYAP1,Synapse-associated protein 1,39675,-0.0409184112648525,0.0064517445470488,-0.0535638305770681,-0.0282729919526368,2.35296446080373e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,39872,-0.0418604094381984,0.00660446886520953,-0.0548051684140091,-0.0289156504623877,2.41348689899534e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G1B,Phospholipase A2,42225,0.0309062600745175,0.00487976131920592,0.0213419278888739,0.0404705922601611,2.47092104956394e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,42124,0.0192220689529762,0.00304170641932901,0.0132603243710914,0.0251838135348611,2.70638583221632e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MMP3,Stromelysin-1,42063,0.0343942006871636,0.00545220217588437,0.0237078844224303,0.045080516951897,2.90918748778939e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42236,-0.034840467791166,0.00552322818843856,-0.0456659950405056,-0.0240149405418264,2.9141198790717e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ICA1,Islet cell autoantigen 1,41842,-0.0553804433012634,0.00878034924199428,-0.0725899278155722,-0.0381709587869546,2.92942584026778e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGF2,Fibroblast growth factor 2,42048,-0.0479055984914959,0.00760136586213124,-0.0628042755812731,-0.0330069214017187,3.02537769189105e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42142,0.0187897859331603,0.00299110739706638,0.0129272154349102,0.0246523564314104,3.4472971402515e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IDS,Iduronate 2-sulfatase,42222,0.00634652511854549,0.00101227936721227,0.00436245755880945,0.00833059267828153,3.73044475727585e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,39927,0.0186848736265124,0.00298287594306474,0.0128384367781055,0.0245313104749193,3.88713626278868e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,39904,-0.0577795269491502,0.00922613811321363,-0.0758627576510489,-0.0396962962472515,3.92376856983051e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,39872,-0.0787106660728538,0.0125802741061544,-0.103368003320916,-0.0540533288247912,4.07538269470085e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39575,-0.0336262425237659,0.00537503994015022,-0.0441613208064604,-0.0230911642410715,4.09691966648225e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AGRN,Agrin,42111,-0.0245254476074989,0.00392734493175706,-0.0322230436737428,-0.0168278515412551,4.37078087751964e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,39869,-0.0424395491478254,0.00679899523395135,-0.05576557980637,-0.0291135184892807,4.47444322699281e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CASP2,Caspase-2,42048,-0.0469142494621813,0.00751869830853621,-0.0616508981469123,-0.0321776007774504,4.51627740275334e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42236,-0.015971621088827,0.00256332787101808,-0.0209957437160225,-0.0109474984616316,4.77662965028447e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39895,-0.0614210992012634,0.00985805770652137,-0.0807428923060453,-0.0420993060964815,4.81351776754211e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ELOA,Elongin-A,41995,-0.0368227049883502,0.00591549762754182,-0.0484170803383322,-0.0252283296383682,4.96600594215623e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",39526,-0.0575377082471005,0.00924558087619378,-0.0756590467644403,-0.0394163697297607,5.04754080167573e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,F3,Tissue factor,42099,0.0178621948271806,0.00287412933175191,0.0122289013369469,0.0234954883174144,5.28950583897938e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TPD52L2,Tumor protein D54,39675,-0.0743685511069201,0.0119776879429382,-0.0978448194750789,-0.0508922827387612,5.52593916297799e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,39675,-0.0567042018608399,0.00915126172789043,-0.0746406748475052,-0.0387677288741747,5.98496942094612e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39696,-0.0718627881953852,0.0116040649757127,-0.0946067555477821,-0.0491188208429883,6.11579693217766e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,41943,-0.0275913297532581,0.00446627705874929,-0.0363452327884067,-0.0188374267181095,6.69316246944237e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42048,-0.0257875744106691,0.00417920098883049,-0.0339788083487768,-0.0175963404725613,7.00478334421057e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GAS6,Growth arrest-specific protein 6,42163,0.0170545798388475,0.00276420424109002,0.011636739526311,0.0224724201513839,7.0322453821534e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MMP10,Stromelysin-2,42050,0.0389756450379808,0.0063220301147343,0.0265844660131015,0.05136682406286,7.24749272858297e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FSTL3,Follistatin-related protein 3,42010,-0.0220844797564062,0.00358769334684026,-0.0291163587162131,-0.0150526007965993,7.69161327024873e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,41995,-0.0139944277917734,0.00227946345401714,-0.018462176161647,-0.00952667942189978,8.51994001325927e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DENR,Density-regulated protein,39597,-0.0387903787283624,0.00632334597014346,-0.0511841368298436,-0.0263966206268812,8.83815801291917e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CETN2,Centrin-2,41766,-0.0459892136596605,0.00749819488305669,-0.0606856756304516,-0.0312927516888694,8.84994755701052e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DPEP2,Dipeptidase 2,41995,0.0202787017736625,0.00330645130853726,0.0137980572089295,0.0267593463383956,8.86234227042662e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42072,-0.0555819194745624,0.0090674530259857,-0.0733541274054944,-0.0378097115436304,9.04300833986055e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42222,-0.0266934166121075,0.00436153421616521,-0.0352420236757913,-0.0181448095484237,9.60276799533554e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39895,-0.0663548664599553,0.0108433973105376,-0.087607925188609,-0.0451018077313015,9.70537162760012e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VCAN,Versican core protein,42174,0.0202161032224602,0.00330532689815442,0.0137376625020776,0.0266945439428429,9.84525632325014e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CACYBP,Calcyclin-binding protein,39652,-0.0698044220334436,0.0114235420342817,-0.0921945644206358,-0.0474142796462515,1.02616609040187e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42041,-0.0540252301313037,0.00884288866621008,-0.0713572919170754,-0.036693168345532,1.02732255070233e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPART,Spartin,39675,-0.052345232884785,0.00856722521441267,-0.0691369943050339,-0.0355534714645362,1.03017873975839e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRG3,Proteoglycan 3,39904,0.0333626834037972,0.00546310578017603,0.0226549960746522,0.0440703707329422,1.049167379857e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41766,-0.0432884564561877,0.00709798196301284,-0.0572005011036929,-0.0293764118086825,1.09929181160993e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IST1,IST1 homolog,39789,-0.066053388228411,0.0108343387432518,-0.0872886921651845,-0.0448180842916375,1.11871686459216e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EPPK1,Epiplakin,39575,-0.0496844409417471,0.00815326151186641,-0.0656648335050053,-0.033704048378489,1.13953633830744e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL15,Interleukin-15,42048,-0.0220564461033915,0.00362051901615462,-0.0291526633750546,-0.0149602288317285,1.14503179769089e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,39590,-0.0314694471866962,0.0051663761245125,-0.0415955443907407,-0.0213433499826517,1.15814720982721e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RILP,Rab-interacting lysosomal protein,42149,-0.0392094409227436,0.00644312036173872,-0.0518379568317515,-0.0265809250137357,1.19279258433397e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42072,0.073840513547539,0.0121431592816202,0.0500399213555635,0.0976411057395146,1.22793345118926e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA3F,Semaphorin-3F,42072,-0.0177962526208733,0.00293015057981707,-0.0235393477573148,-0.0120531574844318,1.28524684785864e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NEXN,Nexilin,39927,-0.0466131229359233,0.00768113365040108,-0.0616681448907094,-0.0315581009811372,1.33220968281838e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41842,-0.0292436685251094,0.00482607024169609,-0.0387027661988338,-0.0197845708513851,1.40233401432891e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41842,-0.0363797590348201,0.00602215280771943,-0.0481831785379502,-0.02457633953169,1.57279053691867e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HSPB1,Heat shock protein beta-1,41879,-0.0465137374904539,0.00770049819672813,-0.061606713956041,-0.0314207610248667,1.57885697990742e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SEZ6L,Seizure 6-like protein,42108,0.0182680189645368,0.00302719478071978,0.012334717194326,0.0242013207347476,1.63490397536848e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,41882,-0.0233488117676455,0.00387126898990685,-0.030936498987863,-0.0157611245474281,1.66958631099062e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41766,-0.0740341054294822,0.0122811236658225,-0.0981051078144942,-0.0499631030444702,1.70141080744053e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41924,-0.0643395355465584,0.0106769297446423,-0.0852663178460573,-0.0434127532470594,1.72465897372989e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39512,-0.0186975849906289,0.00310269636314567,-0.0247788698623944,-0.0126163001188633,1.73241394622902e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39872,-0.0269174427663134,0.00446703066402896,-0.0356728228678102,-0.0181620626648167,1.73530994965064e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42108,-0.0476143513521354,0.00791169286782483,-0.0631212693730721,-0.0321074333311987,1.80904633409886e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42012,-0.0421255183664672,0.00700027477714352,-0.0558460569296685,-0.0284049798032659,1.81529828452835e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,39575,-0.0485288249562587,0.00808578124635967,-0.0643769561991236,-0.0326806937133937,2.01372484165545e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CPQ,Carboxypeptidase Q,39898,-0.0246652832251743,0.00411076805257901,-0.0327223886082291,-0.0166081778421194,2.03160399528125e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39872,0.0169445870257373,0.00282518432680435,0.0114072257452007,0.0224819483062738,2.06280242644366e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPAG1,Sperm-associated antigen 1,39872,-0.0386024891610328,0.00643878294630492,-0.0512225037357905,-0.0259824745862752,2.09319943651482e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TBCB,Tubulin-folding cofactor B,41943,-0.0658167176292347,0.0109813693615843,-0.08734020157794,-0.0442932336805294,2.10682792097983e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,42072,0.022513967456056,0.00375737296474831,0.0151495164451493,0.0298784184669627,2.12637960522758e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,XCL1,Lymphotactin,42187,-0.0358831434006232,0.00600150391331582,-0.0476460910707222,-0.0241201957305241,2.30107020322473e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,39675,-0.0788425123471177,0.0131885635016556,-0.104692096810363,-0.0529929278838728,2.32718593745034e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,42108,-0.0452227452649816,0.00756919037434239,-0.0600583583986926,-0.0303871321312705,2.36484544463831e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39675,-0.057231915615031,0.00957933043942375,-0.0760074032763016,-0.0384564279537605,2.37863406761625e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42048,-0.0477851238331115,0.00800174025267417,-0.0634685347283529,-0.0321017129378701,2.40507797674184e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,42048,-0.0552722143228287,0.00925728180436296,-0.0734164866593801,-0.0371279419862773,2.42230231056273e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,39872,-0.0559732441545279,0.0093828443788534,-0.0743636191370805,-0.0375828691719752,2.51228443518982e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NRGN,Neurogranin,39927,-0.0606774795241724,0.010172929824768,-0.0806164219807176,-0.0407385370676272,2.52554330007196e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39869,-0.0420989948183432,0.00705934547642906,-0.0559353119521441,-0.0282626776845422,2.5416838395519e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,39575,-0.0595590434593916,0.00998962075086084,-0.0791387001310788,-0.0399793867877043,2.56693895803615e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,42048,0.0325349353492988,0.00545937382434097,0.0218345626535905,0.0432353080450071,2.59399810921175e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,39597,-0.0580179641873737,0.00973470648914011,-0.0770979889060883,-0.0389379394686591,2.60120590145607e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CST3,Cystatin-C,42110,-0.0187268188141204,0.00314289810984441,-0.0248868991094154,-0.0125667385188253,2.60969580050001e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,39575,-0.0515975550041177,0.00866548276616666,-0.0685819012258044,-0.0346132087824311,2.69059061871111e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MSTN,Growth/differentiation factor 8,41828,-0.0352533805126492,0.00592678549930386,-0.0468698800912847,-0.0236368809340136,2.78045573946732e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,39869,-0.057267554561395,0.00966369690654049,-0.0762084004982144,-0.0383267086245757,3.19387336457037e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41771,-0.037470468597578,0.00634143075392187,-0.0498996728752648,-0.0250412643198911,3.53047418434016e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RBP2,Retinol-binding protein 2,41995,0.0506146575000894,0.00856922370518291,0.0338189790379309,0.0674103359622479,3.57790869442601e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAP2,Microtubule-associated protein 2,39868,-0.0303849506878472,0.00515214257330638,-0.0404831501315277,-0.0202867512441667,3.79561658088576e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINB9,Serpin B9,41943,-0.0211821508296298,0.00359925998132581,-0.0282367003930284,-0.0141276012662313,4.07261631347479e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39895,-0.0260376059185655,0.0044239389858858,-0.0347085263309017,-0.0173666855062294,4.07842772505583e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42048,-0.0592012179457196,0.0100663575642241,-0.0789312787715988,-0.0394711571198404,4.17236614421323e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41771,-0.0550904792441153,0.00937643411747528,-0.0734682901143668,-0.0367126683738637,4.31965374524869e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,42020,-0.0578058704440002,0.00983961631429164,-0.0770915184200118,-0.0385202224679886,4.33362148907616e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,39868,0.0197519285059626,0.00336202389067024,0.0131623616802489,0.0263414953316762,4.34772352546031e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42063,-0.0359959706150382,0.0061291188114956,-0.0480090434855696,-0.0239828977445068,4.38223781736592e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CASP3,Caspase-3,42236,-0.0567561746650305,0.0096750541048646,-0.0757192807105651,-0.0377930686194959,4.56128302535936e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40452,0.0200785832684205,0.00342473215671818,0.0133661082412529,0.0267910582955882,4.67204668995506e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,41958,-0.0185206313605235,0.00316060628974846,-0.0247154196884305,-0.0123258430326165,4.74248430875463e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OSM,Oncostatin-M,41980,-0.0445280695550217,0.00759944153857193,-0.0594229749706227,-0.0296331641394207,4.75507817654792e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HNMT,Histamine N-methyltransferase,41888,-0.030762639444539,0.00525343782023847,-0.0410593775722064,-0.0204659013168716,4.86183297602941e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,41995,-0.0560194815188685,0.00957017717073214,-0.0747770287735035,-0.0372619342642336,4.92461342932673e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39597,-0.031465083005832,0.00538001795465788,-0.0420099181969614,-0.0209202478147025,5.10122662002357e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,41828,-0.0494375760967378,0.00845704909990735,-0.0660133923325562,-0.0328617598609194,5.16262485710885e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42236,0.0261623469611565,0.0044775938666311,0.0173862629825595,0.0349384309397534,5.24557078367041e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,42048,-0.0317268025162014,0.0054310890191598,-0.0423717369937546,-0.0210818680386481,5.28652705313421e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPOCK1,Testican-1,41943,0.016739876940507,0.00286896942541526,0.0111166968666931,0.0223630570143209,5.51031443113583e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DKK3,Dickkopf-related protein 3,42236,0.0188427777315467,0.00323313666985554,0.0125058298586298,0.0251797256044636,5.7357079145387e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,41771,-0.0487732550587656,0.00837580931352538,-0.0651898413132753,-0.0323566688042558,5.91099900295601e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42048,-0.0465903011340623,0.00800312778226721,-0.062276431587306,-0.0309041706808186,5.9648302015786e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FKBPL,FK506-binding protein-like,39869,-0.0379853657158377,0.00652440659867703,-0.0507732026492447,-0.0251975287824307,5.97194383653244e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42174,-0.0440365161696633,0.00757139957126943,-0.0588764593293514,-0.0291965730099753,6.1568696725679e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD6,T-cell differentiation antigen CD6,42210,-0.0332299183228988,0.00572175260851024,-0.0444445534355788,-0.0220152832102187,6.47718080626646e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,39675,-0.0334666139396332,0.00576808849655632,-0.0447720673928835,-0.0221611604863828,6.73123995009826e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,39868,0.0452782275555186,0.00780587516452609,0.0299787122330474,0.0605777428779897,6.78828132570505e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39597,-0.0514497859377218,0.00887114227975511,-0.0688372248060418,-0.0340623470694018,6.82720522565251e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LPA,Apolipoprotein(a),39713,0.116108165708133,0.0200232070119126,0.0768626799647843,0.155353651451482,6.86597344640509e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PARK7,Parkinson disease protein 7,42063,-0.0322417568508441,0.00556165825569113,-0.0431426070319987,-0.0213409066696895,6.89641824003282e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,42111,-0.0419430391207782,0.00723934186095017,-0.0561321491682405,-0.0277539290733159,7.03599330645635e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42072,-0.0427923139113492,0.00738672977360455,-0.0572703042676141,-0.0283143235550843,7.06284593688357e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39675,0.0266444267078022,0.00460665588818465,0.0176153811669603,0.0356734722486441,7.49645044890512e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,39869,-0.057472468365507,0.00993870887214206,-0.0769523377549055,-0.0379925989761086,7.54688384253333e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PMVK,Phosphomevalonate kinase,41759,-0.0690866253980438,0.0119519548161137,-0.0925124568376266,-0.045660793958461,7.62306324520814e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42149,0.0223656997760208,0.00387018442598642,0.0147801383010875,0.0299512612509542,7.6810490567357e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GDF15,Growth/differentiation factor 15,42236,-0.0290163390161167,0.00502424115794336,-0.0388638516856857,-0.0191688263465477,7.8505904461866e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,41943,0.0231124233994691,0.00400287737502765,0.0152667837444149,0.0309580630545233,7.91575342546445e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42236,0.0102091272710985,0.00177037418154316,0.00673919387527386,0.0136790606669231,8.26158119183409e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,39526,-0.0627834109910161,0.0108978635622917,-0.0841432235731077,-0.0414235984089244,8.58373818128308e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KIF22,Kinesin-like protein KIF22,39512,-0.0787712511990122,0.0136737929131336,-0.105571885308754,-0.0519706170892703,8.60072579772944e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DLK1,Protein delta homolog 1,42236,-0.0365518540831527,0.00635404388822025,-0.0490057801040644,-0.024097928062241,8.98029512770492e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41771,-0.0425475498945442,0.00739683213264991,-0.057045340874538,-0.0280497589145503,9.00840964968269e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39675,-0.0182998614376577,0.00318286228666008,-0.0245382715195115,-0.0120614513558039,9.18746466679277e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DSC2,Desmocollin-2,41911,0.0221207034703684,0.00385151405668817,0.0145717359192596,0.0296696710214772,9.4834673438624e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,39927,-0.0417872471444513,0.00729640513144685,-0.0560882012020871,-0.0274862930868155,1.04761038383239e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DCTN2,Dynactin subunit 2,41995,-0.0597259197694949,0.0104396309013297,-0.080187596336101,-0.0392642432028887,1.08116114229084e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CIAPIN1,Anamorsin,42108,-0.0385926956344614,0.00674699018102436,-0.0518167963892692,-0.0253685948796537,1.08790347863009e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39868,-0.0261276486568468,0.00457157516267604,-0.0350879359756919,-0.0171673613380018,1.12328889891202e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL13,C-C motif chemokine 13,42201,-0.0427548241874081,0.00748276700202572,-0.0574210475113785,-0.0280886008634377,1.12815181271616e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,39575,-0.0266616793913328,0.00466668628531157,-0.0358083845105435,-0.0175149742721222,1.1376083235872e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42032,-0.0214860414340985,0.00376930306725528,-0.0288738754459189,-0.0140982074222781,1.2213415196915e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACYP1,Acylphosphatase-1,39640,-0.0408370466168619,0.00716555304648037,-0.0548815305879634,-0.0267925626457603,1.23542531037712e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,41828,-0.0319169686206098,0.00560842918366572,-0.0429094898205946,-0.020924447420625,1.29058657086649e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD40LG,CD40 ligand,42222,-0.0495143292032584,0.00871287875583475,-0.0665915715646945,-0.0324370868418223,1.35151005661748e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NXPH3,Neurexophilin-3,39597,0.0187150648060223,0.00329504485855743,0.0122567768832497,0.0251733527287949,1.38306386095751e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,39696,-0.0355984693836541,0.00626938595153898,-0.0478864658486705,-0.0233104729186377,1.39585176524089e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42108,-0.0522862878538934,0.00921148746204644,-0.0703408032795044,-0.0342317724282824,1.40548413185436e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MATN3,Matrilin-3,41919,0.020543325710493,0.00362103203778278,0.0134461029164387,0.0276405485045472,1.4296017762497e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42174,-0.040397451464128,0.0071214222802618,-0.0543554391334411,-0.0264394637948149,1.43462346143633e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,42108,0.0154267358956391,0.00272130871655122,0.0100929708111987,0.0207605009800795,1.46686723344133e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",39887,-0.0244793783494172,0.00431844545514368,-0.0329435314414988,-0.0160152252573356,1.47532172864238e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",42034,-0.0682598846459411,0.0120476262012576,-0.0918732320004061,-0.0446465372914761,1.4931289642951e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GFAP,Glial fibrillary acidic protein,41749,0.0283861103892636,0.00501104847439544,0.0185644553794486,0.0382077653990787,1.50365677792284e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39917,0.0152352916144443,0.00269002572580632,0.00996284119186387,0.0205077420370246,1.51822642864914e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,39512,-0.0433059302604403,0.00764639139632869,-0.0582928573972445,-0.0283190031236361,1.51998368003188e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",39575,-0.0389902173426824,0.00689282621200926,-0.0525001567182205,-0.0254802779671442,1.58230196323621e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42039,-0.0166669805016775,0.00295000372713054,-0.0224489878068534,-0.0108849731965016,1.63879376284056e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,42222,-0.026424471773363,0.00467764051312889,-0.0355926471790956,-0.0172562963676304,1.6451549583253e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,41995,0.0427559903087453,0.00757272011281976,0.0279134588876185,0.057598521729872,1.67506700536583e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,42111,-0.0792319417203959,0.0140383020536662,-0.106747013745582,-0.0517168696952102,1.69501459174324e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,39868,-0.0243728979712932,0.00432398193348597,-0.0328479025609257,-0.0158978933816607,1.77526582490884e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,41771,-0.0350962043858276,0.00623435415425215,-0.0473155385281618,-0.0228768702434934,1.84440068903932e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MENT,Protein MENT,39675,0.0147327537259446,0.002617114653553,0.00960320900498069,0.0198622984469085,1.85249958162194e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UNC5D,Netrin receptor UNC5D,39597,0.0161176597600844,0.00286734143943301,0.0104976705387957,0.0217376489813731,1.94349501930963e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42048,-0.0613792053353128,0.0109238889282244,-0.0827900276346326,-0.039968383035993,1.9609962949461e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,39512,-0.0426969334859699,0.00760066749233203,-0.0575942417709406,-0.0277996252009991,1.98457403991294e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,41771,-0.0349951546026664,0.00623108612328225,-0.0472080834042996,-0.0227822258010332,1.99129224263343e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CASC3,Protein CASC3,39590,-0.0266836085085576,0.00475365269804138,-0.0360007677967187,-0.0173664492203964,2.03333901866398e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ALCAM,CD166 antigen,42236,0.0121257346232102,0.00216051823618141,0.00789111888029463,0.0163603503661257,2.03405547561352e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,39869,-0.03570127297403,0.00637555388205092,-0.0481973585828498,-0.0232051873652102,2.19733998380929e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STX7,Syntaxin-7,39597,-0.0301615629738683,0.00539002220176055,-0.040726006489319,-0.0195971194584177,2.24844312474538e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CYTL1,Cytokine-like protein 1,39904,0.0156632042358244,0.00280139555481256,0.0101724689483917,0.021153939523257,2.30718294078666e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,41766,-0.036121403858187,0.00647088435712605,-0.0488043371981541,-0.0234384705182199,2.4226873984767e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41771,-0.0400171220330618,0.00718157151663416,-0.0540930022056648,-0.0259412418604589,2.5648462477519e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TG,Thyroglobulin,39858,0.0641559467455542,0.0115178507945946,0.0415809591881488,0.0867309343029595,2.60389976947743e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42070,-0.019276040614503,0.00346396914180856,-0.0260654201324477,-0.0124866610965582,2.67574517050882e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,39858,-0.0579624197210091,0.0104196215602686,-0.0783848779791354,-0.0375399614628827,2.71520733261187e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA2,Annexin A2,39429,-0.0430381148626613,0.00775606700869081,-0.0582400061996953,-0.0278362235256273,2.94130915411191e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42063,0.0323231889728689,0.00583083887526789,0.0208947447773438,0.0437516331683939,3.02080997627158e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FOXJ3,Forkhead box protein J3,39597,-0.0275708668160101,0.00498092788706983,-0.0373334854746669,-0.0178082481573532,3.17844710504578e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,39872,-0.0326700253010976,0.00590423073238809,-0.0442423175365783,-0.021097733065617,3.21236258068933e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EGFR,Epidermal growth factor receptor,42236,0.00970571636112124,0.00175461779587058,0.00626666548121489,0.0131447672410276,3.23299476853439e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,YWHAQ,14-3-3 protein theta,39675,-0.0451170191491834,0.00816901609824543,-0.0611282907017445,-0.0291057475966224,3.40890837625052e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,39512,-0.0427578618914726,0.00774925294203306,-0.0579463976578574,-0.0275693261250878,3.51354860135476e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,42072,-0.0399796275410231,0.00725030861299956,-0.0541902324225022,-0.0257690226595439,3.56827449984756e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39696,-0.0404716551444451,0.00734377327404894,-0.054865450761581,-0.0260778595273091,3.64737450635853e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SMS,Spermine synthase,39526,-0.03888833740119,0.00707053398481247,-0.0527465840114225,-0.0250300907909576,3.88217178232259e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42048,-0.0398451737920785,0.00725851893536279,-0.0540718709053895,-0.0256184766787674,4.10526902535021e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,41771,-0.027362848821022,0.00498541625289539,-0.037134264676697,-0.017591432965347,4.126749027032e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39872,-0.035934996400429,0.0065494772625947,-0.0487719718351146,-0.0230980209657434,4.18368658166725e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,39858,-0.0314398292475417,0.00573518424316952,-0.0426807903641539,-0.0201988681309294,4.29803550837696e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39904,0.0221372098079108,0.00405122431709752,0.0141968101463997,0.0300776094694219,4.74523167454114e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,39675,-0.0526281995421113,0.00963119839818601,-0.0715053484025559,-0.0337510506816667,4.74675253843645e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,42111,0.0129483182897656,0.00237154457772714,0.00830009091742039,0.0175965456621108,4.84906064900411e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RNASET2,Ribonuclease T2,42185,-0.0160371165226902,0.002944244145065,-0.0218078350470176,-0.0102663979983628,5.21359248794122e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,39597,-0.0527221161702173,0.00968098401957583,-0.0716968448485859,-0.0337473874918487,5.26396040131783e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,F13B,Coagulation factor XIII B chain,39863,-0.0153109896836528,0.00281350547086424,-0.0208254604065467,-0.00979651896075887,5.38006859084686e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,39858,-0.0331470017983867,0.00609844588332608,-0.0450999557297058,-0.0211940478670676,5.58390505710904e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTF1,Cardiotrophin-1,41828,-0.0504057603072721,0.00929504283296269,-0.068624044259879,-0.0321874763546652,5.96817489765193e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41771,-0.0266978295591205,0.0049275648662321,-0.0363558566969354,-0.0170398024213056,6.13094640621585e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,39512,-0.0260374981687118,0.00481847644154193,-0.035481711994134,-0.0165932843432896,6.66612554145963e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CALCA,Calcitonin,41924,-0.0410795810856441,0.00760686525769017,-0.0559890369907168,-0.0261701251805714,6.76598959064357e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLIT2,Slit homolog 2 protein,41766,-0.0306247024632661,0.00567160741189284,-0.0417410529905761,-0.0195083519359561,6.79295460867884e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,39512,-0.0714686707781222,0.0132452579452647,-0.097429376350841,-0.0455079652054033,6.96484631387025e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,39889,-0.0282076926299923,0.00523363474990571,-0.0384656167398075,-0.0179497685201771,7.19977380166382e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CPB2,Carboxypeptidase B2,39897,-0.0132970722838194,0.00246740777149438,-0.0181331915159484,-0.00846095305169042,7.2240344306671e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL2,C-C motif chemokine 2,41919,-0.0307064493138947,0.00569879215538742,-0.041876081938454,-0.0195368166893353,7.23624505693342e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GMFG,Glia maturation factor gamma,39895,-0.0426822983231343,0.00792550098634934,-0.058216280256379,-0.0271483163898896,7.37171895309042e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39872,-0.0389861639337411,0.0072398617851471,-0.0531762930326295,-0.0247960348348528,7.39275078717085e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42222,-0.0208233985544392,0.00386753479078311,-0.0284037667443741,-0.0132430303645042,7.39938460634559e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,41657,-0.0733403288059338,0.0136224634174677,-0.10004035710417,-0.0466403005076971,7.42002722127741e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,42236,-0.0251399464055781,0.00467307679992428,-0.0342991769334297,-0.0159807158777265,7.58247136881897e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SUGT1,Protein SGT1 homolog,41771,-0.0472633378087054,0.00878713282132681,-0.064486118138506,-0.0300405574789049,7.63084413180524e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42174,0.0265466867920063,0.00494120555541095,0.0168619239034009,0.0362314496806118,7.89287564860495e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SMTN,Smoothelin,39836,-0.0547501361679683,0.0101921705984558,-0.0747267905409417,-0.0347734817949948,7.95174450349438e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39675,-0.0253234540783747,0.0047143920038701,-0.0345636624059601,-0.0160832457507893,7.96560926717463e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41771,-0.0497421145326518,0.00928074214529051,-0.0679323691374212,-0.0315518599278824,8.4759250858812e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,41771,-0.0307160774557241,0.00574098903064044,-0.0419684159557793,-0.0194637389556688,8.92730314054343e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB1,Integrin beta-1,42092,0.0123854512421661,0.00231827848314068,0.00784162541521037,0.0169292770691218,9.3152051433795e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,41771,-0.0356652672612168,0.00667913682493102,-0.0487563754380816,-0.022574159084352,9.45940021339023e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39872,-0.0588870110027103,0.011032208899036,-0.0805101404448209,-0.0372638815605997,9.59409619227607e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MICALL2,MICAL-like protein 2,39590,-0.0402367777426496,0.00754353537579724,-0.0550221070792122,-0.025451448406087,9.80111723876768e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42063,-0.0247073875931598,0.00463553115840532,-0.0337930286636342,-0.0156217465226853,9.97965572198209e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITM2A,Integral membrane protein 2A,42048,0.0363353690368117,0.00682319023646693,0.0229619161733365,0.0497088219002869,1.02422552769117e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39872,-0.0287305325683559,0.00539459102461354,-0.0393039309765984,-0.0181571341601133,1.02440984383451e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,39869,0.0318306360621633,0.00597671831370066,0.02011626816731,0.0435450039570166,1.02459580144302e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,41766,-0.0224673705425656,0.00421910533859295,-0.0307368170062078,-0.0141979240789234,1.02528022875202e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAX,Protein max,41766,-0.0622449909729411,0.0116915102237518,-0.0851603510114947,-0.0393296309343875,1.03207041435964e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL7,Interleukin-7,42048,-0.0378005852216334,0.00710387394761096,-0.0517241781589509,-0.0238769922843159,1.04783741546796e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OBP2B,Odorant-binding protein 2b,41906,0.0334499110530671,0.00629326188571126,0.021115117757073,0.0457847043490612,1.08264074010938e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL16,Pro-interleukin-16,42222,-0.0246864996948694,0.00465032665494196,-0.0338011399385557,-0.0155718594511832,1.12234087062004e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NID2,Nidogen-2,42063,-0.0425304953223428,0.0080158237983026,-0.0582415099670159,-0.0268194806776697,1.13947292628823e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,42077,0.0181401747601762,0.00342548353181873,0.0114262270378115,0.0248541224825409,1.20455130884779e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,41943,0.0654747423737585,0.012373784908924,0.0412221239522674,0.0897273607952496,1.2329920197459e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,39590,-0.0253856860651462,0.00479743558000912,-0.0347886598019641,-0.0159827123283283,1.23643688365637e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCRIB,Protein scribble homolog,39575,-0.0510549068504974,0.0096498901623761,-0.0699686915687545,-0.0321411221322402,1.24179148706507e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CERT,Ceramide transfer protein,41766,-0.0357741644015374,0.00676282527929369,-0.049029301948953,-0.0225190268541217,1.24394702132179e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB7,Integrin beta-7,42187,0.0268059484889211,0.0050692415179062,0.016870235113825,0.0367416618640173,1.25604875900758e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42023,-0.0394725768896611,0.00747180681675509,-0.0541173182505011,-0.0248278355288211,1.29164282670499e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CHRDL1,Chordin-like protein 1,42092,0.0189503477526878,0.00358716613717465,0.0119195021238255,0.0259811933815501,1.29189600369951e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,41766,-0.0419368422658219,0.00793909931038465,-0.0574974769141758,-0.026376207617468,1.29592287518237e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DCTD,Deoxycytidylate deaminase,39675,-0.055734152809224,0.0105507840707554,-0.0764136895879045,-0.0350546160305434,1.2987416518556e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",39868,-0.0622065940357191,0.0117800782217356,-0.0852955473503209,-0.0391176407211173,1.31114919419428e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LYZL2,Lysozyme-like protein 2,39500,-0.0210984568638767,0.00399758481621384,-0.0289337231036558,-0.0132631906240976,1.33254487167523e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GP6,Platelet glycoprotein VI,42041,-0.0510761096549998,0.00968538498834431,-0.0700594642321546,-0.0320927550778449,1.35903566434754e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NID1,Nidogen-1,42114,-0.0208897087712079,0.00396177395608228,-0.0286547857251292,-0.0131246318172867,1.36415953367121e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39872,-0.027214312314693,0.00516107060120753,-0.0373300106930598,-0.0170986139363263,1.36696596566577e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,39575,-0.0182252358714621,0.00345897161661004,-0.0250048202400178,-0.0114456515029064,1.39787141407519e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA12,Serpin A12,41682,-0.0627527385954466,0.0119112338743825,-0.0860987569892362,-0.0394067202016569,1.39828043820061e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42236,0.0366157884587731,0.00695623483123476,0.022981568189553,0.0502500087279932,1.43297927199749e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39869,-0.0601525419807158,0.0114401565382226,-0.0825752487956321,-0.0377298351657995,1.48281915613428e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LXN,Latexin,41889,0.039554969809176,0.00752391119648981,0.024808103864056,0.054301835754296,1.48503122014725e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STX8,Syntaxin-8,42048,-0.0276261844834298,0.00526295987040867,-0.0379415858294308,-0.0173107831374288,1.55109027371616e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MESD,LRP chaperone MESD,42063,-0.0701577390612097,0.0133951121759926,-0.0964121589261552,-0.0439033191962642,1.65163260767216e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SNCG,Gamma-synuclein,41943,-0.0383765546519383,0.00733847790507576,-0.0527599713458868,-0.0239931379579898,1.72540356012773e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,42048,-0.0209318735259588,0.00400568797994602,-0.028783021966653,-0.0130807250852646,1.76246363979694e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,39696,-0.0426479445453479,0.00817148065333437,-0.0586640466258833,-0.0266318424648125,1.8302114702442e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLF4,Krueppel-like factor 4,39526,-0.0232931465925418,0.00446940692679553,-0.032053184169061,-0.0145331090160225,1.90545324301283e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,39895,-0.0153576162231867,0.00295002457039162,-0.0211396643811543,-0.0095755680652191,1.96419792704492e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGL1,Fibrinogen-like protein 1,39927,0.0369897893659559,0.00710624482334202,0.0230615495122056,0.0509180292197063,1.97125902207793e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39869,0.0204988953835323,0.00393849741663527,0.0127794404469272,0.0282183503201374,1.97674742835159e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39895,-0.0170276351738586,0.00327341248564959,-0.0234435236457318,-0.0106117467019853,2.00824245149461e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,39744,-0.0321178340931703,0.0061752759777162,-0.0442213750094941,-0.0200142931768466,2.01696107560971e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APOBR,Apolipoprotein B receptor,39575,0.0245724321882889,0.0047245972789201,0.0153122215216055,0.0338326428549723,2.0183533983168e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,39597,-0.0486630842094967,0.00935941715707797,-0.0670075418373695,-0.0303186265816239,2.03554375330943e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLIN3,Perilipin-3,42072,-0.0244931282592774,0.00471611694859499,-0.0337367174785235,-0.0152495390400312,2.0939054130831e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TCOF1,Treacle protein,39895,-0.0185426314300754,0.00357327684999014,-0.025546254056056,-0.0115390088040947,2.14803954384914e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CNTN4,Contactin-4,42063,0.0133894867277286,0.00258194207029858,0.00832888026994344,0.0184500931855139,2.18184859332134e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLK4,Kallikrein-4,42187,0.0356837055464764,0.00688645286523989,0.0221862579306062,0.0491811531623466,2.22991749637219e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42069,0.02177151497374,0.00420185202379742,0.0135358850070971,0.030007144940383,2.2339675851009e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CNPY4,Protein canopy homolog 4,41995,-0.0427964702074808,0.00826619933942419,-0.0589982209127522,-0.0265947195022094,2.28398213235555e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TP53,Cellular tumor antigen p53,41771,-0.0253548400551187,0.00489817847347232,-0.0349552698631245,-0.015754410247113,2.29560435185245e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,42070,0.0135974747750449,0.00262838858753182,0.00844583314348251,0.0187491164066072,2.33281950043289e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,39564,-0.0323963731854084,0.00626172945427727,-0.0446693629157919,-0.020123383455025,2.33545086204867e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,39696,-0.0421704333836158,0.00815664596667613,-0.058157459478301,-0.0261834072889306,2.38079296159233e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RBM17,Splicing factor 45,39872,-0.0437612302945661,0.0084747501078636,-0.0603717405059788,-0.0271507200831534,2.46218783008717e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42111,-0.0682985825099635,0.0132295964011567,-0.0942285914562306,-0.0423685735636964,2.47053918640789e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA3,Annexin A3,42149,-0.0394685013927811,0.00764605073827181,-0.0544547608397938,-0.0244822419457683,2.47854105692612e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FST,Follistatin,42092,0.0276435911002325,0.00535632677237092,0.0171451906263855,0.0381419915740795,2.49224391390871e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,39858,0.0218375199478749,0.00423325775903755,0.0135403347401613,0.0301347051555885,2.53086760777448e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,39696,-0.0417751480120053,0.00810589762322446,-0.0576627073535253,-0.0258875886704854,2.59824541333244e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,39597,-0.0512519608820763,0.00994656195474784,-0.0707472223133821,-0.0317566994507705,2.6117040432519e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GPA33,Cell surface A33 antigen,41995,-0.0757136466299757,0.0147150987151708,-0.10455524011171,-0.046872053148241,2.70864363115985e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SNX15,Sorting nexin-15,39675,-0.0305432091908244,0.00594235435222067,-0.0421902237211769,-0.0188961946604719,2.79545348637315e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42088,-0.0280456791672866,0.00545890907636862,-0.0387451409569691,-0.0173462173776041,2.82156301095107e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MMP7,Matrilysin,41809,-0.0293115348459788,0.00570613040811449,-0.0404955504458832,-0.0181275192460744,2.83361753203926e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HRG,Histidine-rich glycoprotein,39863,-0.0175148772367182,0.00341712674212583,-0.0242124456512848,-0.0108173088221516,3.01484801889015e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DXO,Decapping and exoribonuclease protein,39868,-0.0255678137693154,0.00498829784961268,-0.0353448775545563,-0.0157907499840746,3.01572937628315e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITGA5,Integrin alpha-5,42063,-0.0139841443223768,0.00273082409417852,-0.0193365595469667,-0.00863172909778691,3.08358505271636e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,39869,-0.0278242010626892,0.00543512135312367,-0.0384770389148116,-0.0171713632105668,3.11673625797069e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ASAH1,Acid ceramidase,39815,-0.0265962207306868,0.00519750113418072,-0.036783322953681,-0.0164091185076926,3.15374296119162e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,39575,-0.0322603857204796,0.00630940930303073,-0.0446268279544199,-0.0198939434865394,3.22325625740313e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,41995,-0.0111887940610094,0.00219102880627827,-0.0154832105213148,-0.006894377600704,3.32440423346661e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CA2,Carbonic anhydrase 2,42029,-0.037171646914648,0.00728457667103591,-0.0514494171898783,-0.0228938766394176,3.39255975278497e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42023,-0.0380495233016042,0.00745862959777766,-0.0526684373132484,-0.02343060928996,3.41733269291955e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42048,-0.0672400391963231,0.013207923515943,-0.0931275692875713,-0.0413525091050749,3.61208201304324e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42142,0.0200319159198323,0.00393735043931571,0.0123147090587735,0.0277491227808911,3.67352179081594e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,41967,0.0186493643189924,0.00366716114523846,0.0114617284743251,0.0258370001636598,3.71613391158082e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRADD,Death domain-containing protein CRADD,41924,-0.0416413907596312,0.00819467248328965,-0.0577029488268789,-0.0255798326923835,3.79496323670866e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KIFBP,KIF-binding protein,41995,-0.0461099630964198,0.00908078033917949,-0.0639082925612116,-0.028311633631628,3.87052557247584e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTSS,Cathepsin S,39297,-0.0136225116264059,0.00268426951669443,-0.018883679879127,-0.00836134337368483,3.94127245146542e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39895,0.017267841510708,0.00340596679124255,0.0105921465998726,0.0239435364215433,4.04374872727422e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL25,C-C motif chemokine 25,42222,-0.0273125283892147,0.00540195856118154,-0.0379003671691306,-0.0167246896092989,4.33605922791963e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD84,SLAM family member 5,42048,-0.0177137528260904,0.00350359640933007,-0.0245808017883774,-0.0108467038638035,4.34052055243109e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINI2,Serpin I2,39869,-0.0320558423094854,0.00635321486220526,-0.0445081434394077,-0.0196035411795631,4.59124699630357e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BGN,Biglycan,41748,0.0655215561107736,0.0129955847482936,0.040050210004118,0.0909929022174291,4.67233005385358e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,39696,-0.0379985187056128,0.00753817015009551,-0.0527733321998,-0.0232237052114256,4.70866634966364e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",41995,-0.0576477993781904,0.0114723959550104,-0.0801336954500108,-0.03516190330637,5.10153214329904e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39597,-0.0201421116366295,0.00401107741332663,-0.0280038233667496,-0.0122803999065093,5.20407143337978e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLB,Beta-klotho,41766,0.0412075974154651,0.00822300849998398,0.0250905007554965,0.0573246940754337,5.47780287440199e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42072,-0.0203867127381588,0.00406904154521622,-0.0283620341667826,-0.012411391309535,5.50626251623401e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42174,-0.0279788774898379,0.00558805777134003,-0.0389314707216643,-0.0170262842580114,5.6006061136349e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42198,-0.0182930997989687,0.00365488187783513,-0.0254566682795256,-0.0111295313184119,5.65273182702187e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD207,C-type lectin domain family 4 member K,41757,-0.0215264015541985,0.00430211167889705,-0.0299585404448368,-0.0130942626635603,5.69717123515096e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,42142,0.0179781427065448,0.00359833074286218,0.010925414450535,0.0250308709625547,5.91864912327546e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NGRN,Neugrin,39868,-0.0123298875552472,0.00246902720211262,-0.0171691808713879,-0.00749059423910643,6.00819239586759e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,F2R,Proteinase-activated receptor 1,42092,-0.0314157362234278,0.0063010264179431,-0.0437657480025962,-0.0190657244442593,6.24682343048707e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,41828,-0.0192694833487546,0.00386809036650274,-0.0268509404670999,-0.0116880262304092,6.38395181128277e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLIN1,Perilipin-1,41766,-0.0186120668269796,0.00373654131679965,-0.025935687807907,-0.0112884458460523,6.40273139007924e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,41828,-0.0612833886025004,0.0123062542921204,-0.0854036470150565,-0.0371631301899444,6.44335738820861e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,39597,-0.0277393631496802,0.00557110403584781,-0.0386587270599419,-0.0168199992394185,6.48332256114987e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,39872,-0.0427451171161842,0.00858720439328887,-0.0595760377270304,-0.025914196505338,6.5272543900688e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PER3,Period circadian protein homolog 3,39597,-0.0673185545742674,0.0135259353337138,-0.0938293878283465,-0.0408077213201884,6.55562643232123e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNXB,Tenascin-X,42063,0.014273918947821,0.0028755704033386,0.00863780095727735,0.0199100369383647,6.99525035793556e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,41943,0.0157209420018699,0.00316751543583602,0.00951261174763134,0.0219292722561086,7.02047566186444e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINB6,Serpin B6,42141,-0.0319730122063908,0.00644724933592213,-0.0446096209047982,-0.0193364035079834,7.16526104817147e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DHPS,Deoxyhypusine synthase,39858,-0.0219588466486102,0.00443103743167141,-0.0306436800146862,-0.0132740132825343,7.3122965227977e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,42049,-0.0241632842224414,0.0048768893200436,-0.0337219872897269,-0.014604581155156,7.33413511669504e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,42108,0.0229391258285808,0.00463356264349592,0.0138573430473288,0.0320209086098328,7.48604316588727e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39575,0.0117551385248827,0.00237635305660073,0.00709748653394523,0.0164127905158201,7.65957292867154e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,41771,-0.0194254983169825,0.0039283281720197,-0.0271250215341411,-0.0117259750998239,7.7090775091135e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,INHBB,Inhibin beta B chain,39675,0.0284017377055446,0.00574677286476534,0.0171380628906046,0.0396654125204847,7.83740749279846e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,39512,-0.0357153545758452,0.00723030518653558,-0.0498867527414549,-0.0215439564102355,7.94134518465669e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C2,Complement C2,42124,-0.0122717141207429,0.00248504535580522,-0.0171424030181212,-0.00740102522336471,7.97777964628038e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42063,0.0193891507494565,0.0039275240372124,0.0116912036365202,0.0270870978623928,8.03922680566656e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL3,C-C motif chemokine 3,42048,-0.0320297324205716,0.00649361634469178,-0.0447572204561675,-0.0193022443849757,8.21559954964701e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDH6,Cadherin-6,42072,0.0211043576356433,0.00427948673142517,0.0127165636420499,0.0294921516292366,8.25665155807702e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,42072,-0.0473819667839125,0.00961681557164974,-0.066230925304346,-0.028533008263479,8.44973881848237e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CREG1,Protein CREG1,41888,-0.0218119824849076,0.00443355359430804,-0.0305017475297514,-0.0131222174400638,8.76918241650903e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINC1,Antithrombin-III,39897,-0.00779124683528097,0.00158669007432294,-0.0109011593809539,-0.004681334289608,9.21734214274418e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,41995,-0.0306582764813855,0.00624788175007838,-0.0429041247115392,-0.0184124282512319,9.35736894343451e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42083,-0.0517013414331766,0.010542394391536,-0.0723644344405872,-0.031038248425766,9.49330974891103e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,42111,-0.0474994470077271,0.00969539514242997,-0.0665024214868899,-0.0284964725285644,9.73545763843234e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39597,-0.0239961914127503,0.00489804779408333,-0.0335963650891536,-0.014396017736347,9.76318715614323e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41882,0.0322699091190281,0.0065915360902105,0.0193504983822155,0.0451893198558407,9.91288811745429e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39895,-0.0391505807517374,0.00799636606944186,-0.0548234582478435,-0.0234777032556314,9.91371204270579e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42048,-0.0444536586518925,0.00910917680996651,-0.0623076451994269,-0.0265996721043582,1.07250071687938e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,41828,0.0182226459145574,0.00374171693329178,0.0108888807253055,0.0255564111038093,1.12815177851803e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UBXN1,UBX domain-containing protein 1,39675,-0.0369373716791498,0.00758504082525777,-0.051804051696655,-0.0220706916616446,1.13275232125641e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA11,Annexin A11,42016,-0.0354383984977327,0.00727940112887504,-0.0497060247103277,-0.0211707722851376,1.13837091227409e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DKK4,Dickkopf-related protein 4,41919,-0.0246233162472146,0.00506285046565084,-0.0345465031598903,-0.014700129334539,1.1662930275611e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,39696,-0.0184078223726472,0.00378494007992446,-0.0258263049292991,-0.0109893398159952,1.16947807846721e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,39872,-0.0684475241667016,0.0140868797056492,-0.0960578083897741,-0.0408372399436292,1.19595491384006e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TBCA,Tubulin-specific chaperone A,39675,-0.0448045254668914,0.00925751167133593,-0.0629492483427098,-0.026659802591073,1.31722698752047e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,42172,-0.0151915195444117,0.00313954003296364,-0.0213450180090204,-0.00903802107980298,1.32079948181939e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,39872,-0.0353970561181245,0.00732232766586802,-0.0497488183432259,-0.0210452938930232,1.35497060393162e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PMM2,Phosphomannomutase 2,39512,-0.0319263516170338,0.00660886584034834,-0.0448797286641166,-0.0189729745699511,1.37809896780332e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SOD3,Extracellular superoxide dismutase,39927,0.0322623969783103,0.00667980503747852,0.0191699791048524,0.0453548148517682,1.3843084662728e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,39575,-0.0280014260601413,0.00580227809250452,-0.0393738911214502,-0.0166289609988325,1.41224002970693e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,39895,0.0204549510924785,0.00424017028173589,0.0121442173402762,0.0287656848446809,1.42483861706151e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,41719,-0.0308479668057267,0.00639605082431238,-0.0433842264213789,-0.0183117071900744,1.43024383336352e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTRC,Chymotrypsin-C,42048,0.0345982584722543,0.00717718764872651,0.0205309706807503,0.0486655462637582,1.44701671006978e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39675,-0.03158885552048,0.00655706409568954,-0.0444407011480315,-0.0187370098929285,1.47273112996415e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,41771,-0.0306360655269416,0.00636441060041543,-0.0431103103037558,-0.0181618207501274,1.49841627943315e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,39675,-0.0122257381995844,0.00254321282763648,-0.0172104353417519,-0.00724104105741688,1.55069816723289e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42072,0.0149395700775126,0.00311210483177907,0.00883984460722567,0.0210392955477996,1.5999293773266e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,41995,-0.049487429807291,0.0103111466253843,-0.0696972771930442,-0.0292775824215379,1.60850731402489e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,39590,-0.0323216349481877,0.00673633915944385,-0.0455248597006977,-0.0191184101956778,1.62284210812147e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,39675,-0.0596605786248271,0.0124428990975762,-0.0840486608560765,-0.0352724963935777,1.6499898795158e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ING1,Inhibitor of growth protein 1,41747,-0.0251251700669152,0.00524376326087977,-0.0354029460582395,-0.0148473940755908,1.67399282491918e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MILR1,Allergin-1,41842,0.0268660687654332,0.00561244521092631,0.0158656761520177,0.0378664613788488,1.71230186074086e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39868,-0.0251860099084304,0.005262590490319,-0.0355006872694557,-0.0148713325474052,1.72421285079089e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRDX1,Peroxiredoxin-1,41671,0.048051733687191,0.0100785531423175,0.0282977695282487,0.0678056978461332,1.88330399357002e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,S100P,Protein S100-P,41828,-0.0280761308580869,0.00589269668994055,-0.0396258163703704,-0.0165264453458035,1.91273850893702e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39869,0.0378168681259074,0.00794623258591201,0.0222422522575199,0.053391483994295,1.96880862456494e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GP5,Platelet glycoprotein V,39675,-0.0191621517661131,0.00402652089645865,-0.0270541327231721,-0.0112701708090542,1.97029779199414e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,39675,-0.0661558057106157,0.0139143802178986,-0.0934279909376969,-0.0388836204835345,2.01453174515842e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42048,-0.0633955883976053,0.0133687751171512,-0.0895983876272217,-0.0371927891679889,2.13723062945664e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,39575,-0.0403378336612742,0.00850926496803708,-0.0570159929986268,-0.0236596743239215,2.15913863326854e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,39869,-0.0514705759199501,0.0108816959521382,-0.072798699986141,-0.0301424518537592,2.27229320000653e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,42108,0.0148386601456021,0.00314488376865101,0.00867468795904613,0.0210026323321581,2.40149032174349e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GLRX,Glutaredoxin-1,41986,-0.0288260790067318,0.00611313602864412,-0.0408078256228743,-0.0168443323905894,2.43631845246832e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPRY2,Protein sprouty homolog 2,41842,-0.0480648206637198,0.0101980534904841,-0.0680530055050688,-0.0280766358223709,2.46415916757398e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C3,Complement C3,39383,-0.0237871310777793,0.00506561353733175,-0.0337157336109495,-0.013858528544609,2.68835766553015e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STX4,Syntaxin-4,41995,-0.0304610935638416,0.00649454845087814,-0.0431904085275628,-0.0177317786001205,2.75558897846542e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,39895,-0.03661093372585,0.00782191484991589,-0.0519418868316852,-0.0212799806200149,2.89420799422164e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,42048,0.0228977963828589,0.0048964084955967,0.0133008357314894,0.0324947570342284,2.94726787818055e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,39834,-0.02335147472156,0.00500598388279789,-0.0331632031318439,-0.0135397463112761,3.12615679746557e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PSPN,Persephin,42048,-0.0442961289469852,0.00950208870263071,-0.0629202228041414,-0.025672035089829,3.16582604729751e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,39590,-0.0319661837155436,0.00686677117498408,-0.0454250552185124,-0.0185073122125748,3.27457217276176e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SNX9,Sorting nexin-9,42072,-0.0348043504595589,0.00747969430126992,-0.049464551290048,-0.0201441496290699,3.29970854799369e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TBC1D5,TBC1 domain family member 5,42048,-0.0399375281560524,0.00858489383733436,-0.0567639200772277,-0.023111136234877,3.31752107187913e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,41943,-0.037220625516962,0.00800178388559343,-0.0529041219327251,-0.0215371291011988,3.32628113838753e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,42236,0.015833491086924,0.0034056096156098,0.00915849624032881,0.0225084859335192,3.36287765865321e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TMEM106A,Transmembrane protein 106A,39858,-0.03666393577957,0.00788595508651606,-0.0521204077491415,-0.0212074638099985,3.36898971262475e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,41766,-0.0349661833389259,0.00752772315765892,-0.0497205207279374,-0.0202118459499144,3.43388880815545e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PGA4,Pepsin A-4,39927,-0.0381620942944411,0.00822770392445427,-0.0542883939863715,-0.0220357946025108,3.55317113367719e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ENO2,Gamma-enolase,42174,-0.0332112001558149,0.00716327845830436,-0.0472512259340914,-0.0191711743775383,3.57985260616945e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,39895,-0.0165249091944505,0.00356843197875864,-0.0235190358728174,-0.00953078251608358,3.68213898024388e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD164,Sialomucin core protein 24,42063,-0.0137628568304703,0.00297246281670834,-0.0195888839512187,-0.00793682970972195,3.68872780634494e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,42164,-0.0180544323668396,0.00390744683483149,-0.0257130281631094,-0.0103958365705699,3.86305560856036e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RAB37,Ras-related protein Rab-37,41842,-0.0412624371297741,0.00893293769765561,-0.0587709950171791,-0.0237538792423691,3.88975049074405e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,39512,-0.0184194603230976,0.00398758177417073,-0.0262351206004722,-0.0106038000457229,3.89619506245384e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PODXL,Podocalyxin,41995,0.00767275269279177,0.00166167006618729,0.00441587936306468,0.0109296260225189,3.92012823357297e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42048,-0.0192431667745527,0.00416863108044931,-0.0274136836922333,-0.0110726498568721,3.94477769339831e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GAS2,Growth arrest-specific protein 2,39696,-0.026423788695937,0.00573615016709869,-0.0376666430234504,-0.0151809343684235,4.13988215777986e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,39791,-0.034153524298657,0.00742118342116352,-0.0486990438041374,-0.0196080047931765,4.22716466560903e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLC,Galectin-10,42046,0.033955054431059,0.00738927591169982,0.0194720736441274,0.0484380352179907,4.36307305891267e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,39725,-0.00674931848979963,0.00147032835815264,-0.0096311620717788,-0.00386747490782045,4.47355538611949e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APOC1,Apolipoprotein C-I,39897,0.0194095282138771,0.00423185483493503,0.0111150927374045,0.0277039636903498,4.5552000931017e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,39868,-0.0286891274990048,0.00626284197338632,-0.040964297766842,-0.0164139572311676,4.68062719018798e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CA6,Carbonic anhydrase 6,42029,0.0313830838811935,0.00687672468193327,0.0179047035046042,0.0448614642577827,5.07134506548357e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,39526,-0.0378755904362472,0.00829943916211718,-0.0541424911939969,-0.0216086896784976,5.08244111455618e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42048,-0.020654491657767,0.00452865760627135,-0.0295306605660588,-0.0117783227494751,5.13989877314875e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,39734,0.00408909120886712,0.000897760359750717,0.00232948090375571,0.00584870151397852,5.30002188334105e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39575,-0.0510564762194447,0.0112143020917109,-0.0730365083191981,-0.0290764441196913,5.35061157142443e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,POF1B,Protein POF1B,39597,-0.0227235188125708,0.00499207877927588,-0.0325079932199515,-0.0129390444051901,5.37301718829825e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HDGF,Hepatoma-derived growth factor,42168,-0.0457188284311116,0.0100628474295841,-0.0654420093930965,-0.0259956474691268,5.58503708551932e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FMNL1,Formin-like protein 1,41766,-0.0316629327974452,0.00697057124227013,-0.0453252524322947,-0.0180006131625958,5.6118744417621e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,41995,0.0104270503312793,0.00229597563628481,0.00592693808416105,0.0149271625783975,5.63570352878386e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL17,C-C motif chemokine 17,42033,-0.0456427469684873,0.0100525092953843,-0.0653456651874404,-0.0259398287495341,5.6626751774858e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,42026,-0.0415011341472609,0.0091511178480923,-0.0594373251295219,-0.023564943165,5.80777031216315e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PENK,Proenkephalin-A,39675,-0.0154879959200991,0.00341533263964301,-0.0221820478937994,-0.00879394394639878,5.82518007600633e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39917,0.00960491069909164,0.0021224377859998,0.00544493263853203,0.0137648887596513,6.08916927464548e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LMOD1,Leiomodin-1,39872,0.0172757637102698,0.00382133143535372,0.0097859540969765,0.0247655733235631,6.22122524195941e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,39904,-0.0304380749552533,0.00674299602851643,-0.0436543471711455,-0.0172218027393611,6.42506047331223e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,39854,-0.0435146248982896,0.00964951286135568,-0.0624276701065467,-0.0246015796900325,6.56330504092969e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42128,-0.0562723749211721,0.0125174920353436,-0.0808066593104456,-0.0317380905318987,6.99835525728495e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42072,0.0140812906767813,0.00313283154283502,0.00794094085282466,0.0202216405007379,7.02328347446821e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HMBS,Porphobilinogen deaminase,42187,-0.019860493375703,0.00442557189946212,-0.0285346142986488,-0.0111863724527573,7.25989764357089e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATXN10,Ataxin-10,41766,-0.0362617052776701,0.00808433869653582,-0.0521070091228804,-0.0204164014324599,7.33841974274268e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BMP6,Bone morphogenetic protein 6,41814,-0.0197235814281117,0.00439817814596492,-0.0283440105942029,-0.0111031522620205,7.37047431465833e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42048,0.0302207757394977,0.00674056045531285,0.0170092772470845,0.0434322742319109,7.4063116960296e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MMP9,Matrix metalloproteinase-9,42051,-0.0294608402803504,0.00657778853712725,-0.0423533058131198,-0.016568374747581,7.5669157036997e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CENPF,Centromere protein F,39696,-0.0265622572693153,0.00593621787701743,-0.0381972443082694,-0.0149272702303611,7.73132103892722e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,39868,-0.0334697023403008,0.00750197181657216,-0.0481735671007822,-0.0187658375798194,8.21944989722693e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,41828,-0.0299147108347207,0.00670581768902564,-0.0430581135052109,-0.0167713081642304,8.22477311359085e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42174,-0.0275335065377921,0.00617822346196067,-0.039642824523235,-0.0154241885523492,8.39596292644301e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDHR5,Cadherin-related family member 5,42072,-0.0189498402226766,0.00425260562181491,-0.0272849472414338,-0.0106147332039194,8.41553051368983e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,39512,-0.027487929025647,0.00617122998643469,-0.039583539799059,-0.015392318252235,8.50419637242479e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42008,0.0130739588190664,0.0029362912960619,0.00731882787878511,0.0188290897593478,8.55454354550308e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LAP3,Cytosol aminopeptidase,41842,-0.023338492182414,0.00527858004737927,-0.0336845090752774,-0.0129924752895507,9.88635651814392e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,41842,-0.0206955449913115,0.00468598028653261,-0.0298800663529154,-0.0115110236297076,1.01116015607735e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LPO,Lactoperoxidase,41576,-0.0297679712982274,0.00674581474688608,-0.0429897682021241,-0.0165461743943306,1.02862604075462e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,42114,0.0166918426158679,0.00378401793100518,0.00927516747109777,0.0241085177606381,1.0362180474573e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AIF1,Allograft inflammatory factor 1,41771,-0.0253684753247128,0.00575706389651977,-0.0366523205618915,-0.014084630087534,1.05886892931696e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GM2A,Ganglioside GM2 activator,39673,0.0186001417495317,0.00422718640404227,0.0103148563976089,0.0268854271014546,1.09201395999533e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TMSB10,Thymosin beta-10,42063,-0.0366763594089389,0.00835412862060137,-0.0530504515053176,-0.0203022673125602,1.14105698319445e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39904,0.0196696412092789,0.00448538404671973,0.0108782884777082,0.0284609939408495,1.16887228326715e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39575,-0.0235986019387229,0.00538758891783092,-0.0341582762176715,-0.0130389276597743,1.19681940263596e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,39869,-0.046438780405018,0.0106096959999453,-0.0672337845649109,-0.0256437762451251,1.21400399208878e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANK2,Ankyrin-2,39512,0.0335409236476513,0.00769321483779797,0.0184622225655673,0.0486196247297353,1.31370786223381e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39353,-0.023757499558959,0.00545172411684898,-0.034442878827983,-0.013072120289935,1.32598627594329e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,41981,-0.0300515407163331,0.00689792504807389,-0.043571473810558,-0.0165316076221083,1.33078576627425e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL12B,Interleukin-12 subunit beta,42222,-0.0262327714549049,0.00602413617667771,-0.0380400783611932,-0.0144254645486166,1.34276679204102e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,41828,-0.0245900545015917,0.00566308627484714,-0.0356897036002921,-0.0134904054028913,1.4213505255828e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,41766,-0.023734506671215,0.00547896731517266,-0.0344732826089534,-0.0129957307334766,1.4890222456767e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPRR3,Small proline-rich protein 3,39868,-0.029947397689327,0.00691835543489863,-0.0435073743417283,-0.0163874210369257,1.51295714407017e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,39868,-0.0160896012461705,0.00372216927560397,-0.0233850530263542,-0.00879414946598668,1.55496477132655e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],41800,-0.0224473830256882,0.00520238601575931,-0.0326440596165764,-0.0122507064347999,1.60891969311347e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,39858,-0.0137279177573109,0.00318157305095324,-0.0199638009371792,-0.00749203457744253,1.61095804550715e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COMMD9,COMM domain-containing protein 9,39858,-0.0189203010333842,0.00438991587638278,-0.0275245361510944,-0.0103160659156739,1.64682116292499e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MMP8,Neutrophil collagenase,42149,-0.0339208411367312,0.00787746713694549,-0.0493606767251444,-0.0184810055483181,1.67357394867274e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARFIP1,Arfaptin-1,39872,-0.0328308292914784,0.00763544969544678,-0.0477963106945541,-0.0178653478884027,1.72398243737489e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,39895,0.0168200287067677,0.00391300600909741,0.00915053692893677,0.0244895204845986,1.73405314179341e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OLFM4,Olfactomedin-4,39288,-0.0585602945603825,0.0136349762284745,-0.0852848479681924,-0.0318357411525726,1.76349011814784e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITGA6,Integrin alpha-6,42048,-0.0240478447199051,0.00560102587862725,-0.0350258554420145,-0.0130698339977957,1.77133620682226e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,39576,-0.0271975769131575,0.0063353931546184,-0.0396149474962096,-0.0147802063301054,1.77822339379422e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",41828,-0.0437822163173414,0.0102074416684712,-0.063788801987545,-0.0237756306471378,1.80554188627168e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42222,0.013107858246851,0.00306045554556668,0.00710936537754027,0.0191063511161616,1.85673793319665e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,39590,-0.0315934999306342,0.00737623478288216,-0.0460509201050832,-0.0171360797561851,1.85834672843026e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,WNT9A,Protein Wnt-9a,41842,0.0137016631045956,0.00320098346272369,0.00742773551765719,0.0199755906915341,1.8782438680408e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,41929,-0.0220856964387937,0.00516510395026728,-0.0322093001813176,-0.0119620926962698,1.91653726402999e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,39868,-0.0181825025315146,0.00425934948142337,-0.0265308275151044,-0.00983417754792476,1.98096197240717e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MYO9B,Unconventional myosin-IXb,41842,-0.030938497675289,0.0072483396531548,-0.0451452433954724,-0.0167317519551056,1.9828886894867e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD70,CD70 antigen,42048,0.0207531404798514,0.00486544476270544,0.0112168687449487,0.0302894122147541,2.00894766977541e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42187,0.0155952214579941,0.0036573627238491,0.00842679051924988,0.0227636523967384,2.02099953369006e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",41943,-0.0271403041118451,0.00637214774034965,-0.0396297136829304,-0.0146508945407598,2.06557622338459e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CIT,Citron Rho-interacting kinase,39590,-0.0214814688593684,0.00504462281112082,-0.0313689295691652,-0.0115940081495716,2.07708998981855e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,42051,-0.0436641507933573,0.010285299229604,-0.063823337283381,-0.0235049643033335,2.19768967080213e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CFB,Complement factor B,39732,-0.0152747222903458,0.0035988178551527,-0.0223284052864451,-0.00822103929424651,2.20983207653648e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL14,C-C motif chemokine 14,42077,-0.0188607655746103,0.00444658917021022,-0.0275760803482223,-0.0101454508009982,2.2338821714518e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD5L,CD5 antigen-like,39863,0.022338669821246,0.00527991548958009,0.0119900354616691,0.032687304180823,2.34624971956425e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,39675,-0.0185629208537599,0.00440440196721254,-0.0271955487094965,-0.00993029299802334,2.52173490371738e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39872,-0.0220682918768889,0.00524322778057778,-0.0323450183268213,-0.0117915654269564,2.58591043912292e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,41967,0.0188280665146916,0.00448286493543155,0.0100416512412458,0.0276144817881375,2.68636244292335e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,39858,-0.0202824750392637,0.00483077026362957,-0.0297507847559777,-0.0108141653225498,2.70634851864907e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,42142,0.0270228321324259,0.00643734215562826,0.0144056415073946,0.0396400227574573,2.71212297605462e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,39869,0.0200911444077542,0.00479830695891684,0.0106864627682771,0.0294958260472312,2.84649426857887e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,39696,-0.0326033461556018,0.00781207766777612,-0.047915018384443,-0.0172916739267607,3.02304296070654e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS3,Galectin-3,42123,-0.0135761053456126,0.00325589479913076,-0.0199576591519089,-0.00719455153931637,3.06901547343541e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GSTP1,Glutathione S-transferase P,41686,0.0321407509291745,0.00771690016972412,0.0170156265965153,0.0472658752618338,3.13374111397113e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RILPL2,RILP-like protein 2,39895,-0.0449826353951733,0.0108853141918602,-0.0663178512112194,-0.0236474195791272,3.61561356681638e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BAG6,Large proline-rich protein BAG6,41828,-0.016749433938063,0.00406175187097927,-0.0247104676051824,-0.00878840027094365,3.75116830480199e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SOST,Sclerostin,42056,-0.017558315176687,0.00425807523707581,-0.0259041426413556,-0.00921248771201839,3.75344528623128e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,39500,-0.0227149514423524,0.00551723112665094,-0.0335287244505883,-0.0119011784341166,3.86510288712311e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,39895,0.0181613577747836,0.00441551440358073,0.00950694954376534,0.0268157660058018,3.93184191468596e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NT5E,5'-nucleotidase,42108,-0.0243263857505982,0.0059156299963326,-0.0359210205434101,-0.0127317509577863,3.94187954522875e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",39512,0.0210948925590912,0.00512975811567828,0.0110405666523618,0.0311492184658207,3.94679038837849e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL12A_IL12B,Interleukin-12,41995,-0.0347906643900517,0.00846527802966503,-0.0513826093281951,-0.0181987194519082,3.98347059699868e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42175,0.015615748352707,0.00380524857828777,0.00815746113926294,0.023074035566151,4.08900862518043e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRSS22,Brain-specific serine protease 4,39597,-0.01563452987426,0.00381276639320594,-0.0231075520049436,-0.00816150774357636,4.15092458981785e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,39639,-0.0245171292590735,0.00598829941492113,-0.0362541961123189,-0.0127800624058281,4.26698198849293e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39575,-0.0194019691287229,0.004749153644378,-0.0287103102717038,-0.010093627985742,4.43227034431934e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42187,-0.0279790314624869,0.00685396785150694,-0.0414128084514405,-0.0145452544735333,4.48733073348738e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42187,-0.0240791419545726,0.00590194472443563,-0.0356469536144664,-0.0125113302946787,4.53190242188481e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,39597,0.0190743312846146,0.00467673834709353,0.00990792412431132,0.028240738444918,4.56360809013946e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41924,-0.0323079049636145,0.00792332350647136,-0.0478376190362984,-0.0167781908909306,4.57732895834299e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42048,0.0254692848517877,0.00625886359954302,0.0132019121966833,0.037736657506892,4.7421007417715e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RSPO1,R-spondin-1,41943,0.0152143161382089,0.00374056925353228,0.00788280040128558,0.0225458318751321,4.78179526825115e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,42108,0.0132759414883766,0.00326567075108016,0.0068752268162595,0.0196766561604937,4.82418682852017e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,39675,0.0143931709671742,0.00354618292393956,0.00744265243625264,0.0213436894980957,4.96690557285609e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,39575,-0.027292199655794,0.00673488017816652,-0.0404925648050004,-0.0140918345065876,5.10517392413544e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GET3,ATPase GET3,39895,-0.0241326379401922,0.00595550729608458,-0.035805432240518,-0.0124598436398664,5.10878470987252e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,41766,-0.0282793758292579,0.00698756442652172,-0.0419750021052405,-0.0145837495532754,5.21523321849749e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42187,0.0184368670110054,0.00456160245575391,0.00949612619772776,0.0273776078242831,5.33455877558889e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NADK,NAD kinase,42072,-0.0242908530281261,0.00601580990442626,-0.0360818404408016,-0.0124998656154506,5.4245256916242e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDCD1,Programmed cell death protein 1,42157,0.0186500324476719,0.00461929716401398,0.00959621000620454,0.0277038548891393,5.43399975335352e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,41828,-0.0166809015218743,0.00413911143725734,-0.0247935599388987,-0.00856824310484997,5.60728061117276e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DBN1,Drebrin,39597,-0.0225700175508048,0.00561483596557585,-0.0335750960433335,-0.0115649390582761,5.86582932185058e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRDX6,Peroxiredoxin-6,42187,0.026580415008635,0.00661456022805335,0.0136158769616504,0.0395449530556195,5.88929009134829e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,42048,-0.027258034064837,0.00680229353147746,-0.0405905293865328,-0.0139255387431412,6.17783909978368e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACTN2,Alpha-actinin-2,39512,0.0285146418604076,0.00711707849434695,0.0145651680114876,0.0424641157093277,6.20318132061634e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLPS,Colipase,42041,0.0324313579085414,0.00809645525384864,0.0165623056109981,0.0483004102060847,6.21868721641155e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PARD3,Partitioning defective 3 homolog,39696,-0.0327007977359699,0.00816966629285838,-0.0487133436699724,-0.0166882518019675,6.30286642134478e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UNC79,Protein unc-79 homolog,39500,-0.0245304683306945,0.00613568901683044,-0.0365564188036822,-0.0125045178577069,6.4301854845998e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42108,0.0121571039758032,0.00304136093857593,0.00619603653619442,0.0181181714154121,6.44210162269328e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL22,C-C motif chemokine 22,41918,-0.0227468899776275,0.00569226490773966,-0.0339037291967972,-0.0115900507584577,6.4739809505494e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42048,-0.036348375529585,0.00910673579160064,-0.0541975776811223,-0.0184991733780478,6.60406875154383e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINI1,Neuroserpin,39652,0.0127013803313967,0.00318720113955171,0.00645446609787535,0.018948294564918,6.7879139599896e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL1,Growth-regulated alpha protein,42043,-0.0406789706441844,0.0102176849409386,-0.0607056331284242,-0.0206523081599447,6.89196599592183e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42016,0.0113301886115157,0.00285503997144052,0.00573431026749224,0.0169260669555391,7.27070076752094e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39675,0.0160601887751102,0.00405031259919302,0.00812157608069192,0.0239988014695285,7.38040996149648e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PI16,Peptidase inhibitor 16,39927,0.0105313941568916,0.00265782590132794,0.00532205539028878,0.0157407329234943,7.46522128993475e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TLR3,Toll-like receptor 3,42222,-0.0265911852868962,0.00672500210157212,-0.0397721894059775,-0.0134101811678148,7.72187658784375e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39652,0.0213868253029354,0.00541111249977004,0.0107810448033861,0.0319926058024847,7.78562965401843e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AKAP12,A-kinase anchor protein 12,39675,0.00925869873391329,0.002342733890605,0.0046669403083275,0.0138504571594991,7.7952258208844e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,39904,-0.027926487102224,0.00707123044282907,-0.041786098770169,-0.014066875434279,7.88521452058362e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DTNB,Dystrobrevin beta,39839,-0.0197031550834577,0.00499358522535438,-0.0294905821251523,-0.00991572804176312,8.00534388718374e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39895,-0.0267323614723488,0.00677871778985491,-0.0400186483404645,-0.0134460746042332,8.07617559263674e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41828,0.0136701234272858,0.00346936794147973,0.00687016226198551,0.0204700845925861,8.18203270746178e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C8B,Complement component C8 beta chain,39917,0.0130830370122071,0.00332189148844114,0.00657212969486242,0.0195939443295517,8.25084979267717e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SNX2,Sorting nexin-2,39858,-0.0369742171780471,0.00939252225153135,-0.0553835607910486,-0.0185648735650457,8.31558681839688e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RNASE1,Ribonuclease pancreatic,39927,-0.0106968321361826,0.00271930224679363,-0.0160266645398982,-0.00536699973246711,8.4158423259793e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STX16,Syntaxin-16,41771,-0.024720956166967,0.00629263620914221,-0.0370545231368857,-0.0123873891970483,8.58946103292729e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,39904,-0.02384675238818,0.00607124946983778,-0.0357464013490621,-0.011947103427298,8.62302109802674e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,41771,-0.0320564974184303,0.00817590093427767,-0.0480812632496146,-0.0160317315872461,8.86834616090107e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,39696,-0.0307902544156966,0.00787328033968967,-0.0462218838814883,-0.0153586249499049,9.25666583332939e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STX3,Syntaxin-3,39868,-0.0163628373907278,0.0041954882627504,-0.0245859943857186,-0.008139680395737,9.67098975744346e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,39869,-0.0323932550146943,0.00830954664343006,-0.0486799664358172,-0.0161065435935714,9.74245020482043e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TGFA,Protransforming growth factor alpha,42048,-0.0193967876944228,0.00497868402712698,-0.0291550083875916,-0.00963856700125388,9.82815118186289e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NTF3,Neurotrophin-3,42048,-0.0147243817420514,0.00378079573475369,-0.0221347413821686,-0.00731402210193414,9.88695755357815e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,39759,-0.0141579163517436,0.0036361787290398,-0.0212848266606616,-0.00703100604282558,9.93326132492372e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,41995,-0.0141235953000778,0.00363341285175546,-0.0212450844895185,-0.00700210611063714,0.000101920019927293
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,42055,-0.0407025190901846,0.0104884309003024,-0.0612598436547773,-0.0201451945255919,0.000104650358293382
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRTN3,Myeloblastin,41730,0.0205248236954328,0.00529047336291581,0.0101554959041178,0.0308941514867478,0.000105147135122151
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,42187,0.0262139918500091,0.00676662404047721,0.0129514087306738,0.0394765749693444,0.000107559909450543
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNR,Tenascin-R,41943,0.0178150852464724,0.00459907151038533,0.00880090508611712,0.0268292654068276,0.000107739896556332
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,41828,0.0146893636330915,0.00380103925439449,0.00723932669447825,0.0221394005717047,0.000111818789084625
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39869,-0.0357324892829465,0.00927021410661564,-0.0539021089319132,-0.0175628696339799,0.000116587244194837
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TST,Thiosulfate sulfurtransferase,41736,-0.0320918311761822,0.00832738780719765,-0.0484135112782896,-0.0157701510740749,0.000116866714189657
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,39872,-0.0366659527208657,0.00953270716424451,-0.0553500587627849,-0.0179818466789464,0.000120559733599837
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BAX,Apoptosis regulator BAX,41741,-0.0389302329216212,0.0101292931677711,-0.0587836475304526,-0.0190768183127898,0.000121946757110273
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41771,-0.0245763556448012,0.00639678570004997,-0.0371140556168991,-0.0120386556727033,0.000122615782214877
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OGFR,Opioid growth factor receptor,41995,-0.0135375919150909,0.00353136463227669,-0.0204590665943532,-0.00661611723582858,0.000126895295542205
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,39590,0.013286226840758,0.00346742315115488,0.0064900774644944,0.0200823762170215,0.000127954184650159
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,WDR46,WD repeat-containing protein 46,39858,-0.0153897087626735,0.00403111450076929,-0.0232906931841813,-0.00748872434116564,0.000135406899646402
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,41995,-0.0243645657832627,0.00639608297719317,-0.0369008884185613,-0.0118282431479641,0.000139986161690324
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AOC3,Membrane primary amine oxidase,42142,0.0124168274426239,0.00326045012366466,0.00602634520024121,0.0188073096850067,0.000140533404315087
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,41995,0.0098095563717399,0.00257729232988641,0.00475806340516254,0.0148610493383173,0.000141776335775361
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITGAM,Integrin alpha-M,42063,0.0131704713631144,0.00346746534150587,0.00637423929376293,0.0199667034324659,0.000146332716165191
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",39575,-0.0366488569266233,0.00966824131305982,-0.0555986099002206,-0.0176991039530261,0.00015106178129627
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42046,-0.0409381924440149,0.0108011263270923,-0.0621084000451159,-0.0197679848429139,0.000151196541863634
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CA13,Carbonic anhydrase 13,41895,-0.0439277429930382,0.0115972799980728,-0.0666584117892609,-0.0211970741968155,0.000152679603468279
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,39872,-0.0248512074938342,0.00656620963755881,-0.0377209783834495,-0.0119814366042189,0.000154684449095853
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AMPD3,AMP deaminase 3,39868,-0.0286573036898413,0.00757549831228969,-0.0435052803819291,-0.0138093269977536,0.000155817706673713
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CES2,Cocaine esterase,41995,-0.02317100555167,0.00612743885393785,-0.0351807857053882,-0.0111612253979518,0.000156553720766315
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPM1F,Protein phosphatase 1F,39895,-0.0222233140865612,0.00587664525665907,-0.033741538789613,-0.0107050893835094,0.000156606225552589
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ABO,Histo-blood group ABO system transferase,39927,0.0602374260748258,0.0159577454794412,0.0289602449351211,0.0915146072145304,0.000160948421915373
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39580,-0.0111354516253551,0.00295142987232568,-0.0169202541751134,-0.00535064907559674,0.000162208810639875
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,39858,-0.0258959987776691,0.00686578917309232,-0.0393529455569301,-0.0124390519984082,0.00016294070764564
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39675,-0.0370979217074774,0.00983656392883627,-0.0563775870079965,-0.0178182564069583,0.000163158753241881
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ENSA,Alpha-endosulfine,39858,-0.0219588752635918,0.00582338579519646,-0.0333727114221768,-0.0105450391050067,0.000163551700431716
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39872,-0.027346013062594,0.00725228674328886,-0.0415604950794402,-0.0131315310457479,0.000163638664871688
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42053,0.00920958867846967,0.00244346874884693,0.00442038993072969,0.0139987874262097,0.000164561377045269
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,39590,-0.0273255656634395,0.00726200033230179,-0.041559086314751,-0.0130920450121279,0.000168884855661469
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLC4A1,Band 3 anion transport protein,39904,-0.01969553177259,0.00523967969539217,-0.0299653039755587,-0.00942575956962139,0.000171508249132157
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42050,-0.0222689726848116,0.00592504326013867,-0.0338820574746834,-0.0106558878949399,0.000171692842411244
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,41842,-0.0268541845540097,0.00715941072059862,-0.040886629566383,-0.0128217395416364,0.000176956874174744
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,41771,-0.0235584693336481,0.00629199827210987,-0.0358907859469834,-0.0112261527203127,0.000181743332591376
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,42044,0.0199480279277347,0.00532975149896463,0.009501714989764,0.0303943408657054,0.000182761544017496
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,42156,0.00921235181940904,0.00246193433629173,0.00438696052027725,0.0140377431185408,0.000183376013965325
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42050,0.0163609244380276,0.00437379834287168,0.00778827968599911,0.0249335691900561,0.000184294655191779
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL18,Interleukin-18,41997,-0.0181946984516935,0.00486466337940431,-0.0277294386753259,-0.00865995822806101,0.000184657722593343
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,XRCC4,DNA repair protein XRCC4,41766,-0.015219596546639,0.0040721448870579,-0.0232010005252725,-0.00723819256800549,0.000186653428590285
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,41842,0.0149209592555108,0.00399592535804546,0.00708894555374166,0.0227529729572799,0.000189219590225776
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,41771,-0.0158989962804464,0.00427100933550257,-0.0242701745780315,-0.00752781798286141,0.000198051334656866
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADA,Adenosine deaminase,42222,-0.0145377178535377,0.00390922964183453,-0.0221998079515334,-0.00687562775554203,0.000200959290635694
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,39519,-0.0228313798209621,0.00614262473240071,-0.0348709242964675,-0.0107918353454567,0.00020270849541632
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MARCO,Macrophage receptor MARCO,42072,0.0105347218309003,0.00284304717638928,0.00496234936517728,0.0161070942966233,0.000211874106754696
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39869,-0.019926918378296,0.00539815680724101,-0.0305073057204884,-0.00934653103610363,0.000224048732988954
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL8,Interleukin-8,41960,-0.027543729635574,0.00747780434804477,-0.0422002261577417,-0.0128872331134062,0.000231053520113311
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDCD6,Programmed cell death protein 6,42072,0.028619068168651,0.00777628564497349,0.0133775483045029,0.043860588032799,0.000233867935258814
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41828,-0.0360468316862104,0.00979535937743394,-0.0552457360659809,-0.0168479273064399,0.00023416875198978
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,41995,-0.0217055372199938,0.00589879939934066,-0.0332671840427015,-0.0101438903972861,0.00023446682300512
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39858,-0.0151335577166997,0.00411738251578499,-0.0232036274476383,-0.00706348798576108,0.000238460158219356
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LEFTY2,Left-right determination factor 2,42172,-0.0208207701898523,0.00567099537126839,-0.0319359211175383,-0.00970561926216621,0.000242104640732435
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39872,0.0169388783739163,0.00462316476559353,0.00787747543335293,0.0260002813144796,0.000249529189026348
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41771,-0.0174538470766878,0.00478506921682141,-0.0268325827416578,-0.00807511141171785,0.00026575963368336
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,39512,-0.0203627341455499,0.00559287955367653,-0.0313247780707559,-0.00940069022034395,0.000273015735811972
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,39512,-0.0176788528979752,0.00486227620362669,-0.0272089142570835,-0.0081487915388669,0.000278263949040868
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,39872,-0.0191895175014989,0.00527880644558639,-0.0295359781348482,-0.00884305686814957,0.000279001654579112
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD276,CD276 antigen,42050,0.0142773535942185,0.00393145597936113,0.00657169987467071,0.0219830073137663,0.000282750247077729
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39675,-0.0255850738825281,0.00704672146553551,-0.0393966479549777,-0.0117734998100785,0.000283843929250528
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRYBB1,Beta-crystallin B1,39895,-0.0264365890562509,0.00728811361321792,-0.0407212917381581,-0.0121518863743438,0.000287599351682222
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL8,C-C motif chemokine 8,42164,-0.0241951574922089,0.00667559464524865,-0.0372793229968963,-0.0111109919875216,0.000290670241447198
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,41771,-0.0126240007150589,0.00348413415186012,-0.0194529036527047,-0.00579509777741308,0.000291982887788404
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DCTN6,Dynactin subunit 6,41766,-0.0288637446248836,0.00796878376613347,-0.0444825608065052,-0.013244928443262,0.00029331791315135
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,39872,-0.014822949784173,0.00410551986093911,-0.0228697687116137,-0.00677613085673238,0.000306942104711917
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD300E,CMRF35-like molecule 2,42157,0.0165855561068261,0.00459480300234882,0.00757974222222241,0.0255913699914298,0.000307734760359355
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HEPACAM2,HEPACAM family member 2,39868,0.017345080430312,0.00480764126067169,0.00792210355939552,0.0267680573012285,0.000310123287740341
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42108,-0.0135323751336564,0.003752008135333,-0.0208863110789091,-0.0061784391884037,0.000311231852519238
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,39850,-0.0159207504532902,0.00442765677956327,-0.0245989577412343,-0.00724254316534622,0.000324842371992068
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,42063,0.0126785936794733,0.00352842015459154,0.00576289017647393,0.0195942971824727,0.000327709323640189
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,41990,-0.0179409115667805,0.00499592779325844,-0.0277329300415671,-0.00814889309199399,0.000330454979208492
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,39869,-0.0209193198872279,0.00582772524090266,-0.0323416613593971,-0.00949697841505865,0.000332566804310058
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,39904,0.0106497768443138,0.0029698276727924,0.0048289146056407,0.0164706390829869,0.000337216402448869
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PKD2,Polycystin-2,39512,-0.0231507409145985,0.00645623689639896,-0.0358049652315405,-0.0104965165976566,0.000337521382711087
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MYOC,Myocilin,42063,0.0176184403784575,0.00491967926137827,0.00797586902615614,0.027261011730759,0.000343202108499656
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCG3,Secretogranin-3,42070,0.0130808455321864,0.00365791315846566,0.00591133574159371,0.0202503553227791,0.000350059508197542
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42048,-0.0239574753420983,0.00671445634188311,-0.0371178097721892,-0.0107971409120074,0.000360907461072751
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,39590,-0.0230836753009684,0.0064977564311641,-0.03581927790605,-0.0103480726958867,0.000383099040033512
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,39512,-0.0237791831562053,0.00669354183362923,-0.0368985251501186,-0.010659841162292,0.000383117370259904
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,41842,0.0135321029900669,0.0038120182024908,0.00606054731318493,0.0210036586669489,0.000386782892005026
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TPR,Nucleoprotein TPR,39512,-0.0190840259174523,0.00538990821518721,-0.0296482460192193,-0.0085198058156854,0.000400736207587845
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,42048,0.0172706435441397,0.00487921177521977,0.00770738846470899,0.0268338986235705,0.00040202910571476
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',39868,-0.0172751144014178,0.00488524946396009,-0.0268502033507796,-0.00770002545205607,0.000407590539652059
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FAM3D,Protein FAM3D,39869,-0.0340283375017267,0.00962302233871201,-0.0528894612856022,-0.0151672137178512,0.000407652500895085
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42222,0.0177101762140539,0.00501037749916272,0.00788983631569495,0.0275305161124128,0.00040959369384592
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCGB2A2,Mammaglobin-A,39512,0.0121001037225492,0.00342431869304454,0.0053884390841819,0.0188117683609165,0.000411667708080648
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,39575,-0.00960056304371246,0.00272168868809221,-0.0149350728723732,-0.00426605321505173,0.000421330884083742
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,39597,-0.0249932199942779,0.0070875320051855,-0.0388847827244415,-0.0111016572641144,0.000423022766802218
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,39858,-0.0277582599433562,0.00787395485779,-0.0431912114646246,-0.0123253084220878,0.000424642193427328
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,39575,-0.0199579800260577,0.00567525548096775,-0.0310814807687545,-0.00883447928336091,0.000438767738880539
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC1,Sialoadhesin,42111,0.0160350984413258,0.00456729054066566,0.00708320898162108,0.0249869879010305,0.000448122698407903
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NBN,Nibrin,41842,-0.0209612235122007,0.00597947784507983,-0.0326810000885572,-0.00924144693584425,0.000457210722867677
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,39575,-0.0121987323036026,0.00348284338288166,-0.0190251053340507,-0.00537235927315456,0.000462710977769108
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,42222,-0.0181725716392873,0.00519239417354903,-0.0283496642194434,-0.00799547905913119,0.000467017440983371
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,42173,0.0109036176163069,0.00311628236149146,0.0047957041877837,0.0170115310448302,0.000468646277010003
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,39868,-0.0118942347423436,0.00340003743004412,-0.01855830810523,-0.0052301613794571,0.000470100546119858
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,39858,-0.0223094523198341,0.00637891072195158,-0.0348121173348592,-0.00980678730480902,0.000471670581696657
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SNX5,Sorting nexin-5,39575,-0.011460242803844,0.00327752888057639,-0.0178841994097738,-0.00503628619791432,0.000473071754475237
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,41771,0.0115921859922392,0.00332256417395219,0.0050799602112929,0.0181044117731855,0.000486546657455845
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,39927,0.015615048931902,0.00448776658713865,0.00681902642111023,0.0244110714426937,0.000504296240311591
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDCP1,CUB domain-containing protein 1,41943,-0.0213974583386875,0.00615012786099288,-0.0334517089462335,-0.00934320773114142,0.000504538334443297
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,39696,-0.013526801813708,0.00389201964424558,-0.0211551603164294,-0.00589844331098671,0.00051180846650967
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41771,0.0121581182321476,0.00349995830316262,0.00529819995794882,0.0190180365063463,0.000514812940180565
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PROCR,Endothelial protein C receptor,39512,0.013253346351966,0.00381550941480267,0.00577494789895278,0.0207317448049793,0.000515622434610683
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,41943,0.02655697173754,0.00766138500649678,0.0115406571248063,0.0415732863502737,0.000529254549406845
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,41771,-0.0198329655423809,0.00572542280566253,-0.0310547942414795,-0.00861113684328232,0.000533864249384309
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD59,CD59 glycoprotein,41567,0.0089933972172422,0.00259808366358957,0.00390115323660664,0.0140856411978778,0.000538804308119055
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TYMP,Thymidine phosphorylase,41998,-0.0253378168943741,0.00731999635009071,-0.0396850097405519,-0.0109906240481963,0.000538944896407435
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BST2,Bone marrow stromal antigen 2,42174,-0.0193767767271268,0.00560197479274545,-0.0303566473209079,-0.00839690613334576,0.000544012652366537
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42187,0.0100948363467062,0.00292109388587984,0.00436949233038175,0.0158201803630307,0.000550255076688528
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,39590,-0.0245301104305921,0.00710064801888631,-0.0384473805476093,-0.0106128403135749,0.000553128583539827
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SDC1,Syndecan-1,42072,0.015387713131456,0.004455489946328,0.00665495283665314,0.0241204734262589,0.000554750488463034
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD48,CD48 antigen,42092,0.011660264411773,0.003376883388153,0.00504157297099316,0.0182789558525529,0.000556159463760589
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DMD,Dystrophin,39575,-0.0195638171136376,0.00566706935731957,-0.030671273053984,-0.00845636117329128,0.000558145827300273
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",39590,-0.0149247435492334,0.00432537561378009,-0.0234024797522424,-0.00644700734622442,0.000561634780833424
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39500,-0.0254408794545007,0.00738418408984582,-0.0399138802705985,-0.0109678786384029,0.000572531831917955
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42050,0.00887445018027644,0.00257599538458431,0.00382549922649119,0.0139234011340617,0.000572681806106574
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39675,-0.0265951375566583,0.00772222954015256,-0.0417307074553573,-0.0114595676579593,0.000575358642524583
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39597,-0.0141397651285314,0.00410784690783153,-0.0221911450678812,-0.00608838518918163,0.000579288990116735
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",39904,-0.0163332684076797,0.00475467197549532,-0.0256524254796506,-0.00701411133570891,0.000594235195249173
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BOLA1,BolA-like protein 1,39526,-0.0206394170492221,0.00600819335519489,-0.0324154760254041,-0.00886335807304016,0.000594291769326241
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,41995,0.0119858225989352,0.00349035043560088,0.00514473574515752,0.018826909452713,0.000596570511629467
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,42222,-0.0277818819356894,0.00809954154611749,-0.0436569833660797,-0.0119067805052992,0.000605245301280746
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,39834,-0.0101909337273039,0.00298045768584317,-0.0160326307915565,-0.00434923666305126,0.000630168284567973
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",41995,-0.0260464459250132,0.00762438867712221,-0.0409902477321727,-0.0111026441178537,0.000636898736229926
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41842,-0.0270770333165913,0.0079367023447415,-0.0426329699122847,-0.011521096720898,0.000647704637036948
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BLMH,Bleomycin hydrolase,42236,-0.0115954739108607,0.00340052663789838,-0.0182605061211415,-0.00493044170057988,0.000651736983724249
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,F11,Coagulation factor XI,39760,-0.011749674111464,0.00345509177954025,-0.0185216539993629,-0.00497769422356513,0.000674531659155481
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADA2,Adenosine deaminase 2,42021,0.016360540646598,0.00482500709582168,0.00690352673878747,0.0258175545544084,0.00069894755988942
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PZP,Pregnancy zone protein,39917,0.0123590066065506,0.00364732451009988,0.00521025056675483,0.0195077626463464,0.000705123590312376
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,REG1B,Lithostathine-1-beta,42236,-0.0212573654775714,0.00628119462708905,-0.033568506946666,-0.0089462240084769,0.00071564383900615
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,39512,-0.0270169473464275,0.00800183755659572,-0.0427005489573551,-0.0113333457354999,0.000737126919582798
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,41771,-0.0171976580866559,0.00509437984259087,-0.0271826425781341,-0.00721267359517783,0.000738114001145231
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SEPTIN8,Septin-8,39845,-0.0120737812379088,0.0035869386454958,-0.0191041809830805,-0.00504338149273698,0.000765108189989597
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BMP4,Bone morphogenetic protein 4,41919,0.0174915030228159,0.00519779208234296,0.00730383054142371,0.0276791755042081,0.000767099132782247
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,41771,0.0137852242227977,0.00409823358993402,0.00575268638652706,0.0218177620590684,0.000771246333361458
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,39526,0.0229749512997976,0.00683601985506043,0.00957635238387912,0.036373550215716,0.000779645770055345
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,39512,-0.0361265089110529,0.0107583736268227,-0.0572129212196254,-0.0150400966024805,0.000787800413378029
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,39512,-0.0218093637511666,0.00649592630283178,-0.0345413793047169,-0.00907734819761629,0.000789507281536426
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STX6,Syntaxin-6,41771,-0.0242182482015548,0.00723154430851292,-0.0383920750462401,-0.0100444213568695,0.000813391552429246
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,39868,-0.0123346763034698,0.00368665763085755,-0.0195605252599506,-0.00510882734698901,0.000823251376409156
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,41990,0.0108996980032736,0.00326078827023889,0.00450855299360538,0.0172908430129418,0.000832076352532239
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,39895,-0.00936487095472256,0.00280416178525606,-0.0148610280538244,-0.00386871385562069,0.000841608023621454
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,39843,-0.0166658927629167,0.00499045976521489,-0.0264471939027379,-0.00688459162309547,0.000841869854976817
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39597,-0.0163283283131901,0.00489014580692134,-0.0259130140947559,-0.00674364253162427,0.000843518174714458
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39364,-0.039712069237096,0.0119415899900217,-0.0631175856175386,-0.0163065528566534,0.000885469990950514
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,42174,-0.0111445491813289,0.003357801557387,-0.0177258402338074,-0.0045632581288504,0.000905776798528614
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CABP2,Calcium-binding protein 2,39590,-0.0237721607689538,0.00719642776098638,-0.0378771591804871,-0.00966716235742048,0.000958498886570019
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39601,-0.0142970364300099,0.00433135680453073,-0.0227864957668902,-0.00580757709312971,0.000967090014403806
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,41995,-0.0164555221808612,0.00499188654995935,-0.0262396198187816,-0.00667142454294092,0.000981684813858695
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDHR1,Cadherin-related family member 1,41766,-0.0150363248301316,0.00456604112798891,-0.0239857654409898,-0.0060868842192733,0.00099358597663019
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FADD,FAS-associated death domain protein,42072,-0.0276553123794461,0.00839870996883585,-0.0441167839183644,-0.0111938408405278,0.00099448802983769
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42236,0.0108238282065126,0.00329200481236395,0.00437149877427928,0.017276157638746,0.00101188145161004
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,39500,-0.0106861455476443,0.00325880590184617,-0.0170734051152628,-0.00429888598002584,0.00104443074745437
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TFF1,Trefoil factor 1,42010,-0.0289661569965874,0.00884970401833834,-0.0463115768725306,-0.0116207371206443,0.00106635907420107
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,41771,-0.0189493725345739,0.00579193630474576,-0.0303015676918756,-0.00759717737727222,0.00107184856229512
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,39904,-0.0184621842029962,0.0056499513149456,-0.0295360887802896,-0.0073882796257028,0.00108759785167876
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CST7,Cystatin-F,42074,-0.0339319109134525,0.0103995220928013,-0.054314974215343,-0.013548847611562,0.00110578841009254
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,39869,-0.019148493996405,0.00587042230712943,-0.0306545217183787,-0.00764246627443129,0.00111013058042455
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,39868,-0.016966865595782,0.00521130904932227,-0.0271810313324537,-0.00675269985911041,0.00113416113682472
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,41771,-0.0155921047047578,0.0047926471481703,-0.0249856931151716,-0.00619851629434399,0.00114344810122087
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD55,Complement decay-accelerating factor,41642,0.0094186220475615,0.00289730271825541,0.00373990871978089,0.0150973353753421,0.00115362913182856
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,42174,-0.0279204692239547,0.00859287765095616,-0.0447625094198288,-0.0110784290280806,0.00115988382728547
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42072,-0.0176666153955806,0.00543780413137368,-0.028324711493073,-0.00700851929808816,0.00116156120376974
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MDK,Midkine,42056,-0.018307673165634,0.00563904691107945,-0.0293602051113497,-0.00725514121991826,0.00117082358575297
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,39850,-0.0250486002647785,0.00771901872708518,-0.0401778769698655,-0.00991932355969156,0.00117773265043615
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42236,0.00978269726385255,0.00301917660891859,0.00386511111037211,0.015700283417333,0.00119737643175462
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TFF2,Trefoil factor 2,42092,-0.0207675200862585,0.00641013853515479,-0.0333313916151619,-0.0082036485573551,0.00119906326792014
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,39675,-0.0133309253991917,0.00411671743386255,-0.0213996915695622,-0.00526215922882106,0.00120623218729681
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,41995,-0.0303167014199907,0.0093749614309528,-0.0486916258246582,-0.0119417770153233,0.00122453161833005
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GDF2,Growth/differentiation factor 2,42072,-0.0125684833549808,0.00388679937501024,-0.0201866101300009,-0.00495035657996071,0.00122520726699223
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,42111,-0.00880327425824986,0.00273351997758628,-0.014160973414319,-0.00344557510218075,0.00128274320695984
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39575,-0.0188992877042363,0.00587633758413349,-0.0304169093691379,-0.00738166603933468,0.00130291396750959
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DRAXIN,Draxin,41943,0.0150063521425962,0.00467371668923704,0.00584586743169162,0.0241668368535008,0.00132681322313575
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ELOB,Elongin-B,39512,-0.0138826740716658,0.00432663752561017,-0.0223628836218617,-0.00540246452146985,0.00133744228565347
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,39895,-0.00964990409223868,0.00301124644427063,-0.0155519471230091,-0.00374786106146825,0.00135616202775081
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NGF,Beta-nerve growth factor,41943,0.00429352059436402,0.00133988550125669,0.0016673450119009,0.00691969617682714,0.0013566557144611
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CAT,Catalase,39765,-0.0184356870319344,0.00575863164746961,-0.0297226050609748,-0.00714876900289393,0.00137144314290436
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,39858,-0.0170575848471087,0.00532928025230269,-0.027502974141622,-0.00661219555259543,0.0013746063089382
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,42048,0.0150623728947055,0.00470830747717732,0.00583409023943796,0.024290655549973,0.00138174355636992
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42172,-0.0238223278186812,0.00745000825969206,-0.0384243440076776,-0.00922031162968476,0.00138882519680585
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA10,Annexin A10,41766,-0.0288297464881234,0.00902207436317214,-0.0465130122399407,-0.011146480736306,0.00139933759118305
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39696,-0.0305650583024488,0.00959834820500894,-0.0493778207842663,-0.0117522958206313,0.00145451215428736
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,39536,-0.0145908489760175,0.00458202944600251,-0.0235716266901824,-0.00561007126185257,0.00145479326632097
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42063,0.0123931581947938,0.0039008026146036,0.0047475850701707,0.0200387313194168,0.00149102444746658
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RALY,RNA-binding protein Raly,39858,-0.0168011023625349,0.00529410215625678,-0.0271775425887982,-0.00642466213627164,0.00150991585005259
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,39500,-0.021526279074846,0.00678497036584535,-0.0348248209919028,-0.00822773715778908,0.00151478132237799
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GRSF1,G-rich sequence factor 1,39426,-0.0290356147865998,0.00916070543241407,-0.0469905974341313,-0.0110806321390682,0.00153082999799961
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CST5,Cystatin-D,41774,-0.0195833363555017,0.00617893975407843,-0.0316940582734954,-0.00747261443750793,0.00153120055741262
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACE,Angiotensin-converting enzyme,39927,-0.00943090317110901,0.00297581413790008,-0.0152634988813932,-0.00359830746082485,0.00153274097946651
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39858,-0.0182184214204946,0.005754945758667,-0.0294981151074819,-0.0069387277335073,0.0015512359700089
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,39927,-0.0255644084668773,0.00807713740687784,-0.0413955977843579,-0.00973321914939674,0.00155475710235811
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD46,Membrane cofactor protein,42032,-0.00993774218759892,0.00315045186813242,-0.0161126278491385,-0.00376285652605937,0.00161190606964489
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,JCHAIN,Immunoglobulin J chain,41842,0.0212325691912749,0.00673514427841923,0.00803168640557318,0.0344334519769766,0.00162237800886384
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RP2,Protein XRP2,41995,-0.01478199053626,0.00469092256629929,-0.0239761987662066,-0.0055877823063134,0.00162964528491327
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APOA2,Apolipoprotein A-II,39927,0.0171010335423148,0.00543205488980475,0.00645420595829748,0.0277478611263321,0.00164722426410994
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB2,Integrin beta-2,42008,0.00991769994188843,0.00315293687464551,0.00373794366758323,0.0160974562161936,0.00166140921726071
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,42139,-0.0287348011967351,0.00919428551422552,-0.0467556008046171,-0.0107140015888531,0.00178005809079526
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LCP1,Plastin-2,39904,0.0164105364448665,0.00526762840169277,0.00608598477754865,0.0267350881121843,0.00184182966710816
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42108,0.0156714037305789,0.00503427468190706,0.00580422535404109,0.0255385821071168,0.00185619365186379
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CNTN2,Contactin-2,42187,0.0150865585681992,0.00484728317549811,0.00558588354422285,0.0245872335921754,0.00185974171387248
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",39696,-0.0161694497449888,0.00519808254420533,-0.0263576915316312,-0.00598120795834636,0.00187145183991096
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,42111,-0.022224797720094,0.0071451008964485,-0.0362291954771331,-0.00822039996305497,0.00187163100467064
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42111,-0.00952649331456585,0.0030641316885605,-0.0155321914241444,-0.00352079520498727,0.00188089386504293
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLK7,Kallikrein-7,39417,-0.0135444150264723,0.00436435401347387,-0.0220985488928811,-0.0049902811600635,0.00191792513955913
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TBC1D17,TBC1 domain family member 17,41766,-0.0147258565476914,0.00475131844153971,-0.0240384406931092,-0.00541327240227353,0.0019437426335575
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39904,-0.0214889031151261,0.0069411092993932,-0.0350934773419368,-0.00788432888831542,0.00196703773336888
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,42187,0.0180284409398187,0.00584936329217683,0.00656368888715211,0.0294931929924853,0.00205943171661112
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,39811,-0.0212603924673326,0.00689890331684306,-0.034782242968345,-0.00773854196632025,0.00206316993626003
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,39575,-0.0178138774944111,0.0057856109882207,-0.0291536750313237,-0.00647407995749856,0.00208211737911837
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CASP9,Caspase-9,39597,-0.0216371366449514,0.00702977046604873,-0.035415486758407,-0.00785878653149594,0.00208957301774714
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SNX18,Sorting nexin-18,39869,-0.0148092702768478,0.00481606537359885,-0.0242487584091016,-0.00536978214459408,0.00211025491993043
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MMP13,Collagenase 3,41766,0.0109104715658407,0.00355509110659188,0.00394249299692064,0.0178784501347608,0.00215234196964109
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CFD,Complement factor D,39917,0.00681268531636399,0.00222365682625359,0.00245431793690695,0.011171052695821,0.00219109640539831
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA4,Annexin A4,42015,-0.0243884211189581,0.007973172606237,-0.0400158394271826,-0.00876100281073358,0.00222656050339414
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCRN1,Secernin-1,42048,-0.0186435643250488,0.00609972218514859,-0.03059901980794,-0.00668810884215752,0.00224405682897383
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NECTIN4,Nectin-4,42108,0.0113021455609053,0.00369844246114658,0.00405319833705799,0.0185510927847526,0.00224808643102571
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,41747,-0.0224712986841328,0.00735799023660353,-0.0368929595478757,-0.00804963782038985,0.00226264103301347
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,39742,-0.0187033088226944,0.00617291310750252,-0.0308022185133994,-0.0066043991319895,0.00245195718308709
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CA1,Carbonic anhydrase 1,41817,-0.0187468934211666,0.00618963866236204,-0.0308785851993961,-0.00661520164293696,0.00246038428554597
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,39821,-0.0162221196644469,0.00537631316090886,-0.0267596934598283,-0.00568454586906557,0.00255582504243186
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,39525,0.0114329130685375,0.00379592395002146,0.00399290212649547,0.0188729240105796,0.0026021895742376
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,39872,-0.0131856995164199,0.00437932235947115,-0.0217691713409834,-0.00460222769185648,0.00261051967481041
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,41771,-0.0159947501453551,0.00532010903824953,-0.0264221638603242,-0.00556733643038599,0.00264798078123543
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DNM1,Dynamin-1,39869,-0.0382749971461312,0.0127357330984264,-0.0632370340190469,-0.0133129602732156,0.00265882369045403
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCT,Secretin,39590,-0.0159110165960308,0.00529980447511483,-0.0262986333672558,-0.00552339982480569,0.00268647906565854
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42072,-0.022303996496473,0.00743919443834789,-0.0368848175956349,-0.00772317539731114,0.00272098455193492
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,39872,0.0151555133580379,0.00505967270270968,0.00523855486072695,0.0250724718553489,0.00274721839680297
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CHRDL2,Chordin-like protein 2,42072,-0.0150417942098773,0.00502563888050051,-0.0248920464156583,-0.00519154200409634,0.00276740330737186
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,41771,-0.0244328014826079,0.00818534743427279,-0.0404760824537826,-0.00838952051143325,0.00284151353720296
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SATB1,DNA-binding protein SATB1,39872,-0.00960464589547219,0.00322863941843901,-0.0159327791556126,-0.00327651263533173,0.00293774526542108
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,39927,-0.00874086614397492,0.0029398353779308,-0.0145029434847193,-0.00297878880323056,0.00295284457084735
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACRBP,Acrosin-binding protein,39858,-0.0130685728869884,0.00439928358215391,-0.0216911687080101,-0.00444597706596671,0.00297832656893537
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39512,-0.0150825173627566,0.00507819216339084,-0.0250357740030027,-0.00512926072251058,0.00298393143596243
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,41771,0.0169368153044048,0.00571198637913538,0.00574132200129943,0.0281323086075101,0.00303091614577658
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MYL4,Myosin light chain 4,39575,-0.016828381884601,0.00568051283714059,-0.0279621870453966,-0.00569457672380545,0.00305830127331955
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APOE,Apolipoprotein E,39917,-0.0226904631211004,0.00766188844178699,-0.0377077644670029,-0.00767316177519787,0.00306808819944154
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLSTN2,Calsyntenin-2,42222,0.0130484453345281,0.00440735427134149,0.00441003096269882,0.0216868597063575,0.00307562250633403
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CASP4,Caspase-4,39696,0.0541341285867057,0.0182848184672377,0.0182958843909199,0.0899723727824916,0.00307684894605045
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,39868,0.0132193050272032,0.00447139720345443,0.00445536650843252,0.0219832435459739,0.00311883317009957
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42222,-0.021462458092913,0.00726238199448636,-0.0356967268021063,-0.00722818938371975,0.00312908247897373
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,41771,-0.0232816963353496,0.00788398770279303,-0.038734312232824,-0.00782908043787528,0.00315221322293626
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,41943,-0.0341123104501302,0.0115609496778762,-0.0567717718187676,-0.0114528490814928,0.00317657645574306
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BRDT,Bromodomain testis-specific protein,39512,-0.0118776515383377,0.00403254882723803,-0.0197814472397243,-0.00397385583695121,0.00323171287373479
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CORO1A,Coronin-1A,41812,-0.0287742082669825,0.00977208350810803,-0.0479274919428743,-0.00962092459109077,0.00324007387245949
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,39831,-0.0147096513275101,0.00500288477648878,-0.0245153054894281,-0.00490399716559211,0.00328633148601403
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,42111,0.00866666040588441,0.00296353025597813,0.00285814110416728,0.0144751797076015,0.00345652188685684
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39696,-0.0143547046872323,0.00491865456867579,-0.0239952676418369,-0.00471414173262778,0.0035251552680093
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,39675,-0.0105979494062089,0.00363318770173371,-0.017718997301607,-0.00347690151081088,0.00354144045450807
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,39869,0.0161063586301099,0.00553294997422286,0.00526177668063309,0.0269509405795867,0.00360992095644444
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,INSL3,Insulin-like 3,39868,0.0287967636799831,0.00989560420929092,0.00940137942977287,0.0481921479301933,0.00362071037709455
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CBX2,Chromobox protein homolog 2,39512,0.0126597602294416,0.00435627085594689,0.00412146935178566,0.0211980511070975,0.00366699988102623
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,41766,-0.0235929626588709,0.00811989657367475,-0.0395079599432734,-0.00767796537446838,0.00367190327173255
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42009,0.0107939929052536,0.00372038712691875,0.00350203413649283,0.0180859516740143,0.00372211582198707
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GAD2,Glutamate decarboxylase 2,39597,0.0144788878797671,0.00499052443375957,0.00469745998959839,0.0242603157699359,0.00372383695749309
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BLVRB,Flavin reductase,42063,-0.020294144749578,0.00700350608048856,-0.0340210166673355,-0.00656727283182039,0.00376501603438905
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SAFB2,Scaffold attachment factor B2,39872,-0.00870102762721604,0.00300349649650108,-0.0145878807603582,-0.00281417449407392,0.00377515569240918
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GZMH,Granzyme H,41828,-0.0250771645733362,0.00866748026976632,-0.0420654259020782,-0.00808890324459423,0.00381903190659811
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CA12,Carbonic anhydrase 12,41995,0.0103996430199295,0.00359866487656896,0.00334625986185434,0.0174530261780047,0.00386030194630554
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,42048,0.0153810246809064,0.0053302884187569,0.00493365938014285,0.0258283899816699,0.00391302498846556
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PSAP,Prosaposin,39825,-0.00904818932033544,0.00313697776665729,-0.0151966657429837,-0.00289971289768715,0.0039294976729502
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TCN1,Transcobalamin-1,39744,0.0112876679087498,0.00392417104839362,0.00359629265389832,0.0189790431636013,0.00402943380022988
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41828,-0.00871325680615789,0.00302957259020491,-0.0146512190829595,-0.00277529452935627,0.00403306120218129
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42092,-0.0283858273679633,0.00987698227592223,-0.0477447126287709,-0.00902694210715576,0.00406022637816022
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42070,-0.0081036704811695,0.00282108089223501,-0.0136329890299501,-0.00257435193238887,0.00407821134032228
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AZU1,Azurocidin,41681,-0.0237931123701525,0.00828622723400632,-0.0400341177488049,-0.00755210699150017,0.00409308102002559
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NLGN2,Neuroligin-2,39526,0.0147857441140063,0.00515345768472361,0.00468496705194801,0.0248865211760646,0.00412441224929207
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,41886,0.00956944767220435,0.00334465795046641,0.00301391808929018,0.0161249772551185,0.0042281402760889
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,39512,-0.0109969489562547,0.00384511424156171,-0.0185333728697156,-0.00346052504279373,0.0042447194118301
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRUNE2,Protein prune homolog 2,39696,-0.00910489767679319,0.00318402618968143,-0.0153455890085688,-0.00286420634501758,0.00425027195327157
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HLA_DRA,,41989,0.0114448311243637,0.00400882209633843,0.00358753981554035,0.019302122433187,0.00431150041262082
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DSG4,Desmoglein-4,41943,0.0150437278274922,0.00528037018074115,0.00469420227323953,0.0253932533817448,0.00439252133110569
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41828,-0.0152261863897591,0.00534520816995028,-0.0257027944028616,-0.00474957837665654,0.00439842812796086
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39858,-0.0203684427929267,0.00716244024578369,-0.0344068256746627,-0.00633005991119064,0.00446613900332322
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,39872,0.0139684081462228,0.00491332502864364,0.00433829109008128,0.0235985252023644,0.00447764083630145
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,41842,-0.0117464053872738,0.00414140404326984,-0.0198635573120827,-0.00362925346246491,0.00457039214768151
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,39705,-0.0124040372392534,0.00437893386990011,-0.0209867476242576,-0.0038213268542492,0.00462453762665761
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EVI2B,Protein EVI2B,39500,0.0124372269970931,0.00439870260193977,0.00381576989729119,0.0210586840968951,0.00470020102768894
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLAMF6,SLAM family member 6,41771,-0.0120334975659815,0.00425931825430495,-0.0203817613444192,-0.0036852337875438,0.00473196880831272
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EFNA4,Ephrin-A4,41919,-0.0100166133742726,0.00354586793147077,-0.0169665145199553,-0.00306671222858988,0.00473702204661379
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42029,-0.00758992359599858,0.00268716809458674,-0.0128567730613886,-0.00232307413060857,0.0047423277819969
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ENG,Endoglin,42236,0.00536501920755598,0.0018998375484233,0.00164133761264631,0.00908870080246565,0.00475066846376548
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITGA2,Integrin alpha-2,39675,-0.010779936442832,0.00381808457882893,-0.0182633822173368,-0.00329649066832734,0.00476037320634006
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FCRL1,Fc receptor-like protein 1,42072,0.0141805950099826,0.00503365459782028,0.00431463199825484,0.0240465580217103,0.00485213470775767
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39500,0.00965928651427816,0.00343032003419755,0.00293585924725097,0.0163827137813053,0.00487348534319076
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42236,-0.010013693801828,0.00357817527524828,-0.0170269173413146,-0.00300047026234136,0.00514050574774986
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RGMA,Repulsive guidance molecule A,42174,0.00986949936172012,0.00353667246851123,0.00293762132343811,0.0168013774000021,0.0052681058966538
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",39872,0.0111147972328779,0.00399405499716297,0.00328644943843851,0.0189431450273174,0.00539758197966084
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RPS10,40S ribosomal protein S10,39512,0.0127727960414737,0.0046013258026118,0.00375419746835457,0.0217913946145928,0.00551438082145987
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DCN,Decorin,41828,0.00702317213427729,0.00253205467044618,0.00206034498020278,0.0119859992883518,0.00554996031027776
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39597,-0.0103068056280281,0.00372082432849573,-0.0175996213118797,-0.00301398994417647,0.00561446645987643
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD82,CD82 antigen,39696,0.0125906673405109,0.00456025116063075,0.00365257506567465,0.0215287596153472,0.00577265674315939
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,41766,-0.0126622015243402,0.0045874179837198,-0.021653540772431,-0.00367086227624942,0.00578454880161614
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,39597,-0.0171908149673661,0.00623504922897121,-0.0294115114561496,-0.00497011847858252,0.00584081038021126
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,39500,-0.0230675156340725,0.00836852429783265,-0.0394698232578245,-0.00666520801032052,0.00585276349381941
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CSTB,Cystatin-B,41886,-0.013131099721272,0.0047732648753514,-0.0224866988769608,-0.00377550056558329,0.00594998895306531
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLAMF7,SLAM family member 7,42048,0.0179789497027779,0.00656187284652026,0.00511767892359823,0.0308402204819577,0.00615368078680112
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LGMN,Legumain,42111,-0.0109322141645097,0.0039923499733271,-0.0187572201122308,-0.00310720821678858,0.00618403807978175
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39869,-0.00913690456139619,0.0033393949456654,-0.0156821186549004,-0.00259169046789201,0.00622702795819744
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,42034,0.00910867970198232,0.00334332426377061,0.00255576414499193,0.0156615952589727,0.00644943380179254
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,41874,0.00836510421503625,0.00307151087781456,0.00234494289451972,0.0143852655355528,0.00646885910690074
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39869,-0.0359561434233666,0.0132080950112309,-0.0618440096453792,-0.010068277201354,0.00649327249803814
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DAPK2,Death-associated protein kinase 2,39597,-0.0165655182743648,0.00609417695644145,-0.02851010510899,-0.00462093143973957,0.00657303886465779
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,39675,-0.0122772177185892,0.00451659868739837,-0.02112975114589,-0.00342468429128837,0.0065731544963185
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42063,-0.0112973513501709,0.00417673620248859,-0.0194837543070485,-0.00311094839329325,0.0068425798222059
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,42063,-0.00726934537863322,0.00270039206599193,-0.0125621138279774,-0.00197657692928903,0.00711214500611839
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SWAP70,Switch-associated protein 70,39869,-0.010871868456674,0.00403855048008551,-0.0187874273976416,-0.00295630951570636,0.0071125087480848
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DCUN1D2,DCN1-like protein 2,39500,0.0235623437916381,0.00875519919124318,0.00640215337680143,0.0407225342064747,0.00712955377836765
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,THBS4,Thrombospondin-4,42114,0.0133911766388252,0.00499352818323286,0.00360386139968881,0.0231784918779616,0.00733367020398748
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL20,C-C motif chemokine 20,42222,-0.0255248533969049,0.00951858606913813,-0.0441812820924156,-0.00686842470139416,0.0073363621930969
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NINJ1,Ninjurin-1,41771,0.0160452258447109,0.00599094408660094,0.00430297543497303,0.0277874762544487,0.00741005364789339
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRTAP,Cartilage-associated protein,39590,-0.0145163876012388,0.00542140820303755,-0.0251423476791924,-0.00389042752328516,0.00742608772764032
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,39575,-0.00966668752573191,0.00361376651940277,-0.0167496699037613,-0.00258370514770249,0.00748485731052208
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42047,-0.0215202167049973,0.00805394581690294,-0.037305950506127,-0.00573448290386751,0.00754894768362237
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRYGD,Gamma-crystallin D,39868,-0.0287900815940492,0.0107888073769881,-0.0499361440529458,-0.00764401913515265,0.00762967248154625
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42164,0.0089565752825835,0.00336688766764636,0.00235747545399665,0.0155556751111704,0.00781874411936057
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ROBO2,Roundabout homolog 2,42174,0.0066240838129681,0.00249277150693987,0.00173825165936595,0.0115099159665703,0.00788575789011894
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39512,-0.0191199675599836,0.00721055776076176,-0.0332526607710766,-0.00498727434889054,0.00802122635754198
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TXN,Thioredoxin,39792,-0.0125442775487538,0.00473133816300691,-0.0218177003482474,-0.00327085474926028,0.00802914702157109
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",41828,0.0127225702296786,0.00480222559082648,0.00331020807165871,0.0221349323876985,0.00807528650209562
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL19,C-C motif chemokine 19,42174,-0.0329595268432802,0.0124424258623481,-0.0573466815334824,-0.00857237215307794,0.00808326136006127
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HCG22,Protein PBMUCL2,39512,0.0169814570741288,0.00641418488822441,0.00440965469320892,0.0295532594550486,0.00812095512857134
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,39500,-0.0106155783365957,0.00401559040066253,-0.0184861355218943,-0.00274502115129719,0.00821491393060626
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CGN,Cingulin,39590,-0.0108970215778174,0.00412454586197788,-0.018981131467294,-0.00281291168834071,0.00825364882861853
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,42221,-0.0067561627702515,0.00256558093924953,-0.0117847014111806,-0.00172762412932242,0.00846339112419692
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RNASE6,Ribonuclease K6,39874,-0.00931854477289138,0.0035576393343022,-0.0162915178681237,-0.00234557167765907,0.00882269378156134
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42063,0.0340521218228791,0.0130524335662777,0.00846935203297476,0.0596348916127834,0.00909417610218885
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39581,-0.0103982075749233,0.00398580628865737,-0.0182103879006918,-0.00258602724915488,0.0090981047882996
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GPC5,Glypican-5,41943,-0.0161450512687167,0.00619128942899085,-0.0282799785495388,-0.00401012398789464,0.00912531911886267
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,41859,-0.00970756657275883,0.00373655220472356,-0.017031208894017,-0.00238392425150066,0.00938718938190775
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AFP,Alpha-fetoprotein,41903,-0.0185326988695601,0.00716539258789683,-0.0325768683418379,-0.00448852939728232,0.0097084499645693
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ROBO4,Roundabout homolog 4,39575,0.0051839120535232,0.00200888376394762,0.00124649987618586,0.00912132423086054,0.00987878083025397
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,THPO,Thrombopoietin,41828,-0.0110322155800758,0.00429139591826451,-0.0194433515798742,-0.00262107958027737,0.010157940952124
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,41865,-0.00679476496738458,0.00264356996015581,-0.01197616208929,-0.0016133678454792,0.0101718910416889
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL20,Interleukin-20,41842,0.0131832643353224,0.00513417075359002,0.00312028965828598,0.0232462390123589,0.0102469812266566
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BMP10,Bone morphogenetic protein 10,39675,0.007980430054573,0.00311360339336183,0.00187776740358382,0.0140830927055622,0.0103877556590967
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRH,Corticoliberin,41759,-0.0242050624236511,0.00944659153829931,-0.0427203818387178,-0.00568974300858448,0.0104089819978022
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD300A,CMRF35-like molecule 8,39675,0.00862197812152563,0.00336563387216812,0.0020253357320761,0.0152186205109751,0.010427157495107
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41828,-0.0100600823773856,0.00392764522919285,-0.0177582670266036,-0.00236189772816758,0.0104375498765587
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,41828,-0.0118458897886722,0.00462957127545734,-0.0209198494885686,-0.0027719300887758,0.0105161238021944
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNF,Tumor necrosis factor,41808,-0.0102506320886113,0.00400658605844925,-0.0181035407631718,-0.00239772341405077,0.010525181760381
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,41675,0.0109908595026165,0.00429879838769454,0.00256521466273526,0.0194165043424978,0.0105773639580977
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,39869,-0.0322462981633057,0.0126215107942701,-0.0569844593200752,-0.00750813700653625,0.0106358205505548
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42174,-0.0197153853996997,0.00772634240047908,-0.0348590165046387,-0.00457175429476066,0.0107304312215386
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39512,-0.0112873663521733,0.00442931931384652,-0.0199688322073124,-0.00260590049703407,0.0108375893462632
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDA,Cytidine deaminase,39883,-0.0133649491171229,0.00525160813718149,-0.0236581010659987,-0.00307179716824723,0.0109433189550266
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GUK1,Guanylate kinase,39512,0.0112767349653684,0.00444348594458737,0.00256750251397715,0.0199859674167597,0.0111685586636432
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,42108,0.0222230427646095,0.00875870653987925,0.00505597794644615,0.0393901075827728,0.0111838099226711
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,39869,-0.0139783130180168,0.00551948582420772,-0.024796505233464,-0.00316012080256971,0.0113374351407041
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,41771,-0.013243482514359,0.00523114524169593,-0.023496527188083,-0.00299043784063499,0.0113639210884855
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,39590,0.0190461235711893,0.00754462668191262,0.00425865527464057,0.033833591867738,0.0116015137908304
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,39500,0.0133748379804403,0.00531249438030873,0.00296234899503524,0.0237873269658455,0.011829313544689
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,39858,-0.012411244090897,0.00493277533085054,-0.022079483739364,-0.00274300444242991,0.0118807092045192
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,39696,0.0218694529362165,0.00869545548080097,0.00482636019384664,0.0389125456785865,0.0119157701614931
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42106,0.016011110701693,0.0063675577298237,0.00353069755123856,0.0284915238521475,0.0119322554753543
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GBP1,Guanylate-binding protein 1,39850,-0.0178825108474856,0.00712018463668863,-0.0318380727353953,-0.00392694895957587,0.012035023339691
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,42236,-0.00631179527775872,0.00251399540299863,-0.011239226267636,-0.00138436428788139,0.0120619436420139
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,39526,-0.0133176283507982,0.00530565277332334,-0.0237167077865119,-0.00291854891508441,0.0120846175699938
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,42222,0.0164279917077226,0.00654742094304072,0.00359504665936277,0.0292609367560824,0.0121161798903279
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,39597,-0.0111774927334342,0.00446085002742716,-0.0199207587871914,-0.00243422667967697,0.0122357169840508
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LMNB1,Lamin-B1,39847,0.016855511565191,0.00672759470363464,0.00366942594606712,0.0300415971843149,0.0122443103257632
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,41916,0.00765505153635066,0.00305805522771713,0.00166126329002509,0.0136488397826762,0.0123180221605509
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BTC,Probetacellulin,41771,-0.0202130373992709,0.00808722002108468,-0.0360639886405968,-0.00436208615794491,0.0124531498008432
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CST6,Cystatin-M,41792,0.0135891945701673,0.00546707580794113,0.00287372598660274,0.024304663153732,0.012944077762224
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RYR1,Ryanodine receptor 1,39512,0.00925161790397223,0.00372323962172411,0.00195406824539299,0.0165491675625515,0.0129762006417624
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PALM,Paralemmin-1,39798,0.00834932873266794,0.00336578747507863,0.00175238528151382,0.0149462721838221,0.0131290155012812
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,REST,RE1-silencing transcription factor,39500,0.00933688453530378,0.00376542252734193,0.0019566563817136,0.016717112688894,0.0131665821423478
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL7,C-C motif chemokine 7,42048,-0.0153330381726181,0.00618761683943261,-0.027460767177906,-0.00320530916733018,0.0132235567734717
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42102,-0.0139025865084761,0.00561769458951124,-0.0249132679039181,-0.00289190511303409,0.0133438267816556
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42048,-0.0101239176432352,0.00410257814733379,-0.0181649708120094,-0.00208286447446097,0.0136109131301691
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,39868,-0.00619063712006428,0.00251282289213226,-0.0111157699886435,-0.00126550425148506,0.0137690690077367
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,39510,-0.0275418430773461,0.0111924434547461,-0.0494790322486485,-0.00560465390604382,0.0138799389575226
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AHCY,Adenosylhomocysteinase,42072,-0.0182057068254005,0.00740540606969517,-0.032720302722003,-0.00369111092879792,0.0139669077072133
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,42222,0.00665070287565165,0.00271175619492341,0.00133566073360176,0.0119657450177015,0.014197432693953
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SNU13,NHP2-like protein 1,39512,-0.0170224692099851,0.00694119600823028,-0.0306272133861164,-0.00341772503385372,0.0142069105178006
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD160,CD160 antigen,42222,0.013022987334448,0.00532599044699341,0.00258404605834087,0.0234619286105551,0.0144906968893231
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRDX2,Peroxiredoxin-2,39758,-0.0162316580510894,0.00664287717093578,-0.0292516973061236,-0.00321161879605529,0.0145622453924642
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RCOR1,REST corepressor 1,41828,-0.0119837845308744,0.00491095242261718,-0.0216092512792041,-0.00235831778254475,0.0146915189213438
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39696,-0.0106279922094193,0.00435840521157495,-0.0191704664241062,-0.00208551799473241,0.0147637369053978
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD300C,CMRF35-like molecule 6,42174,0.00941345634295683,0.00386934109462158,0.00182954779749853,0.0169973648884151,0.0149940831253912
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACRV1,Acrosomal protein SP-10,39597,-0.0284002263514442,0.0116960816269288,-0.0513245463402248,-0.0054759063626637,0.0151906164790163
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39858,-0.0144069385097461,0.0059414814138036,-0.0260522420808012,-0.00276163493869108,0.0153322091727747
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DLGAP5,Disks large-associated protein 5,39872,0.0131905976863424,0.00544857095855137,0.00251139860758168,0.0238697967651031,0.0154966362885692
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL17C,Interleukin-17C,41842,-0.0188529278483642,0.00778982212422191,-0.0341209792118391,-0.00358487648488925,0.0155253397165139
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD99,CD99 antigen,42063,0.00529298962058857,0.00218956436901224,0.00100144345732457,0.00958453578385257,0.0156462676258286
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCARB2,Lysosome membrane protein 2,41706,-0.00874124125111833,0.00361648326266323,-0.0158295484459383,-0.00165293405629839,0.0156601881178955
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA4D,Semaphorin-4D,42174,-0.00799519434362253,0.00331080969241102,-0.0144843813407481,-0.00150600734649692,0.0157537062448941
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,39868,0.0100095769449034,0.00415700337369155,0.00186185033246796,0.0181573035573388,0.0160612940219545
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,39526,0.0197583041432796,0.00823668819397107,0.00361439528309635,0.0359022130034629,0.0164648065341523
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,39858,-0.00763063090557814,0.00318342587058081,-0.0138701456119165,-0.00139111619923975,0.0165467045211957
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SDC4,Syndecan-4,42072,-0.0124644010132622,0.00520457586538587,-0.0226653697094185,-0.00226343231710588,0.0166388016160542
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,39512,-0.0112492169846961,0.00469735945754082,-0.0204560415214761,-0.0020423924479161,0.0166463823999982
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TREML1,Trem-like transcript 1 protein,39927,-0.0139813766996225,0.00584183905311584,-0.0254313812437296,-0.00253137215551548,0.0167129546077505
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,41900,0.00648698149595133,0.00271135760283934,0.00117272059438622,0.0118012423975164,0.0167468364568612
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GBP4,Guanylate-binding protein 4,41766,-0.0129324604241972,0.00541086803852154,-0.0235377617796994,-0.00232715906869498,0.0168582286339082
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,41857,0.0108037508718703,0.00452883989302693,0.00192722468153751,0.0196802770622031,0.0170677986010345
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CASP1,Caspase-1,41766,-0.0181023150782024,0.00760351506733496,-0.033005204610179,-0.00319942554622593,0.0172900502816574
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42063,0.00943086976534302,0.00396198795132138,0.00166537338075312,0.0171963661499329,0.0173106068003781
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GZMB,Granzyme B,42048,-0.0177716151100364,0.0074707724128288,-0.0324143290391809,-0.00312890118089196,0.0173820788629566
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NTF4,Neurotrophin-4,41771,0.0099261276277625,0.00417627796733315,0.00174062281178953,0.0181116324437355,0.0174783222220364
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRND,Prion-like protein doppel,39868,0.0127739049945469,0.00537747335553491,0.00223405721769849,0.0233137527713953,0.0175443211612096
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OTOA,Otoancorin,39526,0.0137688453068869,0.00579655277382887,0.0024076018701823,0.0251300887435915,0.0175494391609771
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,42072,0.00827756794953506,0.00348506204297793,0.00144684634529831,0.0151082895537718,0.0175554223063299
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL31,Interleukin-31,39597,0.0145418233348476,0.00612715359116697,0.00253260229616036,0.0265510443735349,0.0176450767533214
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42070,0.00905180787698159,0.00381559121828071,0.00157324908915141,0.0165303666648118,0.0176906819441781
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,41842,-0.00937046760533935,0.00397363138219028,-0.0171587851144323,-0.00158215009624641,0.0183801165620741
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RLN2,Prorelaxin H2,39648,-0.0133156712621452,0.00566547847229377,-0.024420009067841,-0.00221133345644938,0.0187749104104956
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,42174,-0.0332193137416645,0.0141540167272463,-0.0609611865270673,-0.00547744095626165,0.0189401332670054
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,41771,-0.0146349913541688,0.00624739154960224,-0.0268798787913892,-0.0023901039169484,0.0191659249033516
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MSLN,Mesothelin,41973,0.0149698122152403,0.0063957896364005,0.00243406452789529,0.0275055599025852,0.0192687946584901
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41747,-0.0124898194591899,0.00533998718014413,-0.0229561943322724,-0.00202344458610744,0.0193543115357785
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,41771,-0.00930648883251033,0.00398112843648888,-0.0171095005680285,-0.00150347709699212,0.0194202544884113
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,39590,0.0173130890364577,0.00741827193917953,0.00277327603566584,0.0318529020372496,0.0196218256797434
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,39868,0.007060663134232,0.00303842435461124,0.00110535139919397,0.01301597486927,0.0201543949288112
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,F2,Prothrombin,39917,-0.00380039165577012,0.00163566973162588,-0.00700630432975684,-0.000594478981783394,0.0201727871642122
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MATN2,Matrilin-2,42070,-0.00756553268246928,0.00325675588018185,-0.0139487742076257,-0.00118229115731286,0.0201925041500113
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42050,-0.00750499470376133,0.00323348677786996,-0.0138426287883864,-0.00116736061913621,0.0203005166173496
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL6,Interleukin-6,41995,0.0190217071928802,0.00819554293257724,0.00295844304502883,0.0350849713407316,0.0203027526828821
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42111,-0.00701727249931524,0.00303444762900605,-0.0129647898521671,-0.00106975514646339,0.0207630589045717
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39696,0.00886454602986171,0.00383390613974069,0.00135008999596997,0.0163790020637535,0.0207879211433925
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PAEP,Glycodelin,41943,0.0265773962631988,0.0115198328180281,0.00399852393986362,0.0491562685865339,0.0210645291633191
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C1QL2,Complement C1q-like protein 2,39597,0.0108862877107612,0.00472019878614211,0.00163469808992269,0.0201378773315998,0.0211112736657289
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IMPA1,Inositol monophosphatase 1,41943,-0.0154675593552077,0.00672607506189705,-0.0286506664765259,-0.00228445223388947,0.0214839202266763
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,41732,0.00736747659106447,0.0032068748234498,0.00108200193710285,0.0136529512450261,0.0216115707088904
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRELP,Prolargin,42050,0.00589794486912917,0.0025749492706558,0.000851044298643789,0.0109448454396145,0.0220072186240254
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39590,-0.013596528492697,0.00593983759806094,-0.0252386101848965,-0.00195444680049761,0.0220958811192197
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42048,0.00920916379086181,0.00402639436976501,0.00131743082612239,0.0171008967556012,0.0221996897814631
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42063,-0.00756708376533913,0.0033148099819049,-0.0140641113298727,-0.00107005620080552,0.0224570378439372
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,41995,0.00612068358553513,0.00268295491687205,0.000862091948465916,0.0113792752226043,0.0225450328731922
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39597,-0.00700280627873481,0.0030775234010273,-0.0130347521447483,-0.000970860412721292,0.0228970176166781
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EFNA1,Ephrin-A1,42039,0.00735035402966346,0.00323309780680126,0.001013482328333,0.0136872257309939,0.0230135195107952
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MSMB,Beta-microseminoprotein,42032,0.0174222590016852,0.00768124976371373,0.00236700946480628,0.0324775085385641,0.0233356152063024
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,41924,0.00813421300652624,0.00359658726322265,0.00108490197060984,0.0151835240424426,0.0237352306561967
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UBQLN3,Ubiquilin-3,39512,-0.0139620331323236,0.00619280291633904,-0.0260999268483481,-0.00182413941629907,0.0241808327970676
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPM1A,Protein phosphatase 1A,41771,-0.00778593893804556,0.00345424721643802,-0.0145562634822641,-0.00101561439382703,0.024211338201653
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39512,0.00517598143769513,0.00229680529310384,0.000674243063211608,0.00967771981217865,0.0242438221651348
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39512,-0.0216696372213246,0.00962145421314349,-0.0405276874790858,-0.00281158696356335,0.0243281295079108
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39869,-0.0124777466120868,0.00554626578402995,-0.0233484275487855,-0.00160706567538812,0.0244836337273423
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD177,CD177 antigen,42049,0.0318367254123156,0.0141773455023853,0.00404912822764038,0.0596243225969909,0.0247454587705957
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,39512,-0.00953332404298982,0.00424816796658103,-0.0178597332574886,-0.001206914828491,0.0248457766013746
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,39869,-0.0106130964361601,0.00474864625020041,-0.0199204430865529,-0.00130574978576725,0.0254386355458954
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGF7,Fibroblast growth factor 7,39500,0.0190715456325287,0.0085630298431241,0.00228800714000545,0.0358550841250519,0.0259545208889225
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,42174,0.00715189705683749,0.00321608640087312,0.000848367711126169,0.0134554264025488,0.0261790462155319
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42047,0.0143927805505901,0.00647352239921351,0.00170467664813164,0.0270808844530486,0.0262100688645896
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLSTN3,Calsyntenin-3,39868,0.00740208213544157,0.00332999159380221,0.000875298611589235,0.0139288656592939,0.0262454728883363
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,42236,-0.00875211678568328,0.00393749579162958,-0.0164696085372773,-0.0010346250340893,0.0262481740664186
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,39575,-0.0094181491078226,0.00426163184157248,-0.0177709475173047,-0.00106535069834054,0.0271266550831707
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,39512,0.016490591534361,0.00748422828684291,0.00182150409214885,0.0311596789765731,0.0275888623823127
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,41771,0.013825654426429,0.0062757934033298,0.00152509935590263,0.0261262094969555,0.0276110846527562
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39512,0.00897457310292661,0.00409113518572393,0.000955948138907712,0.0169931980669455,0.0282806415648788
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39575,0.00964946628542881,0.00440412516324286,0.00101738096547282,0.0182815516053848,0.0284722827094237
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39869,-0.0105568981261264,0.00481869760382792,-0.0200015454296292,-0.0011122508226237,0.0284852433957793
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,THBD,Thrombomodulin,42072,0.00711921630077337,0.00325066136144595,0.000747920032339306,0.0134905125692074,0.0285353430433432
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39590,0.0143429475705671,0.0065649365853903,0.00147567186320214,0.0272102232779321,0.0289259705208865
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SEZ6,Seizure protein 6 homolog,39590,0.0075199630864101,0.00344641031571048,0.000764998867617558,0.0142749273052027,0.0291328719232701
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,39575,0.00927188054219228,0.00426105781313733,0.000920207228443116,0.0176235538559414,0.0295797001420853
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,39895,0.00670267223670676,0.00308213613941832,0.000661685403446847,0.0127436590699667,0.0296744840288726
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IFNG,Interferon gamma,41842,-0.0271935567030791,0.0125373922394172,-0.0517668454923368,-0.00262026791382133,0.030100705030377
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NEFL,Neurofilament light polypeptide,41724,0.0113167955263875,0.00521889647241244,0.00108775844045908,0.0215458326123158,0.0301441257094977
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CST1,Cystatin-SN,38447,-0.0254694451160286,0.0117610783351922,-0.0485211586530053,-0.00241773157905196,0.0303679463181035
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CFP,Properdin,39917,-0.00563183876090886,0.002602597031608,-0.0107329289428605,-0.000530748578957184,0.0304905463077884
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42050,-0.00939702638668206,0.00434514712792596,-0.0179135147574169,-0.000880538015947181,0.0305857832667495
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,39597,0.00718858019142657,0.00332842627951623,0.000664864683574763,0.0137122956992784,0.0308133034924717
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MDM1,Nuclear protein MDM1,39590,-0.00747751694075537,0.00346253242319709,-0.0142640804902217,-0.000690953391289062,0.0308289712136042
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,39677,0.0125578098398779,0.00582585480227365,0.00113913442742159,0.0239764852523343,0.0311417883467267
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39597,-0.0105820588735324,0.00491538421849645,-0.0202162119417854,-0.000947905805279346,0.0313525680076188
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TSPAN1,Tetraspanin-1,41828,-0.017246935462118,0.00802471208265097,-0.0329753711441139,-0.00151849978012207,0.0316344204757875
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39590,-0.00944875583934833,0.00439668814083788,-0.0180662645953906,-0.000831247083306072,0.031651249690502
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,39847,-0.00858818092159902,0.00399707154983821,-0.0164224411592819,-0.000753920683916137,0.0316859559995382
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRNN,Cornulin,41676,0.0159371779158547,0.0074250279558293,0.00138412312242929,0.0304902327092802,0.0318583711044633
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,39500,0.00718275885883085,0.00334866241501616,0.00061938052539917,0.0137461371922625,0.0319777947657734
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MPO,Myeloperoxidase,42063,-0.0106051425637227,0.0049460166172373,-0.0202993351335078,-0.000910949993937614,0.0320364379204369
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39597,-0.00882318361605735,0.0041190061755106,-0.0168964357200581,-0.000749931512056578,0.0322100585239714
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,S100A16,Protein S100-A16,41741,-0.0143762720447827,0.00671438460214679,-0.0275364658649905,-0.00121607822457503,0.032283076302227
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA1,Annexin A1,39639,-0.0104732459632756,0.00490014771885864,-0.0200775354922385,-0.000868956434312642,0.0325928487204412
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39590,-0.0128568089677124,0.00602130649481533,-0.0246585696975505,-0.00105504823787437,0.0327651603955667
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42236,0.008130542690462,0.00382402219676053,0.000635459184811358,0.0156256261961126,0.0335065538116001
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLK6,Kallikrein-6,42085,0.00721625465286027,0.00339643728827644,0.000559237567838441,0.0138732717378821,0.033633617978027
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PMS1,PMS1 protein homolog 1,39590,-0.0115426371243259,0.00543918902517893,-0.0222034476136766,-0.000881826634975222,0.0338495772168583
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ESPL1,Separin,39500,0.0124403752540357,0.00587019213917766,0.000934798661247495,0.0239459518468239,0.0340923149884753
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PAPPA,Pappalysin-1,41842,0.0110239846548397,0.00521755358562518,0.000797579627014343,0.021250389682665,0.0346310143940639
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",39868,0.0137860661597692,0.00652523109754686,0.00099661320857734,0.026575519110961,0.03464562584361
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MYH4,Myosin-4,39512,0.0106554342413311,0.00504918046247187,0.000759040534886212,0.020551827947776,0.0348526853713038
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA3G,Semaphorin-3G,39675,0.0105447604931658,0.00500240175510245,0.000740053053164953,0.0203494679331666,0.0350586277653672
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,39512,0.0245823580514236,0.0116741190606978,0.00170108469245596,0.0474636314103913,0.0352519744284139
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CYB5A,Cytochrome b5,39500,-0.0164635414038391,0.00782579090776067,-0.03180209158305,-0.00112499122462821,0.0354227341016995
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39526,0.0113123488747331,0.00538925540070701,0.000749408289347376,0.0218752894601188,0.0358348518597452
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42236,-0.00682209441662781,0.00326723556141974,-0.0132258761170105,-0.000418312716245123,0.0368134011614169
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RBM19,Probable RNA-binding protein 19,39512,0.0110056891836221,0.00528130067635908,0.000654339857958354,0.0213570385092859,0.0371927017848869
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,41967,0.00650126567326858,0.00312431821528924,0.000377601971301668,0.0126249293752355,0.0374658070368178
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD300LF,CMRF35-like molecule 1,42187,0.0137670848657851,0.00661618751787226,0.000799357330755483,0.0267348124008147,0.0374692154741648
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ELAVL4,ELAV-like protein 4,39526,-0.0186616971580498,0.00901564553559855,-0.036332362407823,-0.000991031908276672,0.0384829463002479
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VWF,von Willebrand factor,42236,0.0168338321376738,0.00814335925840337,0.000872847991203216,0.0327948162841444,0.0387355270967504
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HMOX2,Heme oxygenase 2,41766,-0.0108428435677293,0.00524748916954383,-0.0211279223400352,-0.000557764795423356,0.0388204516249384
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PVALB,Parvalbumin alpha,42133,-0.0254089280522386,0.0123261130480648,-0.0495681096264456,-0.00124974647803153,0.0392848899686069
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,41842,-0.0129595152865206,0.00628803376708643,-0.02528406147001,-0.000634969103031204,0.039324377243641
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SDHB,Succinate dehydrogenase,39869,-0.0148213181125826,0.0071978410768963,-0.0289290866232993,-0.000713549601865825,0.0395043450822967
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ROBO1,Roundabout homolog 1,42070,0.00541684700774411,0.00263345892730499,0.000255267510226317,0.0105784265052619,0.0397119410869271
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41842,-0.00979989169302094,0.00476676956947929,-0.0191427600492004,-0.000457023336841533,0.0398139380342445
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42054,-0.00705422540099345,0.0034339155521481,-0.0137846998832037,-0.000323750918783177,0.0399678366119483
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39917,-0.0041451228238019,0.00201856346397267,-0.00810150721318834,-0.00018873843441546,0.0400469072837895
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,42072,-0.0139051794299496,0.00677203982601531,-0.0271783774889396,-0.000631981370959602,0.0400606074833418
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,39696,-0.0102176053452582,0.00497646819239128,-0.0199714830023451,-0.000463727688171271,0.040078118363559
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,39872,-0.0065908948936366,0.00321193119876779,-0.0128862800432215,-0.000295509744051722,0.0401923450392993
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,39500,-0.0189151080012642,0.00922394546615697,-0.0369940411149318,-0.000836174887596523,0.040324646998752
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BSG,Basigin,42210,-0.00467115467591696,0.00229111540472698,-0.00916174086918184,-0.000180568482652078,0.0414880290899605
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",39895,-0.0121814063056869,0.00598492333528023,-0.0239118560428362,-0.000450956568537695,0.0418390886733069
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,INSR,Insulin receptor,39597,0.00382136590091605,0.00187797217395724,0.000140540439959852,0.00750219136187225,0.0418912861467182
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42072,0.00563532899736172,0.00277636776442352,0.000193648179091617,0.0110770098156318,0.0424016980248229
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MRC1,Macrophage mannose receptor 1,39927,0.00632718265052058,0.003125840919603,0.000200534448098693,0.0124538308529425,0.0429777578303308
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,39597,0.0194689845715554,0.009633209325805,0.000587894292977571,0.0383500748501332,0.0433010621894623
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39512,0.0127734438383262,0.00632709374620711,0.00037234009576027,0.0251745475808921,0.0435273760933702
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TP73,Tumor protein p73,39590,0.00759621044028856,0.00376814646649062,0.000210643365966952,0.0149817775146102,0.0438346115474365
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HEBP1,Heme-binding protein 1,41828,0.0115394502939976,0.00573034291517373,0.000307978180257042,0.0227709224077381,0.0440565066881577
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LAMA1,Laminin subunit alpha-1,39512,0.011463686926806,0.00569437584438178,0.000302710271817741,0.0226246635817943,0.0441223609444998
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KEL,Kell blood group glycoprotein,41766,-0.00803071630386533,0.00399238759255163,-0.0158557959852665,-0.000205636622464133,0.0442922510110743
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41842,-0.025586234275819,0.0127494205283844,-0.0505750985114525,-0.000597370040185487,0.0447854271782913
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RBP7,Retinoid-binding protein 7,39869,-0.0137801382847508,0.00687190786815855,-0.0272490777063416,-0.000311198863160077,0.04495638487214
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42142,0.00950190908216922,0.00474462521649571,0.000202443657837621,0.0188013745065008,0.0452328340023342
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,41842,0.00889961332193878,0.0044445277133601,0.000188339003752987,0.0176108876401246,0.0452647164167931
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,39590,0.00798780430005246,0.00399022439088213,0.000166964493923493,0.0158086441061814,0.0453261112640391
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RTKN2,Rhotekin-2,39512,0.0112172815369937,0.00561225095268911,0.000217269669723033,0.0222172934042643,0.0456641280826346
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,41842,-0.0143633190650599,0.00721570673153713,-0.0285061042588727,-0.000220533871247125,0.0465494686482345
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,39869,0.00954173997280901,0.00481756477593342,9.93130119795078e-05,0.0189841669336385,0.0476587677064569
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39526,-0.00989676212769302,0.0049988051128412,-0.0196944201488618,-9.91041065242747e-05,0.0477481856705061
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,41741,-0.01597622421944,0.00807362752747434,-0.0318005341732897,-0.000151914265590306,0.047857557518516
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,39526,0.0164059395998277,0.00833619069256648,6.70058423973587e-05,0.032744873357258,0.0490889201757121
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,41995,0.00741062525140802,0.00376949399388831,2.2417023386942e-05,0.0147988334794291,0.0493253602785556
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FAM171B,Protein FAM171B,39858,0.00572005213469212,0.00291551683310289,5.63914181046007e-06,0.0114344651275738,0.0497947481745873
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,39696,0.0142577431806225,0.00726991623892129,8.70735233674848e-06,0.0285067790089082,0.049880933950226
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42008,-0.00681001658192998,0.00347782562050464,-0.0136265547981191,6.5216342591129e-06,0.0502360771006837
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PALLD,Palladin,39597,0.0082214259460027,0.00420081435952514,-1.21701986665855e-05,0.016455022090672,0.0503606345522824
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42005,0.00761872352824025,0.00389650338170082,-1.84230998933584e-05,0.0152558701563739,0.050571735718954
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,39927,0.00567582985175855,0.00290782882710614,-2.35146493694945e-05,0.0113751743528866,0.0509731022583474
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EVPL,Envoplakin,39696,0.00718111529348183,0.0036818106552952,-3.52335908967681e-05,0.0143974641778604,0.0511499884502582
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCN3,CCN family member 3,42226,-0.00724753268062176,0.00373269496001556,-0.0145636148022522,6.85494410087297e-05,0.0522018398346167
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLTA,Clathrin light chain A,41828,-0.0100017409362664,0.00515794481862221,-0.020111312780766,0.000107830908233086,0.0525111057683965
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39868,-0.00778722376353249,0.00401742563425962,-0.0156613780066813,8.69304796163673e-05,0.0526040600266447
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCGB1A1,Uteroglobin,42091,0.0113728452241164,0.00588826612248319,-0.00016815637595061,0.0229138468241835,0.0534493206018243
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,39696,-0.0121699912361345,0.00630186983191565,-0.0245216561066892,0.000181673634420159,0.0534872910051051
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RGMB,RGM domain family member B,42174,0.00594985002329953,0.00308366485185275,-9.41330863318554e-05,0.0119938331329309,0.0536929072902543
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,39868,-0.0511749780912574,0.0265588784945919,-0.103230379940658,0.000880423758142783,0.0540234280302687
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SYT1,Synaptotagmin-1,39868,0.00849312926837842,0.00440912484500802,-0.000148755427837301,0.0171350139645941,0.0540968032039483
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UPK3A,Uroplakin-3a,39526,0.0102589079898765,0.00533708694661119,-0.000201782425481477,0.0207195984052344,0.0546075254863937
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,41828,-0.0109042079944786,0.0056827973355252,-0.022042490772108,0.000234074783150798,0.0550298871921201
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,39696,0.016122427688325,0.00840326715310409,-0.000347975931759021,0.032592831308409,0.0550618203035679
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,42072,-0.0060622676738249,0.00316082450252472,-0.0122574836987734,0.000132948351123557,0.0551398995162412
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,39575,-0.0070852502607184,0.00369960269416946,-0.0143364715412905,0.000165971019853743,0.0555008504840547
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",41995,-0.00725975241438443,0.00379492370774514,-0.0146978028815649,0.00017829805279605,0.0557672129860997
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,39575,-0.0202721454886655,0.0106014709728354,-0.041051028595423,0.000506737618091873,0.0558763989493525
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",39887,-0.00481189186854076,0.00252354143697505,-0.00975803308501185,0.000134249347930327,0.0565716989970081
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,XG,Glycoprotein Xg,42187,0.00723990468797361,0.00380730897632281,-0.000222420905619092,0.0147022302815663,0.057247144984631
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTN,Pleiotrophin,41828,-0.0104090650032715,0.0054786262731099,-0.0211471724985669,0.000329042492023902,0.0574626279886385
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DGCR6,Protein DGCR6,39526,-0.00870715208493245,0.00460311184349502,-0.0177292512981827,0.000314947128317779,0.0585734490061419
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,39858,-0.00731426773914625,0.00387130973854428,-0.014902034826693,0.000273499348400531,0.0588703189589034
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,39526,0.0069049439141925,0.00366111042038022,-0.000270832509752738,0.0140807203381377,0.0593181548475074
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL9,Interleukin-9,39696,0.0116694912109908,0.00618860637287737,-0.000460177279848852,0.0237991597018304,0.0593694196720018
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,39575,-0.00902173239373789,0.00478780148965632,-0.0184058233134643,0.000362358525988496,0.0595486094723306
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FABP9,Fatty acid-binding protein 9,42048,0.0116949891627112,0.00620732832413908,-0.000471374352601354,0.0238613526780238,0.0595781913408082
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SOX2,Transcription factor SOX-2,39853,0.00509393902657029,0.00270660411987288,-0.000211005048380544,0.0103988831015211,0.0598562781825882
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42016,-0.0178545936134625,0.00951206588853809,-0.0364982427549971,0.000789055528072194,0.0605333516681179
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FCRLB,Fc receptor-like B,41771,-0.0126974698569133,0.00678681269058392,-0.0259996227304578,0.000604683016631169,0.0613806493320383
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL28,C-C motif chemokine 28,42004,-0.0121283420456137,0.00648762182339036,-0.0248440808194589,0.000587396728231366,0.0615807895827649
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39512,-0.00774668509786429,0.00415025860185246,-0.0158811919574951,0.000387821761766523,0.0619905858791866
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DAND5,DAN domain family member 5,39597,0.0112356725542883,0.00602230684584244,-0.000568048863562926,0.0230393939721394,0.0621133330089665
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39872,0.00779482048933679,0.00419158688773184,-0.000420689810617606,0.0160103307892912,0.0629632576087801
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42056,-0.0118080734394352,0.00636167175535996,-0.0242769500799407,0.000660803201070372,0.0634572419717947
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TLR4,Toll-like receptor 4,39597,0.00579464402078391,0.00312540180594554,-0.000331143518869344,0.0119204315604372,0.0637590929677763
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39858,0.0154464083520377,0.00833248666715205,-0.000885265515580332,0.0317780822196557,0.0638000234550937
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41842,-0.00750919555475771,0.00405120857146609,-0.0154495643548312,0.000431173245315816,0.0638230383878499
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VGF,Neurosecretory protein VGF,39872,-0.00614443125466216,0.00332516985453451,-0.0126617641695498,0.000372901660225471,0.0646495235553706
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STC2,Stanniocalcin-2,42039,-0.00486080287780304,0.00263302327300097,-0.0100215284928849,0.000299922737278867,0.0649008430477076
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NMI,N-myc-interactor,39814,0.0147934619345418,0.00802295897028698,-0.000931537647220669,0.0305184615163043,0.0652253898251625
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42072,-0.011683512659058,0.00635461536756831,-0.0241385587794919,0.000771533461375871,0.0659979666098169
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39526,0.0124426334173171,0.00677573665877173,-0.000837810433875496,0.0257230772685097,0.0663328572344418
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DNLZ,DNL-type zinc finger protein,39526,0.0169792938047517,0.00930126467932449,-0.00125118496672429,0.0352097725762277,0.0679555677766681
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,41863,0.0339105261062025,0.0185809683201971,-0.00250817180138385,0.0703292240137888,0.0680214076247968
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LMNB2,Lamin-B2,39868,-0.00574889516929174,0.00315732351340409,-0.0119372492555638,0.000439458916980279,0.0686618223309755
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GRN,Progranulin,42003,-0.00502658997767767,0.00276327851025083,-0.0104426158577693,0.000389435902413962,0.0689234442922554
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,39696,0.0144406197608951,0.00795552480311721,-0.00115220885321464,0.0300334483750048,0.0695249700244097
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,39868,-0.0111010846757541,0.00613094537378627,-0.0231177376083752,0.000915568256867024,0.0702194354955372
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLK8,Kallikrein-8,41599,-0.00730204029515652,0.00403340785398489,-0.0152075196889669,0.000603439098653863,0.0702584453684275
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,42051,-0.00579690305127489,0.00320270637467869,-0.0120742075456451,0.000480401443095331,0.0703178765611662
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,41592,0.0097173102053707,0.0053764021917358,-0.000820438090431455,0.0202550585011729,0.0707230289691951
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANPEP,Aminopeptidase N,42112,0.00541080192022378,0.00299560711210636,-0.000460588019504687,0.0112821918599522,0.0709022390667048
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCN5,CCN family member 5,42063,0.00749263089569979,0.00417005234516362,-0.000680671700820909,0.0156659334922205,0.0723943209527926
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLMP,CXADR-like membrane protein,42187,-0.00437501084364054,0.00243502547690219,-0.00914766077836883,0.000397639091087751,0.0724054244182444
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PCDH7,Protocadherin-7,39869,-0.00689777422354495,0.00383953324267833,-0.0144232593791945,0.000627710932104577,0.072439621150331
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39500,-0.011226834132896,0.00625590689204734,-0.0234884116413088,0.0010347433755168,0.0727455689978367
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,39597,0.00827867880458538,0.00461381216279179,-0.000764393034486532,0.0173217506436573,0.0727887568892817
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,42236,0.00498063913746308,0.00278411087754087,-0.000476218182517019,0.0104374964574432,0.0736448266403057
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42236,0.00449689324808456,0.00251399192787615,-0.00043053093055269,0.00942431742672181,0.0736779059665733
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,39917,0.00302986113236169,0.00169402757878494,-0.000290432922056792,0.00635015518678018,0.0737132846691392
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RALB,Ras-related protein Ral-B,39597,0.00582659477419817,0.00325967839445029,-0.000562374878924402,0.0122155644273207,0.0738882217643157
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39590,0.0105938611278187,0.00593240425372198,-0.00103365120947642,0.0222213734651137,0.074165392047608
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL17A,Interleukin-17A,41806,0.00842219330500672,0.0047182894774701,-0.000825654070834674,0.0176700406808481,0.0742826604400451
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39597,0.00674112197860724,0.00378070615063912,-0.000669062076645423,0.0141513060338599,0.0746085857276759
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,39868,-0.0055104901760353,0.00309162185925868,-0.0115700690201823,0.000549088668111705,0.0747118193933767
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MN1,Transcriptional activator MN1,39590,0.0115631463823082,0.00648988791200567,-0.00115703392522286,0.0242833266898394,0.0748229290893356
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42222,0.00719599986301006,0.00404427749406698,-0.000730784025361234,0.0151227837513813,0.0752121966080834
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39512,0.00666117912660542,0.00375189714120194,-0.000692539270150378,0.0140148975233612,0.0758570500495399
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42024,0.0074868291539776,0.0042170967826071,-0.000778680539932314,0.0157523388478875,0.0758625167346224
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNN,Tenascin-N,39904,0.00842751632070306,0.00475242756065768,-0.000887241698185989,0.0177422743395921,0.0762046560390917
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,42020,0.00798415629496897,0.00450985737530854,-0.000855164160635781,0.0168234767505737,0.076686742560651
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,39512,0.00513366126562465,0.0029146936708098,-0.000579138329162556,0.0108464608604119,0.0782149864324484
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AMY2B,Alpha-amylase 2B,41227,0.0097159973595404,0.0055173509515899,-0.00109801050557581,0.0205300052246566,0.0782643736659407
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,41995,-0.0103122519327385,0.00586064257811361,-0.0217991113858411,0.00117460752036421,0.0785023774902772
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",39575,0.0170387906040792,0.00968637806104388,-0.00194651039556683,0.0360240916037252,0.0785974527223948
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA11,Serpin A11,42236,0.00808008012813651,0.00459371542726468,-0.000923602109302261,0.0170837623655753,0.0786097448561789
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,41771,-0.00777298613170697,0.0044274108531797,-0.0164507114039392,0.000904739140525251,0.0791713446171232
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,41943,-0.0065025293662221,0.00371097689892722,-0.0137760440881194,0.000770985355675253,0.0797551831800017
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39479,-0.0166703792569024,0.00952310244577322,-0.0353356600506179,0.00199490153681314,0.0800568493192867
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MSLNL,Mesothelin-like protein,39590,0.00730411377307394,0.00417435345763936,-0.000877619003899204,0.0154858465500471,0.0801877651925561
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39858,0.0171771461383729,0.00982264428929231,-0.00207523666864007,0.0364295289453858,0.080365070989761
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL13,Interleukin-13,41842,0.00930049496893645,0.00533445775728189,-0.00115504223533605,0.019756032173209,0.0812738447704648
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TEX33,Testis-expressed protein 33,39696,0.00740806718011358,0.00425331923869264,-0.000928438527723995,0.0157445728879512,0.0815861499586829
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42210,0.00733889511427686,0.00421505023491844,-0.000922603346163291,0.015600393574717,0.0816856893266075
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MEP1B,Meprin A subunit beta,42072,-0.0219569904655299,0.0126119970720602,-0.046676504726768,0.00276252379570817,0.0817133072387025
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PALM3,Paralemmin-3,39512,-0.0144476625624836,0.00830298703809676,-0.0307215171571533,0.00182619203218605,0.0818773743537809
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATXN2,Ataxin-2,39526,-0.0203027274800727,0.0116871304926959,-0.0432095032457567,0.00260404828561133,0.0823824046104373
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,39512,-0.00754472068650664,0.00434360171530203,-0.0160581800484986,0.000968738675485338,0.0824200824543615
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,39868,-0.00582999378744099,0.00336097063670951,-0.0124174962353916,0.000757508660509647,0.0828361710195096
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,41828,-0.010718686700634,0.00620106100568803,-0.0228727662717825,0.00143539287051455,0.0839175432937894
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42063,-0.00809386066120885,0.00468842801339072,-0.0172831795674547,0.00109545824503697,0.0843076765975048
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRYBB2,Beta-crystallin B2,39868,-0.0132427678681826,0.00767152981482719,-0.0282789663052439,0.00179343056887872,0.084334791517694
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42063,0.0100784609307692,0.00584320671504041,-0.00137422423070998,0.0215311460922484,0.0845834498353245
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,39512,0.00925411570169128,0.00537790235088435,-0.00128657290604205,0.0197948043094246,0.0853215013261459
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLAMF8,SLAM family member 8,41771,0.0101841249362232,0.00592482081829712,-0.00142852386763917,0.0217967737400855,0.0856576037638595
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGF9,Fibroblast growth factor 9,39479,0.00776796348767369,0.00453278641950528,-0.00111629789455667,0.016652224869904,0.0866071597155031
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",39869,-0.0166692982964686,0.00973537138965957,-0.0357506262202014,0.0024120296272641,0.0868798473987141
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,41943,-0.00759832897943283,0.0044384042432399,-0.016297601296183,0.00110094333731736,0.0869290027443806
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,41919,0.00483039439192316,0.00282407654207535,-0.000704795630544532,0.0103655844143909,0.0872090767854921
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39512,0.0124132781022031,0.00725833600800187,-0.00181306047348054,0.0266396166778868,0.0872554923394313
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,39500,-0.00709772609064201,0.00415105545630621,-0.0152337947850022,0.00103834260371815,0.0873201179871475
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,39512,0.00805706197901459,0.00471409653108257,-0.00118256722190725,0.0172966911799364,0.0874530207187395
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ERVV_1,,39512,0.00820854294023481,0.00480756500375899,-0.00121428446713282,0.0176313703476024,0.0877720643365262
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,39872,-0.00735282831198129,0.00431156858185701,-0.015803502732421,0.00109784610845845,0.0881526202384735
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39597,-0.0116376608830049,0.00685442923350536,-0.0250723421806754,0.00179702041466561,0.0895679984710575
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HSP90B1,Endoplasmin,41702,0.0119176253396958,0.00702193244027624,-0.00184536224324567,0.0256806129226372,0.0896825623925491
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL34,Interleukin-34,41741,-0.00684455016552604,0.00403379944372358,-0.0147507970752243,0.00106169674417218,0.0897581951095292
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39597,0.00557239613059172,0.00328545618262558,-0.000867097987354428,0.0120118902485379,0.089899057176873
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,39590,0.00783395073675972,0.00461955613278306,-0.00122037928349508,0.0168882807570145,0.0899476799081987
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SHC1,SHC-transforming protein 1,39500,0.021732737219006,0.0128656678082569,-0.00348397168517748,0.0469494461231895,0.091208947452221
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FXN,"Frataxin, mitochondrial",42187,-0.0135133586028439,0.00801026391339837,-0.0292134758731047,0.00218675866741693,0.0916252657988666
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RAB44,Ras-related protein Rab-44,39858,-0.00834565274058078,0.00494707671884159,-0.0180419231095103,0.00135061762834875,0.0916336091618914
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CENPJ,Centromere protein J,39696,-0.0130490408305636,0.00774953590795734,-0.02823813121016,0.00214004954903281,0.0922391682688887
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,41771,-0.00878809890424217,0.00522251117976577,-0.0190242208165831,0.00144802300809873,0.0924502326299386
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,39512,0.00858211352886447,0.00510031304131009,-0.0014145000321033,0.0185787270898322,0.0924687488695373
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NPHS2,Podocin,39597,0.0187714761410052,0.0111616166437216,-0.00310529248068913,0.0406482447626996,0.0926382937437666
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,39597,0.00406779522310696,0.00242099742892729,-0.000677359737590529,0.00881295018380444,0.0929439722785462
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IFNW1,Interferon omega-1,39512,0.00645473252564163,0.00384204005803228,-0.00107566598810164,0.0139851310393849,0.0929806116319091
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,41995,-0.00985661451096572,0.00587604937796304,-0.0213736712917733,0.00166044226984184,0.0934833208922854
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,POMC,Pro-opiomelanocortin,39575,-0.0135308990818493,0.00807065266917131,-0.029349378313425,0.00228758014972652,0.0936578676057686
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,39597,0.0053636345837512,0.00320067265690029,-0.000909683823773377,0.0116369529912758,0.0938090254122764
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STX1B,Syntaxin-1B,39590,0.00740819834151323,0.00442343026126173,-0.00126172497055977,0.0160781216535862,0.0940091480326538
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NPTX2,Neuronal pentraxin-2,39904,0.00630398614961403,0.00376517689339262,-0.00107576056143551,0.0136837328606636,0.0941019021240052
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,39556,-0.00691028915149599,0.00412924688614143,-0.0150036130483332,0.00118303474534121,0.0942577161457624
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LCN15,Lipocalin-15,39872,-0.0112057695762554,0.00669611853319481,-0.0243301619013172,0.0019186227488064,0.0942620816710771
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TPT1,Translationally-controlled tumor protein,41842,0.0117509213137825,0.00702789005896183,-0.00202374320178272,0.0255255858293476,0.094539835275992
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TCN2,Transcobalamin-2,42213,0.00555377570862089,0.00332646672513526,-0.000966099072644223,0.012073650489886,0.0950270662901624
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,39500,0.00859401127620442,0.00514966311417585,-0.00149932842758025,0.0186873509799891,0.0951759844245351
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TFRC,Transferrin receptor protein 1,42125,0.00687932578185218,0.00412706486468456,-0.00120972135292955,0.0149683729166339,0.0955612343280392
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,41766,-0.0122709470504585,0.0073731660890623,-0.0267223525850206,0.00218045848410363,0.0960820665483777
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",39590,-0.0156454853189543,0.00942007069686408,-0.0341088238848079,0.00281785324689932,0.096768670312556
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APOA1,Apolipoprotein A-I,39917,0.00499042080998703,0.00300896590946223,-0.000907152372558943,0.010887993992533,0.0972408917808691
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42089,-0.00934765486897714,0.0056438415353395,-0.0204095842782426,0.00171427454028829,0.0976929423805945
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,39526,0.00536600910205967,0.00324083686683571,-0.000986031156938316,0.0117180493610577,0.0978015834629481
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,42108,-0.006238832129466,0.00377016128986927,-0.0136283482576098,0.00115068399867778,0.0979899622082646
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,39696,0.0067663989459308,0.00409407559201762,-0.00125798921442374,0.0147907871062853,0.0984142471524438
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39669,0.0112847950399093,0.006831838015956,-0.00210560747136448,0.024675197551183,0.0986047380647673
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39868,-0.0101559707218224,0.00615915764116871,-0.022227919698513,0.00191597825486831,0.0991914857291876
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",39500,-0.0172004289826163,0.0104530075951503,-0.0376883238691109,0.00328746590387821,0.0998954771274674
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TLR1,Toll-like receptor 1,39597,0.00483443922634299,0.00294521634765402,-0.000938184815058886,0.0106070632677449,0.10073165783517
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINB8,Serpin B8,42222,-0.010495627926618,0.00643893551460856,-0.0231159415352508,0.00212468568201472,0.103119266052897
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLGN,Calmegin,39590,-0.00811889902126272,0.00499766811739878,-0.0179143285313643,0.00167653048883889,0.104289830853992
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IKZF2,Zinc finger protein Helios,41771,0.0159173638080821,0.00981173068274805,-0.00331362833010409,0.0351483559462683,0.104767575347392
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FCRL6,Fc receptor-like protein 6,42048,-0.0122411025258324,0.00755666914510067,-0.0270521740502297,0.00256996899856489,0.10527566682712
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPL,Periplakin,39597,-0.00574976167534967,0.0035529108217494,-0.0127134668859785,0.00121394353527915,0.105621419256429
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS1,Galectin-1,42072,-0.0062377196640192,0.00385548574798123,-0.0137944717300624,0.00131903240202402,0.105711515033885
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,39526,0.0102372748145672,0.00632797392197382,-0.00216555407250146,0.0226401037016359,0.10573870818884
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,39833,0.00682454180974481,0.00422288469830174,-0.0014523121989266,0.0151013958184162,0.106103957913935
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,41943,-0.00534755740623251,0.00331663564491304,-0.0118481632702621,0.00115304845779705,0.106910765245689
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39872,-0.0209017822276746,0.0129734881457474,-0.0463298189933395,0.00452625453799037,0.107182643476706
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,39512,0.00564026896787449,0.00350138647987917,-0.00122244853268868,0.0125029864684377,0.107237572618464
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RBM25,RNA-binding protein 25,39500,0.0083054445268098,0.00515606824550473,-0.00180044923437946,0.0184113382879991,0.107250170376526
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39696,-0.0125095439818734,0.00777179956160553,-0.0277422711226202,0.00272318315887348,0.107512097509254
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL10,Interleukin-10,41842,-0.0136035513656905,0.00845594972257015,-0.030177212821928,0.00297011009054701,0.107693763447687
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,39512,0.00684151407429566,0.00426911535850732,-0.00152595202837868,0.01520898017697,0.109060745457297
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CALB2,Calretinin,41766,-0.00519949927912675,0.00324536869176274,-0.0115604219149817,0.00116142335672822,0.109151077149358
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,41842,0.00844231927302609,0.00527177560851136,-0.00189036091965617,0.0187749994657084,0.109308099184686
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NLGN1,Neuroligin-1,39590,0.011815638113741,0.00739043038707099,-0.00266960544491816,0.0263008816724001,0.109899269348489
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITGAL,Integrin alpha-L,39597,-0.00768748291104003,0.00481020373081934,-0.0171154822234459,0.00174051640136587,0.110035746191145
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,41771,-0.00936226268740435,0.00588354670315782,-0.0208940142255937,0.00216948885078498,0.111574685242175
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PKLR,Pyruvate kinase PKLR,42069,-0.0108971096444221,0.00685042742307585,-0.0243239473936508,0.00252972810480655,0.11169614705411
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39597,-0.0102425354047287,0.00645329221338911,-0.0228909881429714,0.00240591733351393,0.112500665816665
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,39590,0.00624492990564879,0.00394065310446975,-0.00147875017911192,0.0139686099904095,0.113053078235819
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLK3,Prostate-specific antigen,39904,0.0198585331593558,0.0125705049817835,-0.00477965660493981,0.0444967229236514,0.114187044619525
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GKN1,Gastrokine-1,41468,-0.00491614280248063,0.00312001000646951,-0.0110313624151609,0.00119907681019962,0.115123749953153
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,41842,0.0110646182366588,0.00703017233384695,-0.0027145195376812,0.0248437560109988,0.115540051287801
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,41895,-0.00739981446117899,0.00472194820989896,-0.016654832952581,0.00185520403022296,0.117112672337624
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HMCN2,Hemicentin-2,39660,-0.0100165390050055,0.00639392006204042,-0.0225486223266047,0.0025155443165937,0.117243270795048
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGF19,Fibroblast growth factor 19,42111,-0.0133681724711488,0.0085381270555075,-0.0301029014999435,0.00336655655764595,0.117441546624739
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42149,-0.0117968471721757,0.00754192027047483,-0.0265790109023064,0.00298531655795495,0.117800950555665
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39696,-0.010876071310019,0.00695663929813,-0.0245110843343538,0.00275894171431579,0.117984982011031
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,42039,-0.00409862781040804,0.00262534753261571,-0.00924430897433483,0.00104705335351875,0.118505933745901
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS9,Galectin-9,42055,-0.00537957055516285,0.00345212103300591,-0.0121457277798544,0.00138658666952873,0.119176721681636
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39512,0.0143727839964374,0.00924363562558341,-0.00374474182970608,0.0324903098225809,0.120002625534665
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NFIC,Nuclear factor 1 C-type,39872,-0.0078526912553537,0.00505051363834111,-0.0177516979865023,0.00204631547579488,0.120014583126582
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LAYN,Layilin,41924,0.00609744894536435,0.00392616114491928,-0.00159782689867745,0.0137927247894061,0.120439541884073
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NRTN,Neurturin,41842,-0.00845727748947722,0.00545591175974172,-0.019150864538571,0.00223630955961656,0.121138393210664
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,39597,-0.00618288137772317,0.00400173848338236,-0.0140262888051526,0.00166052604970625,0.122363226399244
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39872,-0.0157821654213921,0.0102168404176104,-0.0358071726399085,0.0042428417971244,0.122441895435462
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,39597,-0.00646442298223505,0.00419084862560199,-0.014678486288415,0.00174964032394485,0.12297865306739
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42187,-0.00687572256795606,0.00446227552645231,-0.0156217825998026,0.00187033746389048,0.123375203566474
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGF3,Fibroblast growth factor 3,39597,0.00500861618104381,0.00325192804175986,-0.00136516278080552,0.0113823951428931,0.123540635937157
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APOL1,Apolipoprotein L1,39927,-0.00904471838866619,0.00587915841907454,-0.0205678688900523,0.0024784321127199,0.123969586552932
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,41766,0.00675405085784519,0.00440111159875484,-0.0018721278757143,0.0153802295914047,0.124900277488378
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RSPO3,R-spondin-3,42187,0.00473259899577673,0.00309283829259853,-0.00132936405771639,0.0107945620492698,0.125995484991292
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,39526,-0.00748002308963897,0.00490357814612698,-0.0170910362560478,0.00213099007676991,0.12718296607837
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PFDN4,Prefoldin subunit 4,39500,0.00884379455002673,0.00580583831218854,-0.0025356485418628,0.0202232376419163,0.127722969715933
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39526,0.00526989824690517,0.00346894501132048,-0.00152923397528297,0.0120690304690933,0.12875001957006
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,39858,-0.00720928886331358,0.0047554888132497,-0.016530046937283,0.00211146921065583,0.129549139348409
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL21,C-C motif chemokine 21,42111,-0.00637427547715709,0.00420819987595451,-0.0146223472340279,0.00187379627971375,0.129864855757049
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,41771,0.00802641062725383,0.00531280601932912,-0.00238668917063124,0.0184395104251389,0.130871881388283
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,39917,0.00304437033174192,0.00201772126295752,-0.00091036334365482,0.00699910400713866,0.131373700370566
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FSHB,Follitropin subunit beta,39575,0.00681353621396893,0.00451920718673911,-0.00204410987203973,0.0156711822999776,0.13166421436601
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,42236,0.00542857287843778,0.00360258424564683,-0.00163249224303001,0.0124896379999056,0.131870936453027
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42174,-0.00392669977761958,0.00260791094760998,-0.00903820523493514,0.00118480567969599,0.132170597914823
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42050,-0.0494521190582524,0.0329094340313391,-0.113954609759677,0.0150503716431722,0.132946857154474
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NOP56,Nucleolar protein 56,39512,-0.0184116134623031,0.0123007545361592,-0.0425210923531751,0.00569786542856889,0.134477527965052
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL36A,Interleukin-36 alpha,39597,0.00946464290053681,0.00632674621872764,-0.00293577968816937,0.021865065489243,0.134689330943459
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TPSG1,Tryptase gamma,39597,0.00431582162717291,0.00288536201155331,-0.00133948791547159,0.0099711311698174,0.13474377097827
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",39500,-0.00793249291942688,0.00530958410300462,-0.0183392777613159,0.00247429192246216,0.135205832107514
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,39872,0.00591106964942935,0.00396976515916014,-0.00186967006252453,0.0136918093613832,0.136509419876457
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,41919,0.00551156555660151,0.00370811354670378,-0.00175633699493791,0.0127794681081409,0.137209454339278
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GBP6,Guanylate-binding protein 6,39512,0.0073069163965389,0.00491615407569932,-0.00232874559183176,0.0169425783849096,0.137226709476002
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,39869,-0.00787915325175477,0.00530544438560059,-0.0182778242475319,0.00251951774402238,0.137543420986322
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39869,-0.00655669534379293,0.0044223664797727,-0.0152245336441474,0.00211114295656155,0.138202981954766
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42042,-0.00542347784282167,0.003664990245696,-0.0126068587243858,0.00175990303874248,0.138948222648326
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VIM,Vimentin,41828,-0.0186849121479452,0.0126456788640024,-0.0434704427213899,0.00610061842549942,0.139545945101464
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,39858,0.00663516300445234,0.00449225696736848,-0.00216966065158988,0.0154399866604946,0.139697673762123
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,39696,0.00444551307100746,0.00301395280746003,-0.00146183443161421,0.0103528605736291,0.14024692085888
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,39682,0.00869082205781982,0.00590624128246598,-0.0028854108558135,0.0202670549714531,0.141194041976184
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,39597,0.0112111761774568,0.00762161956656084,-0.00372719817300246,0.0261495505279161,0.141327755658111
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRTG,Protogenin,42187,-0.00397474790971152,0.00270257288201735,-0.00927179075846553,0.00132229493904248,0.141388018267356
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FABP6,Gastrotropin,41809,0.0091947401676215,0.00625916475787778,-0.00307322275781895,0.021462703093062,0.141855427452072
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42210,-0.00838611760583184,0.00571138206334832,-0.0195804264499945,0.00280819123833086,0.142041329803574
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,39526,0.01550412840222,0.0105936505690488,-0.00525942671311572,0.0362676835175556,0.143351100878844
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AFAP1,Actin filament-associated protein 1,39675,-0.0134758951769411,0.00921818354800042,-0.0315435349310219,0.00459174457713974,0.143801963562761
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,41932,-0.0163940154287917,0.0112283749584069,-0.0384016303472691,0.00561359948968582,0.144299245395505
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DEFB116,Beta-defensin 116,39526,0.0120300367854405,0.00825393398915995,-0.00414767383331301,0.028207747404194,0.145009557510967
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,41807,0.00849315136714814,0.00587271326163232,-0.00301736662565121,0.0200036693599475,0.148143247030016
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL24,C-C motif chemokine 24,42092,0.0130550351950813,0.00905149732378101,-0.00468589955952945,0.0307959699496921,0.149239084540361
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,39526,0.0131604549419923,0.00917846217890724,-0.00482933092866587,0.0311502408126505,0.151646272250952
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EXOSC10,Exosome component 10,39512,0.00918255593106732,0.0064170394576624,-0.00339484140595098,0.0217599532680856,0.152469013888922
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,39597,0.00722152852262442,0.00505516047442829,-0.00268658600725503,0.0171296430525039,0.153163207802077
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39696,0.00582670967108092,0.00408117436458688,-0.00217239208350938,0.0138258114256712,0.153405166835796
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL1B,Interleukin-1 beta,41754,-0.0088560296361203,0.00620772405958583,-0.0210231687929085,0.00331110952066792,0.153714753900971
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,JUN,Transcription factor AP-1,41842,0.00757826381736813,0.00531631184040139,-0.0028417073898186,0.0179982350245549,0.154043827390774
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SH3GL3,Endophilin-A3,39629,-0.0133711821669364,0.00939107042078525,-0.0317776801916755,0.00503531585780268,0.154527235458836
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DCLRE1C,Protein artemis,39500,0.0047315446639446,0.00333964069812329,-0.00181415110437704,0.0112772404322662,0.156575092081373
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39512,0.004878786868323,0.00344416374083439,-0.0018717740637124,0.0116293478003584,0.15664675799144
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39590,-0.00786228111451436,0.00555477743961148,-0.0187496448961529,0.00302508266712414,0.156976993943479
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,39500,0.00622975261676795,0.00440942330149799,-0.0024127170541681,0.014872222287704,0.157735128354354
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39526,-0.00959246213266907,0.00679704503467548,-0.022914670400633,0.00372974613529488,0.158193647334902
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,41849,0.00444009710913108,0.00315501921290617,-0.00174374054816502,0.0106239347664272,0.159358284641539
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",39872,-0.00645118251355086,0.00458637649970707,-0.0154404804529767,0.002538115425875,0.159574550479897
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,39597,0.00337466217767815,0.00241531821377373,-0.00135936152131836,0.00810868587667467,0.162384169188645
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD2,T-cell surface antigen CD2,39512,-0.00599799301338332,0.00429314043957975,-0.0144125482749596,0.00241656224819299,0.162408653289774
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NCLN,Nicalin,41842,0.00785719640219073,0.00564146663555176,-0.00320007820349072,0.0189144710078722,0.163716439852568
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39872,-0.00481528685605546,0.00345792760550145,-0.0115928249628383,0.00196225125072738,0.163787774641569
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,39597,0.0087515452085664,0.00628750843770371,-0.00357197132933286,0.0210750617464657,0.163982651193913
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,39597,0.00828117861100446,0.00595874908101232,-0.00339796958777969,0.0199603268097886,0.164632577823152
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TAGLN3,Transgelin-3,39500,0.00917825356947876,0.00660617503625947,-0.00376984950158979,0.0221263566405473,0.164756369569662
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39575,-0.00422251754814764,0.00303922215524628,-0.0101793929724303,0.00173435787613506,0.164757107791569
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,39858,0.00543713871722905,0.00391637688005053,-0.00223895996766998,0.0131132374021281,0.165070640538227
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLK1,Kallikrein-1,41944,0.0195402533599327,0.0140857228721979,-0.00806776346957519,0.0471482701894405,0.165392297796293
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB5,Integrin beta-5,42108,-0.00587750581864359,0.00423767749736833,-0.0141833537134855,0.00242834207619833,0.165475648359818
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,39674,0.00770242258213618,0.0055628564120781,-0.00320077598553691,0.0186056211498093,0.166197670551714
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,41943,-0.00702027002225991,0.00509163232079985,-0.0169998693710276,0.00295932932650779,0.167983938897506
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FOLR1,Folate receptor alpha,42037,0.00447723073804575,0.00324867996374804,-0.00189018199090041,0.0108446434669919,0.168173994917407
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,41995,0.00392671037312632,0.00285610820992638,-0.00167126171832937,0.00952468246458202,0.169202035188517
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ERC2,ERC protein 2,39590,-0.0111555579571985,0.00812006818451182,-0.0270708915988417,0.00475977568444462,0.169523835784199
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TREML2,Trem-like transcript 2 protein,42063,0.00520399914277046,0.00378990823893357,-0.00222422100553934,0.0126322192910803,0.169737884599704
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,41766,-0.0225085419933624,0.0164090122393706,-0.0546702059825287,0.00965312199580397,0.170174530416036
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC3B,Tetranectin,39664,0.0031648227546542,0.00230965412581693,-0.00136209933194698,0.00769174484125538,0.170634084544109
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,39526,0.00841465878552145,0.00614462907147415,-0.00362881419456789,0.0204581317656108,0.170892061648566
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,41943,0.00644465635550312,0.00470724383113108,-0.0027815415535138,0.01567085426452,0.170993133171084
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ABHD14B,Protein ABHD14B,41903,-0.00838608450196782,0.00614434003368666,-0.0204289909679937,0.00365682196405803,0.172324203738147
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EDN1,Endothelin-1,39575,-0.00440188668930333,0.0032332298913699,-0.0107390172763883,0.00193524389778169,0.173398901095312
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42198,0.00714004860636291,0.00524568015228189,-0.00314148449210959,0.0174215817048354,0.17349540781022
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EPGN,Epigen,39858,0.00693883421104551,0.00510309744821701,-0.00306323678745983,0.0169409052095508,0.173942641511825
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41360,0.00627324285711405,0.00461457165503828,-0.00277131758676098,0.0153178033009891,0.174030569670091
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41828,0.00469914805596438,0.00345776504850818,-0.00207807143911167,0.0114763675510404,0.174165602115362
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL24,Interleukin-24,41842,0.00720644664143294,0.00530705751945565,-0.00319538609670013,0.017608279379566,0.174518958664142
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NPPB,Natriuretic peptides B,41828,0.0208946854928257,0.0154387466835829,-0.00936525800699691,0.0511546289926482,0.175953366785749
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RETN,Resistin,42034,0.00634724506798051,0.00470236389918575,-0.00286938817442356,0.0155638783103846,0.177103278646185
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39904,0.0205780518829135,0.0152581881820827,-0.00932799695396866,0.0504841007197956,0.177474400395687
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLHL41,Kelch-like protein 41,39872,-0.00777843206266622,0.00578370370292873,-0.0191144913204065,0.00355762719507409,0.178688556354525
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,39872,0.00513728866850315,0.00382007118669071,-0.00235005085741065,0.0126246281944169,0.178712073690631
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39526,-0.00868261590113835,0.00647292484319945,-0.0213695485938093,0.00400431679153257,0.179826793958407
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41771,-0.00739867135481769,0.00552645087958053,-0.0182305150787955,0.00343317236916014,0.180667210101772
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AMBN,Ameloblastin,41842,0.00401795223430804,0.00300153775946965,-0.00186506177425248,0.00990096624286855,0.180713729614352
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",39481,0.00391529014809878,0.00292593595441883,-0.00181954432256213,0.00965012461875969,0.180881193165397
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TMEM132A,Transmembrane protein 132A,39575,-0.0092438370504847,0.00690961088996736,-0.0227866743948207,0.00429900029385133,0.180981830013143
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL33,Interleukin-33,41842,0.00579560335138627,0.00434148489821022,-0.00271370704910577,0.0143049137518783,0.181920329044429
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OMP,Olfactory marker protein,39526,0.00703712873484814,0.00527437472205182,-0.00330064572037343,0.0173749031900697,0.182162524493343
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACTN4,Alpha-actinin-4,41842,0.00463422404913825,0.00347410207905922,-0.00217501602581782,0.0114434641240943,0.182248318560468
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB6,Integrin beta-6,41842,0.00450032460998883,0.00337856161494907,-0.00212165615531136,0.011122305375289,0.182875279818909
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TEX101,Testis-expressed protein 101,39590,-0.00897926676927579,0.0067842047253306,-0.0222763080309238,0.00431777449237219,0.185678474765687
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRR4,Proline-rich protein 4,39591,0.0103189994662351,0.00782063748923624,-0.00500945001266796,0.0256474489451381,0.187043665001037
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLNS1A,Methylosome subunit pICln,39590,-0.00488138104826772,0.00370034741795919,-0.0121340619874677,0.00237129989093229,0.187140333970507
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GAGE2A,G antigen 2A,39500,0.00948237448884138,0.00719006698424471,-0.00461015680027824,0.023574905777961,0.187258381983581
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,39500,-0.00861205927047867,0.00654652070760263,-0.0214432398573798,0.00421912131642249,0.188363878013872
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39526,0.00828028292455462,0.00629638407658503,-0.00406062986555205,0.0206211957146613,0.188508793582425
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BRK1,Protein BRICK1,41766,0.00658125604642413,0.00501560665726295,-0.00324933300181126,0.0164118450946595,0.189490536428378
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39575,-0.0133037496454691,0.0101455433066003,-0.0331890145264056,0.00658151523546749,0.189787232925094
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,41766,-0.00553453323157374,0.00422305774416557,-0.0138117264101383,0.00274265994699078,0.190032309171354
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42063,-0.00347115474500327,0.00265004855425386,-0.00866524991134084,0.0017229404213343,0.190270384006347
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,39597,0.010308350516635,0.00787726127905248,-0.00513108159030791,0.0257477826235778,0.190690068825593
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42149,-0.00917706451261508,0.00701320082072038,-0.022922938121227,0.00456880909599687,0.190711894683149
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,39869,-0.0111569150387344,0.00855134121455141,-0.0279175438192551,0.00560371374178641,0.192022454908447
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,39675,0.00419464526962694,0.00321649399741943,-0.00210968296531514,0.010498973504569,0.192224954382917
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COPB2,Coatomer subunit beta',39512,-0.00618426459613654,0.00474541379880137,-0.0154852756417872,0.00311674644951414,0.192531014261999
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAPT,Microtubule-associated protein tau,41766,0.007592728774325,0.00583194794999492,-0.00383788920766504,0.019023346756315,0.192966564541302
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39512,0.00376653792434318,0.00290106623653657,-0.00191955189926851,0.00945262774795486,0.194201803389246
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COPE,Coatomer subunit epsilon,41766,0.00664900555758468,0.00512547867651029,-0.00339693264837548,0.0166949437635448,0.194569365848134
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39590,0.0110000280884377,0.00849566188439291,-0.00565146920497245,0.0276515253818478,0.195422725600674
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39512,0.00706809044951117,0.00546151061753317,-0.00363647036085385,0.0177726512598762,0.195636165615875
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39696,-0.00984124733969833,0.00761279429578976,-0.0247623241594463,0.0050798294800496,0.196133203230776
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,39500,0.00915018629909589,0.00708874712709601,-0.00474375807001229,0.0230441306682041,0.19679887324254
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,39590,0.00579326337103749,0.00449730684433314,-0.00302145804385547,0.0146079847859304,0.197716419069934
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,39512,-0.0131160898609712,0.0101911690639207,-0.0330907812262558,0.00685860150431331,0.198119697317465
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",39512,-0.00539791689951543,0.00421184477103178,-0.0136531326507377,0.00285729885170685,0.200008844851936
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,42048,-0.00337694562111143,0.00263981596593891,-0.0085509849143517,0.00179709367212884,0.200836299932811
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,41919,-0.00570063271735565,0.00445971645257935,-0.0144416769644112,0.00304041152969987,0.201183553598967
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39575,-0.00509317235541488,0.00398659551359113,-0.0129068995620535,0.00272055485122373,0.201426556758835
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CBLN4,Cerebellin-4,42187,-0.00445498857882826,0.00349336863054951,-0.0113019910947053,0.00239201393704878,0.202235459895832
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MYO6,Unconventional myosin-VI,39872,-0.00526165963790108,0.00413064005422312,-0.0133577141441784,0.00283439486837625,0.202756249472535
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42149,0.0057565179138351,0.00451959602717433,-0.00310189029942659,0.0146149261270968,0.202798786760189
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41590,0.00864047449823283,0.00687313377608411,-0.00483086770289203,0.0221118166993577,0.208726437430895
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TJP3,Tight junction protein ZO-3,39526,0.00576636044125511,0.00458900500434858,-0.00322808936726811,0.0147608102497783,0.20893984592943
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39575,-0.00644865797081869,0.00513951177952559,-0.0165221010586888,0.00362478511705147,0.209606452500972
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDCL2,Phosducin-like protein 2,39500,-0.00717438485484162,0.00573490037545037,-0.0184147895907243,0.00406601988104111,0.210959770296576
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,41766,0.00703570135935729,0.00562435273600123,-0.00398803000320511,0.0180594327219197,0.210980313389969
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,39500,0.00936183174037622,0.00750798790724719,-0.00535382455782828,0.0240774880385807,0.212455019255531
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,39858,-0.0054445840293413,0.00436944481638852,-0.0140086958694628,0.0031195278107802,0.212768833218329
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39576,0.00535365063054133,0.00429936232194252,-0.00307309952046601,0.0137804007815487,0.213077588843507
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39032,0.00775364674938398,0.00622780495066405,-0.00445285095391756,0.0199601444526855,0.213157970140094
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,42063,0.00844389943877647,0.00680053319341573,-0.00488514562031836,0.0217729444978713,0.21438641198514
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39512,0.00695464265594146,0.00560327797969467,-0.0040277821842601,0.017937067496143,0.214568177292463
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,41771,-0.00636274551174448,0.00513291930529882,-0.0164232673501302,0.0036977763266412,0.215146999304863
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPON1,Spondin-1,42070,-0.00443489399916812,0.0035860649862078,-0.0114635813721354,0.00259379337379917,0.216219270701779
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39526,-0.00747413269699795,0.00604568228761625,-0.0193236699807258,0.00437540458672991,0.21638251656138
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39895,-0.0101709671574257,0.00824799980058669,-0.0263370467665756,0.00599511245172421,0.217547901717477
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL4,Interleukin-4,41842,0.0127561348930166,0.0103545938462309,-0.00753886904559585,0.0330511388316291,0.217997105155417
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,39896,0.00266681165734095,0.002170287137743,-0.00158695113263533,0.00692057444731724,0.219178823830561
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,39512,0.0136951511284774,0.0111561826256038,-0.00817096681770603,0.0355612690746609,0.219629657441766
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MORN4,MORN repeat-containing protein 4,39500,-0.0105372976906388,0.0086090125463974,-0.0274109622815777,0.00633636690030009,0.220984540360611
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,41995,0.00637414792596916,0.00520934513277811,-0.00383616853427594,0.0165844643862143,0.221125174004139
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39500,-0.0069747560312026,0.00571028795257723,-0.018166920418254,0.00421740835584877,0.221947085466214
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CBLN1,Cerebellin-1,39526,0.0124637633603933,0.0102129478512088,-0.00755361442797584,0.0324811411487625,0.222344000602935
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,39861,-0.00268779506116614,0.0022046151973776,-0.00700884084802623,0.00163325072569395,0.222806184663006
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,YY1,Transcriptional repressor protein YY1,39597,0.00372901380882712,0.00307154625229991,-0.0022912168456807,0.00974924446333494,0.224754319612132
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",39597,0.00392255464568464,0.00323124773269724,-0.00241069091040195,0.0102558002017712,0.224795078569344
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C5,Complement C5,39917,-0.00200514803971416,0.00165183611317428,-0.00524274682153576,0.00123245074210743,0.224814901718041
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,39526,0.00946683943309623,0.00780309871219388,-0.00582723404280378,0.0247609129089962,0.225073709879895
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41842,0.00573125291298605,0.00472671322977168,-0.00353310501736645,0.0149956108433385,0.225333518768538
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PSCA,Prostate stem cell antigen,39869,0.0345641261355331,0.0285883037605574,-0.0214689492351593,0.0905972015062256,0.226676561781429
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,39500,-0.0102670144204333,0.00849851144914525,-0.026924096860758,0.00639006801989139,0.227036695884171
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LEG1,Protein LEG1 homolog,39339,0.00935302489691082,0.00775927662443448,-0.00585515728698076,0.0245612070808024,0.228075836333101
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,41903,-0.00392280679257786,0.00325728462814052,-0.0103070846637333,0.00246147107857756,0.228488084906933
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ECM1,Extracellular matrix protein 1,39658,-0.00483054115876471,0.00401407742137492,-0.0126981329046595,0.00303705058713013,0.228847292253417
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39858,-0.0132655906232908,0.011025014391514,-0.0348746188306582,0.00834343758407653,0.228913944142976
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FZD10,Frizzled-10,39590,-0.00787420198025912,0.00654692024257671,-0.0207061656557095,0.00495776169519124,0.229105277127492
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41900,0.00455750638812484,0.00378994882688353,-0.00287079331256688,0.0119858060888166,0.229181780341123
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,39512,0.00587944795829101,0.00489491095263562,-0.0037145775088748,0.0154734734254568,0.229724980645019
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42187,-0.00442851063563192,0.00368794304560438,-0.0116568790050165,0.00279985773375266,0.22984671373059
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,39597,-0.00545731615529098,0.00455646081167514,-0.0143879793461743,0.0034733470355923,0.231055964780271
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39500,0.0107592505742067,0.00898591680752846,-0.00685314636854906,0.0283716475169625,0.231197802051019
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APOH,Beta-2-glycoprotein 1,42063,0.00480180922988543,0.00402470937031608,-0.00308662113593408,0.0126902395957049,0.232858195257867
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,REG1A,Lithostathine-1-alpha,42030,-0.00653659991849823,0.00549236488429364,-0.0173016350917138,0.0042284352547173,0.234018362910659
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42063,-0.00379808668319476,0.00319810486915803,-0.0100663722267445,0.00247019886035498,0.235009852670711
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MYOM1,Myomesin-1,39526,-0.00640488019346611,0.00540447866813593,-0.0169976583830125,0.00418789799608032,0.236001307531295
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FCRL2,Fc receptor-like protein 2,42155,0.00650875235431573,0.00549623432660859,-0.00426386692583711,0.0172813716344686,0.236346626406136
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,39526,0.00758377684838903,0.00641150442035787,-0.0049827718155124,0.0201503255122905,0.236898737502456
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,39868,-0.0061124338898825,0.00517963707259239,-0.0162645225521636,0.00403965477239859,0.237989642314456
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,39500,0.00338652751559346,0.00287029086421166,-0.00223924257826139,0.00901229760944831,0.23808357159624
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39868,-0.0032899602233859,0.00279283455485759,-0.00876391595090678,0.00218399550413499,0.238821324553875
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MYOM3,Myomesin-3,39675,0.0125565410544584,0.0106916302580382,-0.00839905425129638,0.0335121363602132,0.240249219908913
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,41945,-0.0075790224555958,0.00645711459267347,-0.0202349670572358,0.0050769221460442,0.240517103763748
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41828,0.00380811658569287,0.00324586614224884,-0.00255378105311486,0.0101700142245006,0.240728532010604
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLK13,Kallikrein-13,41766,-0.00579639065778139,0.0049411392940247,-0.0154810236740698,0.00388824235850702,0.240781785590265
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NEDD9,Enhancer of filamentation 1,39597,0.00436084844605318,0.00373003386941528,-0.00295001793800076,0.0116717148301071,0.242381572749752
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,39575,0.00730942239071344,0.00625584841301528,-0.00495204049879651,0.0195708852802234,0.242665091663975
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD109,CD109 antigen,42063,0.00436802380270989,0.00375317757778279,-0.00298820424974438,0.0117242518551642,0.24451751722854
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,39895,0.00366148526005431,0.0031489415916534,-0.00251044025958636,0.00983341077969497,0.244948629116855
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ENO1,Alpha-enolase,42044,-0.0100221034343926,0.00866333254761122,-0.0270022352277106,0.00695802835892543,0.24735763926392
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ZNF830,Zinc finger protein 830,39858,-0.00988737673581828,0.00855297684126752,-0.0266512113447026,0.00687645787306606,0.24769920815272
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,39897,-0.00235190286500007,0.00203458791378007,-0.006339695176009,0.00163588944600887,0.247721839899741
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LTO1,Protein LTO1 homolog,41842,0.00524529941212518,0.00454968456604407,-0.00367208233732119,0.0141626811615716,0.248975122976907
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,39872,-0.00344804670584156,0.00299549751325548,-0.00931922183182229,0.00242312842013918,0.249725193032248
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42108,-0.0139110593936616,0.0120985625543382,-0.0376242420001644,0.00980212321284126,0.250242111098492
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,41842,-0.00752626704504625,0.0065539766070248,-0.0203720611948149,0.00531952710472235,0.250844345218969
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42097,0.00339911975809966,0.00296628698963579,-0.0024148027415865,0.00921304225778581,0.251849663536354
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SEPTIN7,Septin-7,39696,0.00671504252038598,0.00586455010261595,-0.00477947568074128,0.0182095607215132,0.252224484031927
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39858,0.00554936257132922,0.00485118937458238,-0.00395896860285224,0.0150576937455107,0.252681990685124
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NEB,Nebulin,39512,0.00496825987893334,0.00439334369008429,-0.00364269375363186,0.0135792135114985,0.258138565281072
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,42207,-0.00647523130433721,0.00572960000641209,-0.0177052473169049,0.00475478470823049,0.258438543549474
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42174,-0.00351421026655726,0.00311082714471137,-0.00961143147019155,0.00258301093707704,0.25863497136212
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",41766,-0.00346561617369071,0.00306899112972177,-0.00948083878794537,0.00254960644056395,0.25881874031609
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MUCL3,Mucin-like protein 3,39500,0.00526481905868014,0.00467129413026568,-0.00389091743664059,0.0144205555540009,0.259742802333807
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,39500,0.00484134754954639,0.00429804092982792,-0.00358281267291632,0.0132655077720091,0.260017673838734
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C7,Complement component C7,39661,0.00411584028557511,0.00366258547488973,-0.00306282724520876,0.011294507816359,0.261142344300891
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,41542,0.00399951665429159,0.00356325840159193,-0.00298446981282859,0.0109835031214118,0.261699460636868
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41629,0.0104202039865281,0.00929568713301512,-0.00779934279418157,0.0286397507672377,0.262320487966574
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,39597,0.00302971027564679,0.00270283914955447,-0.00226785445747996,0.00832727500877354,0.26233949326071
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MYOM2,Myomesin-2,39512,0.00686749712438833,0.00613889982113277,-0.00516474652503189,0.0188997407738086,0.263299034705536
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FAP,Prolyl endopeptidase FAP,42236,-0.00336703372019404,0.00302862331755406,-0.0093031354226,0.00256906798221192,0.266270687847846
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41771,-0.00573774711998564,0.00517950747755841,-0.0158895817760001,0.00441408753602884,0.267977708921529
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DCUN1D1,DCN1-like protein 1,39526,-0.00916783647171144,0.00829159345130326,-0.0254193596362658,0.00708368669284296,0.268890051643064
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OGN,Mimecan,42063,0.00524923032386677,0.00475314871288254,-0.00406694115338301,0.0145654018011166,0.269452818454146
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GSAP,Gamma-secretase-activating protein,41771,-0.0102569880397318,0.00929393943703022,-0.028473109336311,0.00795913325684748,0.269777679560119
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39895,-0.0034975584003056,0.0031708832045526,-0.0097124894812287,0.00271737268061749,0.270040500021783
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,JAM2,Junctional adhesion molecule B,42174,-0.00331125881918384,0.00300441234858102,-0.00919990702240264,0.00257738938403495,0.270423854969029
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39597,0.00517914027429375,0.00469967785223405,-0.00403222831608499,0.0143905088646725,0.270476975413709
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,39590,-0.00937764518594201,0.00851301355835968,-0.026063151760327,0.00730786138844296,0.270674577384946
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CA7,Carbonic anhydrase 7,39696,0.00406761702911996,0.00370004720501029,-0.00318447549270022,0.0113197095509401,0.271642801569485
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",41766,0.00711935876016389,0.00647851735911906,-0.00557853526370947,0.0198172527840373,0.271823967996335
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39575,-0.00527841209533003,0.00481478135200663,-0.014715383545263,0.00415855935460296,0.272974535424163
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",39858,0.00509009455557254,0.0046455157334245,-0.00401511628193948,0.0141953053930846,0.273233241976791
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD302,CD302 antigen,41995,-0.00374952375281689,0.00342442956722612,-0.0104614057045801,0.00296235819894631,0.273565317650795
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GAD1,Glutamate decarboxylase 1,39500,0.0031695365315827,0.00289517388112938,-0.00250500427543088,0.00884407733859629,0.273643567186314
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39512,0.00439050363254113,0.00402395345342196,-0.00349644513616591,0.0122774524012482,0.275256470654918
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MYL6B,Myosin light chain 6B,39590,-0.0109414507496943,0.0100386791631867,-0.0306172619095403,0.00873436041015173,0.275768177341791
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42106,0.00584210777100379,0.00537169515782048,-0.00468641473832436,0.0163706302803319,0.276803297408844
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,41842,-0.00449823374591039,0.00414036946105586,-0.0126133578895799,0.00361689039775909,0.277307272888868
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,39597,0.00492690142723622,0.00455485324327102,-0.00400061092957498,0.0138544137840474,0.279417703445542
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,39512,0.00410771942954856,0.00379805256923259,-0.00333646360614732,0.0115519024652444,0.279483962031321
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGF6,Fibroblast growth factor 6,39597,0.00464706426044794,0.00429908170705228,-0.00377913588537452,0.0130732644062704,0.279745968373049
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTTG1,Securin,39696,-0.00494274471539617,0.00457968208874672,-0.0139189216093397,0.0040334321785474,0.28048780321984
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,41771,0.00461116075333982,0.00430660295125036,-0.00382978103111088,0.0130521025377905,0.284315506070339
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39500,-0.00755969655223064,0.00706312299527335,-0.0214034176229664,0.00628402451850512,0.284505699636898
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,39500,0.0100512063311187,0.00939226894795521,-0.00835764080687348,0.028460053469111,0.284572151902114
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42187,0.0039452186060825,0.00368716899227745,-0.0032816326187813,0.0111720698309463,0.284644690470594
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42063,-0.00364293976754784,0.0034052638970552,-0.010317257005776,0.00303137747068036,0.284730048597945
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CA3,Carbonic anhydrase 3,42213,0.00689903934373505,0.00646426720399172,-0.00577092437608873,0.0195690030635588,0.28587438235936
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL17D,Interleukin-17D,41842,0.00399770930682267,0.00374835532299181,-0.00334906712624129,0.0113444857398866,0.2862064732164
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DSG3,Desmoglein-3,42121,0.00410552996944151,0.00386806745761344,-0.00347588224748082,0.0116869421863638,0.288531439988609
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39512,-0.00560350202582338,0.00528208939846396,-0.0159563972468128,0.00474939319516599,0.288781770509147
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,42003,0.00513395831015299,0.00484013099726836,-0.004352698444493,0.014620615064799,0.288842427565682
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C1R,Complement C1r subcomponent,39917,-0.00218994067441442,0.00206906781663944,-0.00624531359502773,0.00186543224619888,0.289887054756379
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CPA4,Carboxypeptidase A4,39458,0.00512817759100996,0.00484896849913148,-0.00437580066728774,0.0146321558493076,0.290269976462187
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",39512,-0.00451462230286274,0.00427552144138287,-0.0128946443279732,0.00386539972224769,0.291026678600163
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,41842,-0.00429118882452815,0.00407327395837586,-0.0122748057829448,0.00369242813388853,0.292131711439795
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL18,C-C motif chemokine 18,41945,-0.00811746467216668,0.00773223610459398,-0.0232726474371709,0.00703771809283752,0.293819379713678
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CPLX2,Complexin-2,39500,0.00349287259477889,0.00333128906036208,-0.00303645396353079,0.0100221991530886,0.294429336103584
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MTR,Methionine synthase,39512,-0.0075359862332036,0.00720113849725066,-0.0216502176878149,0.0065782452214077,0.295353758263914
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,41842,0.00510857585915809,0.00488346700670271,-0.00446301947397923,0.0146801711922954,0.295535753465245
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42088,-0.00755741193557844,0.00723090077652164,-0.0217299774575609,0.00661515358640398,0.295970078246939
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,39868,-0.00440182186897034,0.00423001807011338,-0.0126926572863926,0.00388901354845189,0.29807641661755
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD7,T-cell antigen CD7,39576,0.00511701640534937,0.00492867680143954,-0.00454319012547213,0.0147772229361709,0.299193764790843
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39526,0.00744456869496624,0.00717282076757798,-0.00661416000948661,0.0215032973994191,0.299346201519582
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRKCQ,Protein kinase C theta type,41842,-0.00488561926136621,0.00470962514132266,-0.0141164845383586,0.00434524601562621,0.299582848327632
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CFHR2,Complement factor H-related protein 2,39842,-0.00650176392595819,0.00627600640794746,-0.0188027364855352,0.00579920863361883,0.300237710283899
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41771,0.00403845963427159,0.00389849830766297,-0.00360259704874783,0.011679516317291,0.300267189088407
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39872,0.00274944407695368,0.00266279067386882,-0.00246962564382919,0.00796851379773656,0.301840282835732
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42219,-0.00680813060435239,0.00661502271595382,-0.0197735751276219,0.00615731391891709,0.303407586093025
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,39696,0.00821721121811595,0.00806728482988901,-0.0075946670484665,0.0240290894846984,0.30842247779653
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,39597,-0.00720472929360341,0.00707809892079157,-0.0210778031783549,0.00666834459114807,0.308752413589117
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DEFB118,Beta-defensin 118,39526,-0.00637845138959862,0.00627414787972338,-0.0186757812338565,0.00591887845465921,0.309354685951663
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,39872,-0.00405969291304221,0.00400098654728089,-0.0119016265457127,0.00378224071962833,0.31028352042696
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,39526,0.00384527658507721,0.00379598600537751,-0.00359485598546272,0.0112854091556171,0.31108979478726
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HMOX1,Heme oxygenase 1,41937,0.00547640771038345,0.00541152466581889,-0.00513018063462157,0.0160829960553885,0.311561293852848
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,39927,0.00293678245589534,0.00290923940246832,-0.00276532677294257,0.00863889168473325,0.312772071773674
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SAT1,Diamine acetyltransferase 1,39512,0.00538047668117388,0.00533693014429991,-0.00507990640165394,0.0158408597640017,0.313400264640505
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,39590,0.00312385325212739,0.00310340223290906,-0.00295881512437436,0.00920652162862914,0.314154065620284
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,39526,0.0061762411050783,0.00616378507939486,-0.00590477765053563,0.0182572598606922,0.316355718130579
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39872,-0.00331086980619219,0.00331040996475116,-0.00979927333710446,0.00317753372472008,0.317264758372507
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTNNA1,Catenin alpha-1,39526,0.00372056070894792,0.00372804601540332,-0.00358640948124259,0.0110275308991384,0.318305259904191
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,42108,0.00403659332776171,0.00406588515667473,-0.00393254157932075,0.0120057282348442,0.320827305888496
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL17RA,Interleukin-17 receptor A,42063,-0.0048207946342611,0.00488212916863906,-0.0143897678047937,0.00474817853627145,0.323446233460496
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLSPN,Claspin,41747,0.00383803136818667,0.00389120167004625,-0.00378872390510398,0.0114647866414773,0.323986527291433
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",39512,0.00600073777066847,0.00608807346857364,-0.00593188622773586,0.0179333617690728,0.324324476793857
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,39512,0.00601360296137807,0.00610545590355642,-0.00595309060959252,0.0179802965323487,0.32466772061873
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PMCH,Pro-MCH,39512,0.00893955633809604,0.00908238409731722,-0.00886191649264571,0.0267410291688378,0.325002534403568
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,39590,0.00548610649543234,0.00559148060183409,-0.00547319548416248,0.0164454084750272,0.326538143604746
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STX5,Syntaxin-5,39597,-0.00429448192087846,0.0043812162444594,-0.0128816657600189,0.00429270191826197,0.327007417820761
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,39526,0.00778845631616,0.00794862036998369,-0.00779083960900803,0.023367752241328,0.327181821994119
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EPN1,Epsin-1,39696,-0.00467109754355172,0.00476772397023909,-0.0140158365252203,0.0046736414381169,0.327239185211965
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TSPAN7,Tetraspanin-7,39526,0.0104875153549905,0.0107603699271386,-0.0106028097022012,0.0315778404121822,0.329759132087704
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,41771,-0.00572718206502308,0.00587798458155747,-0.0172480318448757,0.00579366771482956,0.329903400516473
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TCP11,T-complex protein 11 homolog,39696,0.00619463252962867,0.00637099769020168,-0.00629252294316662,0.018681788002424,0.33091381657788
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,39512,-0.00352725326600075,0.00363426006740555,-0.0106504029981156,0.00359589646611414,0.331790889566514
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,39590,-0.00823295827576127,0.00850216694304862,-0.0248972054841366,0.00843128893261401,0.332897668516293
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,39500,0.00424453303433541,0.00438637521964706,-0.00435276239617282,0.0128418284648436,0.333234168723479
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MB,Myoglobin,42236,0.00596420655459493,0.00616818005248116,-0.00612542634826815,0.018053839457458,0.333595510900274
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL11,Interleukin-11,41842,0.00645781050502222,0.00668746931360784,-0.00664962934964915,0.0195652503596936,0.334232807855866
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,39590,0.00382231030298215,0.00398995831643651,-0.00399800799723341,0.0116426286031977,0.338092648931196
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FBN2,Fibrillin-2,39590,-0.0063237315126473,0.00661495961098416,-0.0192890523501762,0.00664158932488165,0.33910623645602
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,39590,-0.00862963759699649,0.00904689763153007,-0.0263615569547954,0.00910228176080246,0.34016632548482
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRSS27,Serine protease 27,42034,-0.00421475081052643,0.00442479733340173,-0.0128873535839938,0.00445785196294096,0.340845555928711
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CAPG,Macrophage-capping protein,41942,-0.00617610039935447,0.00649550366134071,-0.0189072875755823,0.00655508677687333,0.341709416525747
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,39590,-0.00527168294003401,0.00555938965764074,-0.0161680866690099,0.00562472078894185,0.343023808576292
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39512,-0.0061558510214978,0.00652357037896626,-0.0189420489642717,0.00663034692127607,0.345378527112123
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,39675,0.00370155395281891,0.00393647472039471,-0.00401393649915472,0.0114170444047925,0.347072904183857
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LIF,Leukemia inhibitory factor,41766,-0.00517106594317667,0.00549955487920137,-0.0159501935064114,0.00560806162005802,0.347096382765382
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LTB,Lymphotoxin-beta,39858,0.00355225959283754,0.00379061995154382,-0.00387735551218836,0.0109818746978634,0.348717775105764
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SKIV2L,Helicase SKI2W,39512,-0.00407250588031439,0.00435629773445199,-0.0126108494398403,0.00446583767921151,0.349883816569236
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,41766,0.00623454068651723,0.00667348593975473,-0.00684549175540204,0.0193145731284365,0.350204721675285
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EP300,Histone acetyltransferase p300,39597,0.00316789465179425,0.00339298660194093,-0.00348235908800997,0.00981814839159847,0.350499989019268
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41766,-0.00704324551132306,0.00755771954597782,-0.0218563758214396,0.00776988479879346,0.351391162999453
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,39895,-0.00308762251104676,0.00331995927146193,-0.00959474268311213,0.00341949766101862,0.352381542386697
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GC,Vitamin D-binding protein,39917,-0.00263889126071138,0.00284115337299395,-0.00820755187177952,0.00292976935035675,0.353007444379009
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,39500,-0.014966164749347,0.0161204463393067,-0.0465622395743882,0.0166299100756941,0.353222530060209
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPT2,Angiopoietin-2,42187,-0.0038011312171919,0.00411270786784399,-0.0118620386381661,0.00425977620378231,0.355377522047271
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NRXN3,Neurexin-3,39590,-0.00364842642628934,0.00395715897778928,-0.0114044580227563,0.00410760517017765,0.35655858912079
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ESR1,Estrogen receptor,39597,0.00579828211132128,0.00629480333671414,-0.00653953242863845,0.018136096651281,0.357006918958026
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42111,0.00442867492788572,0.0048098806163677,-0.00499869108019498,0.0138560409359664,0.35719986332242
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TEK,Angiopoietin-1 receptor,42108,-0.00224127212354396,0.00243813354003551,-0.00702001386201356,0.00253746961492564,0.357977406243636
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STEAP4,Metalloreductase STEAP4,39526,-0.00736071529059353,0.00802685447839159,-0.023093350068241,0.00837191948705398,0.359157022312119
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GBP2,Guanylate-binding protein 2,41842,0.00610418244507628,0.00666714162497652,-0.00696341513987771,0.0191717800300303,0.359913269033967
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,41771,0.00546318690509523,0.00597324193226387,-0.00624436728214196,0.0171707410923324,0.360413141294965
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,39526,0.00522265108583518,0.00574403073014715,-0.00603564914525323,0.0164809513169236,0.363248233657891
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FZD8,Frizzled-8,39526,-0.00431527988715387,0.00475066533450244,-0.0136265839427786,0.0049960241684709,0.363711919524045
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RRP15,RRP15-like protein,39526,0.00913117085066017,0.0100533397678662,-0.0105733750943576,0.0288357167956779,0.363754363477602
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GAL,Galanin peptides,42111,0.00665108007264357,0.00732629998161809,-0.0077084678913279,0.021010628036615,0.363980980098945
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGF5,Fibroblast growth factor 5,41842,0.00340115822454518,0.00374934133214351,-0.00394755078645609,0.0107498672355465,0.364351992331322
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39512,0.00615574351202793,0.00678903704835252,-0.007150769102743,0.0194622561267989,0.364575853223903
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BSND,Barttin,39500,-0.00334729996904168,0.0036941150086072,-0.0105877653859118,0.00389316544782844,0.364894020383137
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLASP1,CLIP-associating protein 1,39500,-0.0074730919507616,0.00825212924997033,-0.0236472652807035,0.00870108137918025,0.365169954473286
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SDK2,Protein sidekick-2,39675,0.00392559673343906,0.0043372474782232,-0.00457540832387842,0.0124266017907565,0.365437713812633
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NXPE4,NXPE family member 4,39512,0.0031799203507753,0.00353027742846596,-0.00373942340901799,0.0100992641105686,0.367737678201809
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TUBB3,Tubulin beta-3 chain,39526,0.00283237362405676,0.00315455016900989,-0.00335054470720263,0.00901529195531614,0.369275039488176
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD244,Natural killer cell receptor 2B4,42222,-0.00271464694032104,0.00302691938312617,-0.00864740893124834,0.00321811505060626,0.369822871391861
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,41771,0.00375096870713557,0.00419132225367221,-0.00446402291006197,0.0119659603243331,0.370837204158954
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39869,0.0021062589855088,0.00236759700737724,-0.00253423114895059,0.00674674911996819,0.373689558163563
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,41828,0.00743873038712813,0.00836615244155399,-0.0089589283983177,0.023836389172574,0.37394082635195
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42048,0.00336687548146716,0.00379930081684104,-0.00407975411954128,0.0108135050824756,0.375534813563937
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,39575,-0.0039216120247475,0.00443326794435952,-0.0126108171956922,0.00476759314619716,0.376398697642268
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,39512,0.00676990638005827,0.00765768087384808,-0.00823914813268397,0.0217789608928005,0.376679282450174
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42048,-0.014547837716861,0.0164973102024499,-0.0468825657136628,0.0177868902799409,0.377884026044923
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CASQ2,Calsequestrin-2,39512,0.00461133206531376,0.00524273344382217,-0.00566442548457769,0.0148870896152052,0.379113628582023
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,41997,-0.00259906664734138,0.00295566436805744,-0.00839216880873396,0.0031940355140512,0.379226721334505
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,39869,0.0054175123310191,0.00620533529164724,-0.00674494484060949,0.0175799695026477,0.382659315062527
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39696,-0.00459595516393415,0.00527474892621387,-0.0149344630593133,0.00574255273144504,0.383602347458966
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",41828,-0.00803624515149954,0.00923287427335866,-0.0261326787272825,0.0100601884242834,0.384100517680419
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39512,-0.00443612507487317,0.00511166680239049,-0.0144549920075585,0.00558274185781218,0.385499283028949
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,41766,-0.00481273658601053,0.00555088562826191,-0.0156924724174039,0.00606699924538281,0.385946089459091
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39869,0.0164100854371966,0.0189351264723048,-0.0207027624485209,0.0535229333229141,0.386153474122205
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BEX3,Protein BEX3,39500,0.00445000731532006,0.00514294811082418,-0.00563017098189532,0.0145301856125355,0.386913005379038
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,41943,-0.0034790967600659,0.00402245900432968,-0.0113631164085521,0.00440492288842026,0.387099406246371
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ZNF75D,Zinc finger protein 75D,39696,0.00582085288418745,0.00674243715564471,-0.00739432394087618,0.0190360297092511,0.387982490060322
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,41995,-0.00687331536525136,0.00796773224370464,-0.0224900705629125,0.00874343983240974,0.388348746892071
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDH22,Cadherin-22,39696,0.00261580526797631,0.00303605208703347,-0.0033348568226093,0.00856646735856191,0.38893666223158
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MLLT1,Protein ENL,39500,0.00627121217846995,0.00729062540537132,-0.00801841361605783,0.0205608379729977,0.38971161758668
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CALB1,Calbindin,41995,-0.00427927697997528,0.00498131975570524,-0.0140426637011575,0.00548410974120698,0.390320081266443
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39590,0.00296234290310649,0.00345044384195761,-0.00380052702713042,0.0097252128333434,0.390613261419608
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GUCA2A,Guanylin,42009,0.00330540460402655,0.00386539823724201,-0.00427077594096779,0.0108815851490209,0.392496379083048
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCIN,Adseverin,39526,0.00694017048898563,0.00813658772966674,-0.00900754146116119,0.0228878824391324,0.393701096108639
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39872,-0.00630276094074687,0.00744354411475776,-0.0208921074056721,0.00828658552417834,0.397156955797526
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD22,B-cell receptor CD22,42222,0.00395231600200405,0.00468874468613593,-0.00523762358282237,0.0131422555868305,0.399278524260133
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DCC,Netrin receptor DCC,39590,-0.00206804307319973,0.00246425030113789,-0.00689797366342999,0.00276188751703052,0.401365273169959
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MELTF,Melanotransferrin,39895,0.0027788648578093,0.0033118641983508,-0.00371238897095827,0.00927011868657686,0.401451351022412
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PGR,Progesterone receptor,39597,0.00925506874038122,0.0110445868807288,-0.0123923215458472,0.0309024590266096,0.40206392005616
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BRD1,Bromodomain-containing protein 1,39696,-0.00280905538786221,0.00335297682020708,-0.00938088995546808,0.00376277917974366,0.402172574884761
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,39512,0.00328469714097739,0.00393256828600716,-0.00442313669959665,0.0109925309815514,0.403592461479882
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,39526,0.00459803108839022,0.00551367985689169,-0.0062087814311175,0.0154048436078979,0.404337839420884
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39696,0.00623681769027896,0.00750642767144917,-0.00847578054576141,0.0209494159263193,0.406068553166012
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SSB,Lupus La protein,41766,-0.00539893462710399,0.00650423623538315,-0.018147237648455,0.00734936839424698,0.406517451828339
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CR2,Complement receptor type 2,42142,0.00425275831309709,0.00512762354624632,-0.00579738383754571,0.0143029004637399,0.406902942149656
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CHGB,Secretogranin-1,42135,0.00385076461853924,0.00464977096236671,-0.00526278646769952,0.012964315704778,0.407593241633765
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,39590,-0.00274004645969264,0.00331632878139113,-0.00924005087121926,0.00375995795183398,0.408692231359118
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,39500,-0.00520713652594797,0.00631628506606964,-0.0175870552554445,0.00717278220354853,0.409731152807995
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PXDNL,Peroxidasin-like protein,39858,0.00519352554351584,0.0063014206244921,-0.00715725888048868,0.0175443099675204,0.40985288403401
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ULBP2,UL16-binding protein 2,41943,-0.00354592168079783,0.00432316206703622,-0.0120193193321888,0.00492747597059317,0.412108295695087
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,39868,-0.00246940854090296,0.00301139105114844,-0.00837173500115391,0.00343291791934799,0.412220602767903
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TMOD4,Tropomodulin-4,39500,-0.00361456491065854,0.00441026108423358,-0.0122586766357564,0.00502954681443927,0.412473094047704
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PFDN6,Prefoldin subunit 6,39590,0.00578563856712747,0.00712557022049254,-0.00818047906503792,0.0197517561992929,0.416835345244673
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39590,-0.0042480253127768,0.00523259377994901,-0.0145039091214769,0.00600785849592326,0.416901426704068
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DUOX2,Dual oxidase 2,41828,0.00628664739618719,0.00774877793582477,-0.00890095735802936,0.0214742521504037,0.417203276141666
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL5,Interleukin-5,41842,-0.0123164655766297,0.0151906060451479,-0.0420900534251196,0.0174571222718602,0.417498047860552
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COLEC12,Collectin-12,42050,-0.00243603336824003,0.00300528236425711,-0.00832638680218397,0.00345432006570391,0.417619032721237
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,41943,-0.00213176757852902,0.0026333324970237,-0.00729309927269547,0.00302956411563743,0.418223496512806
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LY75,Lymphocyte antigen 75,42048,-0.00342218126788273,0.00426073617573734,-0.0117732241723279,0.00492886163656246,0.421879041331029
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,41747,-0.00361238477489393,0.00450125815616911,-0.0124348507609854,0.00521008121119753,0.422262224544704
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,39590,-0.00322758725827628,0.00404613191342626,-0.0111580058085918,0.0047028312920392,0.425063584364547
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BLNK,B-cell linker protein,39597,-0.00367395105535832,0.00460906622068608,-0.012707720847903,0.00535981873718639,0.425402055324636
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,39872,0.00684868851798861,0.00862149688655574,-0.0100494453796606,0.0237468224156379,0.426994759742999
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,41943,-0.00537553904316178,0.00676902398518051,-0.0186428260541156,0.00789174796779202,0.427129231681319
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NDRG1,Protein NDRG1,41766,-0.00579366532453126,0.00729582332663584,-0.0200934790447375,0.00850614839567498,0.427147379454041
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,39927,0.00249396363457844,0.00314248979451288,-0.0036653163626668,0.00865324363182369,0.42742944024148
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,42174,0.00412870427627897,0.00520505949794464,-0.00607321233969253,0.0143306208922505,0.427669454896292
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL22,Interleukin-22,39858,-0.00613577021320791,0.00775293874449243,-0.0213315301524131,0.00905998972599726,0.428720173265433
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,39526,0.00263373940466267,0.00334408964873028,-0.00392067630684869,0.00918815511617403,0.430959277815461
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41409,0.00259297238029855,0.00329566064076212,-0.00386652247559521,0.00905246723619232,0.431422998502289
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,39696,0.00383482764744217,0.00489659381272221,-0.00576249622549336,0.0134321515203777,0.433548528099266
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HBZ,Hemoglobin subunit zeta,39895,0.00924800287485265,0.0118347522187108,-0.0139481114738205,0.0324441172235258,0.434567379571412
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,39526,0.00788801941850729,0.0101293814057387,-0.0119655681367406,0.0277416069737551,0.436157608490925
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,39872,0.0063836242945476,0.00820002421540264,-0.00968842316764158,0.0224556717567368,0.436297443111084
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,39845,-0.00328294557356864,0.00421750782923391,-0.0115492609188671,0.00498336977172982,0.436344379893719
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,39512,0.00641396085555623,0.00824256273756072,-0.00974146211006278,0.0225693838211752,0.436496698520873
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,39590,0.0031204259459959,0.00401912470533783,-0.00475705847646624,0.010997910368458,0.437532854006279
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FCRL5,Fc receptor-like protein 5,42063,-0.0050464408520646,0.00650012832428301,-0.0177866923676593,0.00769381066353011,0.437549982867076
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39590,-0.00883875195034486,0.0113994393257119,-0.0311816530287402,0.0135041491280505,0.43813936309902
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TSHB,Thyrotropin subunit beta,42072,-0.00580958048536109,0.00750206588001309,-0.0205136296101868,0.00889446863946457,0.438709397082561
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RELB,Transcription factor RelB,39597,-0.00398576998894102,0.00515687323811198,-0.0140932415356405,0.00612170155775847,0.43959557528667
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TFF3,Trefoil factor 3,42069,-0.00304845141760276,0.00396731469935182,-0.0108243882283323,0.00472748539312681,0.442268021932001
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PROK1,Prokineticin-1,42048,0.00419836069074356,0.00547425271276128,-0.00653117462626854,0.0149278960077557,0.443137461620418
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LTA,Lymphotoxin-alpha,42048,0.00334767145751309,0.00440752985969567,-0.00529108706749042,0.0119864299825166,0.447546134214456
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPON2,Spondin-2,41997,-0.00291681549875987,0.00384127622161711,-0.0104457168931294,0.00461208589560966,0.447665542857644
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,39526,0.00417828822984968,0.0055081038207022,-0.00661759525872664,0.014974171718426,0.448125544398255
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KITLG,Kit ligand,42072,0.0031804174009107,0.00419716911403118,-0.00504603406259042,0.0114068688644118,0.448612130075424
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42175,0.00349121782297344,0.00460747730648633,-0.00553943769773977,0.0125218733436867,0.448626562451765
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,41995,-0.00271633177813769,0.00360507482115664,-0.00978227842760469,0.00434961487132932,0.451178100552823
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,39526,0.00610559156723516,0.00813082375163118,-0.00983082298596195,0.0220420061204323,0.452717463896482
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL18BP,Interleukin-18-binding protein,42142,0.00258839084411399,0.00344715844464525,-0.00416803970739069,0.00934482139561868,0.452739930862603
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,39500,-0.00360369021406302,0.00480578040662064,-0.0130230198110395,0.00581563938291342,0.453351737769963
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RTBDN,Retbindin,41995,-0.00246745850050482,0.00330004604951037,-0.00893554875754515,0.0040006317565355,0.454651684818366
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,39597,-0.00242473091841192,0.00325089002212884,-0.00879647536178444,0.00394701352496061,0.455763828500612
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GNLY,Granulysin,42063,0.00442602072865278,0.00593934327323632,-0.0072150920868904,0.016067133544196,0.456161580516644
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,41842,-0.00510089088040094,0.00685491630144017,-0.0185365268312237,0.0083347450704218,0.456816152387788
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GJA8,Gap junction alpha-8 protein,39500,-0.00506238445810828,0.00683125946126428,-0.0184516530021863,0.0083268840859697,0.458672020758354
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39526,0.00608830951841258,0.00822827133432815,-0.0100391022968706,0.0222157213336958,0.459360970410505
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,39590,-0.00414730279052869,0.00562748561182451,-0.0151771745897047,0.00688256900864734,0.461154734852475
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ZNF174,Zinc finger protein 174,39597,0.00297389953539018,0.00404486098272572,-0.00495402799075223,0.0109018270615326,0.462215653009423
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,42111,0.0023354763324917,0.00318487865441411,-0.00390688583015995,0.00857783849514335,0.463387275912785
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42175,-0.00251016630412567,0.00342566749599363,-0.00922447459627318,0.00420414198802184,0.463722069784837
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41766,-0.00424039720169003,0.0057882712157512,-0.0155854087845624,0.00710461438118233,0.463824989332642
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,39696,-0.00550529325725488,0.00753572708699567,-0.0202753183477664,0.00926473183325663,0.465063986391343
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GPC1,Glypican-1,42187,0.00237457757029669,0.00325607288398814,-0.00400732528232006,0.00875648042291344,0.465845090081049
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,39526,0.00487006653886262,0.00668601878835379,-0.00823453028631081,0.017974663364036,0.46638707824824
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,41995,0.00328282307437437,0.00451859767643858,-0.00557362837144525,0.012139274520194,0.467536612714079
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,39868,-0.0055136844664525,0.00760825071687937,-0.0204258558715361,0.00939848693863107,0.468652338490405
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPRR1B,Cornifin-B,39696,-0.00688292807351514,0.00950937723163613,-0.025521307447522,0.0117554513004917,0.469201151545947
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,39597,-0.0083381451249303,0.0115305152192848,-0.0309379549547284,0.0142616647048678,0.469610942459201
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39512,0.00401690105685484,0.00555911182766849,-0.00687895812537539,0.0149127602390851,0.469953662346477
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,39901,0.00203413095527646,0.00281575938587066,-0.00348475744103003,0.00755301935158296,0.470057778071786
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DDI2,Protein DDI1 homolog 2,39675,-0.00595183076429256,0.00825064570417786,-0.0221230963444812,0.010219434815896,0.470692469925384
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39479,0.00426289285829534,0.00591259369774642,-0.00732579078928765,0.0158515765058783,0.470934081112054
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDSN,Corneodesmosin,42172,0.00346403793548433,0.0048161593660644,-0.00597563442200189,0.0129037102929706,0.471997322447082
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39512,0.00310615866365911,0.00434362472552097,-0.00540734579836199,0.0116196631256802,0.474557912680514
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,39597,0.00519278757072153,0.00727530361599383,-0.00906680751662637,0.0194523826580694,0.475393562366317
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,39575,0.00185778981718435,0.00260317958427199,-0.00324444216798876,0.00696002180235746,0.475451511090331
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,39590,-0.00503633175079276,0.00706776433706693,-0.0188891498514439,0.00881648634985843,0.476122199614205
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GPR15L,Protein GPR15L,39869,-0.00488585641552391,0.00686676982346334,-0.0183447252695121,0.00857301243846424,0.476775675517614
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,39696,0.00511442400055607,0.00719016924045703,-0.0089783077107397,0.0192071557118518,0.476908425248658
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41903,-0.00317623257163331,0.00448883464735209,-0.0119743484804434,0.00562188333717679,0.479215335954566
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,39597,0.00457453814193192,0.00648009991962488,-0.00812645770053284,0.0172755339843967,0.480242669623559
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,39512,0.0030385873456095,0.00432281892004139,-0.00543413773767163,0.0115113124288906,0.482121831668622
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GHRL,Appetite-regulating hormone,42072,0.00640480234320738,0.00914237857633649,-0.0115142596664121,0.0243238643528269,0.483588544781564
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGF16,Fibroblast growth factor 16,39597,-0.00356587788927443,0.00512387791555063,-0.0136086786037537,0.00647692282520481,0.486485232777099
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41747,-0.00360356564572431,0.00517991947145238,-0.013756207809771,0.00654907651832235,0.486641638572581
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,41995,-0.00339333812262329,0.00495109230580153,-0.0130974790419943,0.0063108027967477,0.493121312241311
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA6C,Semaphorin-6C,39597,0.0019402434431564,0.00284177152495591,-0.00362962874575718,0.00751011563206998,0.494773888308534
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CHIT1,Chitotriosidase-1,42135,-0.0117615720824172,0.0172518749984176,-0.0455752470793158,0.0220521029144814,0.495404813650755
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GLI2,Zinc finger protein GLI2,39597,0.00245885894963735,0.00365404555286147,-0.00470307033397114,0.00962078823324584,0.501016050580278
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL17F,Interleukin-17F,41842,0.00540702320566657,0.00805282441513425,-0.0103765126479966,0.0211905590593297,0.501949232165506
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MUC2,Mucin-2,39904,-0.006828851290658,0.0102151928228253,-0.0268506292233956,0.0131929266420796,0.503828451326075
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,41766,-0.00632801214453596,0.0094863317647555,-0.0249212224034567,0.0122651981143848,0.504741481053375
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HDAC9,Histone deacetylase 9,39526,0.00489858806032005,0.00735449122721428,-0.00951621474501993,0.01931339086566,0.505381977689605
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,B2M,Beta-2-microglobulin,39917,0.00222512155793905,0.00334650878461604,-0.0043340356599084,0.0087842787757865,0.506122678003236
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LRP2BP,LRP2-binding protein,39590,-0.00564807006892922,0.00854189706193944,-0.0223901883103305,0.0110940481724721,0.508485331401919
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",39512,-0.00457710632528221,0.00694243815092207,-0.0181842851010895,0.00903007245052504,0.50972104535287
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,39696,0.0059361604983777,0.00902938475716822,-0.011761433625672,0.0236337546224274,0.51092009147905
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41771,0.00567084539974976,0.00863381114695587,-0.0112514244482837,0.0225931152477833,0.511309213923301
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",39895,0.00556736764801609,0.00848916868931187,-0.0110714029830352,0.0222061382790674,0.511953225802881
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BGLAP,Osteocalcin,39904,-0.0060432784569914,0.00925199028881755,-0.0241771794230738,0.012090622509091,0.51364910695802
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39869,-0.00746205229693526,0.0114534939500131,-0.0299109004389608,0.0149867958450903,0.514731373014805
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,39526,0.00545069957326373,0.00837577516997305,-0.0109658197598834,0.0218672189064109,0.515208933479085
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GH2,Growth hormone variant,41771,0.0116122275073604,0.0178662990037276,-0.0234057185399458,0.0466301735546666,0.515734897778688
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,S100A13,Protein S100-A13,39597,-0.00254585683051251,0.00391939326814823,-0.0102278676360831,0.00513615397505803,0.515994044003158
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,39858,-0.00371127530489804,0.00572211728446426,-0.014926625182448,0.0075040745726519,0.516620349539266
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39512,-0.00473999384142027,0.00740580489266883,-0.0192553714310512,0.00977538374821063,0.522161570774032
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,39858,0.00375631145061933,0.00587607786892292,-0.0077608011724696,0.0152734240737083,0.522670142147685
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FOSB,Protein fosB,41766,-0.00271213946909574,0.00424960018797301,-0.0110413558375228,0.00561707689933136,0.523347761924701
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39526,0.00378588211591845,0.00593868315487152,-0.00785393686762974,0.0154257010994666,0.523815681674246
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41771,-0.00551308874144246,0.0086690816095533,-0.0225044886961669,0.011478311213282,0.524821092375563
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",41766,0.00292156110572003,0.0046003854766341,-0.00609519442848281,0.0119383166399229,0.525394606053772
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39696,0.00440747994575562,0.00697042740194496,-0.00925455776205652,0.0180695176535677,0.527196515695802
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42072,-0.00244312771730256,0.00386794871852305,-0.0100243072056077,0.00513805177100262,0.527636815780021
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TPSD1,Tryptase delta,39872,-0.00254480705357185,0.00403572013156,-0.0104548185114294,0.00536520440428574,0.528334015370527
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NPHS1,Nephrin,39597,-0.00230696283648814,0.00366143830505641,-0.00948338191439871,0.00486945624142243,0.528661805588819
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,41842,-0.00387084260920387,0.00614439133840562,-0.0159138496324789,0.00817216441407114,0.528718650906938
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42056,-0.00226843769160842,0.00360224420215203,-0.00932883632782639,0.00479196094460956,0.528882587932634
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,39858,0.00424253559231281,0.00675911730233672,-0.00900533432026716,0.0174904055048928,0.530228952874805
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SHISA5,Protein shisa-5,39904,-0.00178892611259221,0.00285582133022997,-0.00738633591984295,0.00380848369465853,0.531056158583594
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",39512,0.00277805060392633,0.00444710256112342,-0.00593827041587557,0.0114943716237282,0.53218905938521
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39500,0.00228132880020634,0.00369097080323701,-0.0049529739741382,0.00951563157455089,0.536533096348103
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39597,-0.00588284741254193,0.00952131037074078,-0.0245446157391939,0.01277892091411,0.536679689785832
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,39696,-0.00354179455235631,0.00577979318980522,-0.0148701892043745,0.00778660009966191,0.54002832496448
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DPT,Dermatopontin,42236,0.00170317084331267,0.00278696679581967,-0.00375928407649388,0.00716562576311923,0.541130399386766
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,39590,0.00372674330408156,0.00610297246925426,-0.00823508273565678,0.0156885693438199,0.541447938131275
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NEO1,Neogenin,39872,0.0015139209155475,0.00249037883989936,-0.00336722161065524,0.00639506344175024,0.543260821745821
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,39895,-0.00224448620760341,0.00369781819690949,-0.00949220987354601,0.00500323745833919,0.543879163966814
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39858,0.0039456169652084,0.00652227138729372,-0.00883803495388729,0.0167292688843041,0.545227581531106
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BRD3,Bromodomain-containing protein 3,39512,0.00316401309150117,0.00524109750732877,-0.00710853802286321,0.0134365642058656,0.546060417454642
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,42048,0.0022225653984292,0.00368388737025466,-0.00499785384726994,0.00944298464412834,0.546305559572392
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,39597,-0.00270290177723895,0.00448533464015299,-0.0114941576719388,0.00608835411746091,0.546781442072169
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MUC16,Mucin-16,41995,0.012655361132727,0.0210178799407698,-0.0285396835511818,0.0538504058166358,0.547102070630324
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VIT,Vitrin,39895,-0.00254563672979171,0.00423410175678466,-0.0108444761730896,0.00575320271350623,0.547703946372495
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,41842,0.00187060614495464,0.00311394391309361,-0.00423272392470883,0.00797393621461811,0.548037256747768
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,39575,0.00312396417238576,0.00521233427698384,-0.00709221101050258,0.0133401393552741,0.548958071438814
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITGAX,Integrin alpha-X,39696,0.003411435157048,0.00569589399385074,-0.00775251707089945,0.0145753873849955,0.549232568433974
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IFNL1,Interferon lambda-1,41766,0.00300555417723221,0.00502064616869282,-0.00683491231340572,0.0128460206678701,0.549423998182197
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39512,0.00334224478569742,0.00559644719070168,-0.00762679170807787,0.0143112812794727,0.550380701040034
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41547,0.00250520076582644,0.00420060377528259,-0.00572798263372743,0.0107383841653803,0.550924720168104
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,METAP1,Methionine aminopeptidase 1,41766,-0.00189402906886609,0.00320416686640992,-0.00817419612702952,0.00438613798929735,0.554453941780882
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42048,-0.00552577858864808,0.0093745000629883,-0.0238997987121052,0.012848241534809,0.555570810590974
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PITHD1,PITH domain-containing protein 1,39479,-0.00500824913970519,0.00850820990083697,-0.0216843405453456,0.0116678422659353,0.556116871831705
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,39512,0.00316319368356642,0.00540614655839975,-0.00743285357089708,0.0137592409380299,0.558485447044752
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGF20,Fibroblast growth factor 20,39597,0.00274915615814491,0.00474967385734596,-0.00656020460225316,0.012058516918543,0.562729601871403
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARG1,Arginase-1,41942,0.00320356571468358,0.00556808925131484,-0.00770988921789352,0.0141170206472607,0.565068496722205
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,39590,-0.00232705597971907,0.00404491615837302,-0.0102550916501302,0.00560097969069204,0.565097572659079
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLK15,Kallikrein-15,39839,0.00332626386818797,0.00578754543149777,-0.00801732517754765,0.0146698529139236,0.565486834731791
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42111,-0.00180648638315855,0.00315346302812473,-0.00798727391828302,0.00437430115196593,0.566750407242995
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,39864,-0.0038576809435771,0.00675579570618667,-0.017099040527703,0.00938367864054878,0.567998834063267
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,39696,0.00261672641318078,0.00462049480428816,-0.00643944340322401,0.0116728962295856,0.571180690027516
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,39512,0.00264045520610476,0.00467730210164816,-0.00652705691312563,0.0118079673253351,0.572408314707163
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PFDN2,Prefoldin subunit 2,41766,-0.00342430228889041,0.00609220618065568,-0.0153650264029755,0.00851642182519473,0.574071637599961
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDH4,Cadherin-4,39526,0.00283452866987272,0.00512800209761061,-0.00721635544144407,0.0128854127811895,0.580442511584922
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LHB,Lutropin subunit beta,41771,0.00539014069165517,0.00975958994642192,-0.0137386556033318,0.0245189369866421,0.580757875904305
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,41828,-0.00201080532465325,0.00364459059559595,-0.0091542028920213,0.0051325922427148,0.581147306253651
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EXTL1,Exostosin-like 1,39512,-0.00287855645994742,0.0052452031831382,-0.0131591546988983,0.00740204177900345,0.583155384226804
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STAM,Signal transducing adapter molecule 1,39858,-0.00218581941782286,0.00398421912207705,-0.00999488889709388,0.00562325006144815,0.58327763247284
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FCRL3,Fc receptor-like protein 3,41842,0.00322293565250632,0.00588298167267582,-0.00830770842593829,0.0147535797309509,0.583810657219119
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,39512,0.00213374630468691,0.00390181358314073,-0.00551380831826892,0.00978130092764273,0.584486007519316
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NPTX1,Neuronal pentraxin-1,42063,-0.00251036345105442,0.00459211012313208,-0.0115108992923933,0.00649017239028446,0.584615334667912
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,39927,-0.001587135814863,0.00290356994365788,-0.00727813290443245,0.00410386127470645,0.584653808580036
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,39526,-0.00707602103326782,0.0129460880681158,-0.0324503536467748,0.0182983115802391,0.584681222458839
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41771,-0.00761027470384216,0.0139269008545309,-0.0349070003787227,0.0196864509710383,0.584769865583626
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL25,Interleukin-25,39450,0.0020651393645537,0.00378163414747088,-0.00534686356448922,0.00947714229359662,0.585010435122235
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SOX9,Transcription factor SOX-9,39590,0.00165368020086695,0.00304234754011232,-0.00430932097775319,0.00761668137948709,0.586759440850572
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39526,0.00193553754116218,0.00357253641868598,-0.00506663383946234,0.0089377089217867,0.587979429099114
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,39526,0.00276948211059146,0.00514016424876642,-0.00730523981699072,0.0128442040381736,0.590040994231846
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42222,0.0020860136978123,0.00387283531568749,-0.00550474352093518,0.00967677091655978,0.590153049513895
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,41995,-0.00221284266857094,0.00414364601527577,-0.0103343888585114,0.00590870352136956,0.593327739288506
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CA9,Carbonic anhydrase 9,42187,0.00272290921020746,0.00514375263643773,-0.00735884595721049,0.0128046643776254,0.596562728740149
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ENAH,Protein enabled homolog,41842,-0.00280274588330244,0.00529679158522247,-0.0131844573903385,0.00757896562373361,0.596716997193606
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42149,0.00174853602774192,0.00333899662836576,-0.00479589736385496,0.00829296941933881,0.600515886757613
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,39500,0.00316042699505155,0.00604220199992672,-0.00868228892480483,0.0150031429149079,0.600943959516376
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,39696,-0.00305653769242304,0.00593014932512615,-0.0146796303696703,0.00856655498482422,0.606267456760461
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CAPN3,Calpain-3,39858,-0.00221185190680894,0.0042975321783939,-0.010635014976461,0.00621131116284311,0.606787073147482
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39512,0.00355739944852213,0.00691904075597724,-0.0100039204331933,0.0171187193302375,0.60716009578792
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39590,0.00318324509608133,0.00619175663715873,-0.00895259791274977,0.0153190881049124,0.607185300001781
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDAN1,Codanin-1,39868,-0.0012376276385069,0.00240833249656593,-0.00595795933177613,0.00348270405476233,0.607336174271537
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,41828,0.00268926365800954,0.00525909959424471,-0.0076185715467101,0.0129970988627292,0.609111462015743
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,41766,0.00369910519414025,0.00726573121202873,-0.0105417279814361,0.0179399383697166,0.610678949410468
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,39590,-0.00348508691659829,0.00685189925538249,-0.016914809457148,0.0099446356239514,0.611021254280293
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CNTF,Ciliary neurotrophic factor,39526,-0.00192755798947558,0.00380983796785675,-0.0093948404064748,0.00553972442752364,0.612907399320248
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39526,0.00299059131785264,0.00591878655089125,-0.00861023032189421,0.0145914129575995,0.613378686072309
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGLON5,IgLON family member 5,39500,0.00507077282425317,0.0101712026569161,-0.0148647843833025,0.0250063300318088,0.61811205666896
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39575,0.00171295068079902,0.00346294690147434,-0.00507442524609068,0.00850032660768872,0.620856288106623
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CAPS,Calcyphosin,39868,0.00515258742199896,0.0104388817670801,-0.015307620841478,0.0256127956854759,0.621601340267691
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42039,-0.00233794078210392,0.00475191606319952,-0.011651696265975,0.00697581470176713,0.622727665569378
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39590,-0.00245810582134836,0.00500671660262671,-0.0122712703624967,0.00735505871979998,0.62346337837557
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HLA_E,,42048,0.00158504972361414,0.0032286181524647,-0.00474304185521668,0.00791314130244496,0.623478664199876
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,39696,0.00221230024346591,0.00451752249238922,-0.00664204384161696,0.0110666443285488,0.624344998422527
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TSC1,Hamartin,39597,0.00397379236461865,0.00815638446080639,-0.0120127211785619,0.0199603059077992,0.626126155115883
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNPO1,Transportin-1,39696,0.00188421500302784,0.00391140550614569,-0.00578213978901772,0.0095505697950734,0.630012052350164
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,39500,0.00176877597706777,0.00367834871191507,-0.00544078749828576,0.00897833945242131,0.630624647082604
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,41766,0.00172307216449018,0.00359681036354031,-0.00532667614804883,0.00877282047702919,0.631907027589688
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,41766,0.00293923903880333,0.00613937530210135,-0.00909393655331531,0.014972414630922,0.632122921495161
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,41766,0.00443892922311227,0.00938638576082866,-0.0139583868681119,0.0228362453143364,0.636284201134915
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD27,CD27 antigen,42108,0.00222177828871935,0.00469958338706172,-0.00698940514992162,0.0114329617273603,0.63639156006695
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PCDH1,Protocadherin-1,42190,-0.00107068305528828,0.00226778671520462,-0.00551554501708933,0.00337417890651278,0.636843811242357
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL36G,Interleukin-36 gamma,39564,0.00349141292099565,0.0073965577728231,-0.0110058403137376,0.0179886661557289,0.636913249064753
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,39858,-0.00277874075833569,0.00589948912296329,-0.0143417394393437,0.00878425792267236,0.637640010191365
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,39696,-0.00444123702465972,0.00949868386765166,-0.023058657405257,0.0141761833559375,0.640106018074668
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARTN,Artemin,41842,0.00231184455849508,0.00497247264721519,-0.00743420183004668,0.0120578909470369,0.641990260350528
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41766,-0.00154923024333463,0.00333314197148331,-0.00808218850744192,0.00498372802077265,0.642085413422434
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,39590,0.00187578282967387,0.00404300020102541,-0.00604849756433593,0.00980006322368366,0.64268693019654
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,41842,-0.00157689173460586,0.00340154681205173,-0.00824392348622725,0.00509014001701554,0.642955744533839
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VWC2,Brorin,41900,-0.0020758746297737,0.00449365487908712,-0.0108834381927845,0.00673168893323706,0.644119824112737
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TOP1,DNA topoisomerase 1,39869,-0.00612746056592281,0.0132753647116039,-0.0321471754006664,0.0198922542688208,0.644401297217587
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,39675,-0.00123670994035471,0.00271227142944099,-0.00655276194205906,0.00407934206134963,0.648421674935725
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,39597,0.00226334808065927,0.00497179544342183,-0.00748137098844751,0.0120080671497661,0.64894732109968
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,39869,0.00831575193323977,0.0182844124128424,-0.0275216963959314,0.044153200262411,0.649261845125342
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FSTL1,Follistatin-related protein 1,39575,0.00115892976177834,0.00255799647433973,-0.00385474332792752,0.00617260285148421,0.650513401953209
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,39512,-0.00496573229545291,0.010979780654798,-0.026486102378857,0.0165546377879512,0.651089583212099
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,39858,-0.00297648435935009,0.00661961007608603,-0.0159509201084787,0.00999795138977853,0.65297402563479
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LAMA4,Laminin subunit alpha-4,42111,0.00169142100588585,0.00376246948601871,-0.00568301918671081,0.00906586119848252,0.653041613113997
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,39696,-0.00208917524553361,0.0046491588157339,-0.0112015265243721,0.00702317603330483,0.653176222125483
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRX,Cone-rod homeobox protein,41828,0.00530941140514981,0.0118528117558779,-0.0179220996363709,0.0285409224466705,0.654200004743891
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TLR2,Toll-like receptor 2,39696,0.00114150964419333,0.00254907019156486,-0.00385466793127379,0.00613768721966045,0.654296089066378
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",39512,0.00198743116391919,0.00445570863471042,-0.00674575776011323,0.0107206200879516,0.655576086260476
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EGFLAM,Pikachurin,39869,0.00150499021171562,0.00338834872402661,-0.00513617328737653,0.00814615371080778,0.656930906150721
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,39872,-0.00166092552890497,0.00374813887295966,-0.0090072777199059,0.00568542666209595,0.657677750777299
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,42072,0.0022452619513533,0.0050688565644783,-0.00768969691502417,0.0121802208177308,0.657807309523289
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LY6D,Lymphocyte antigen 6D,41968,0.0019223752891162,0.00436889931622763,-0.00664066737068994,0.0104854179489223,0.65993434231661
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ICOSLG,ICOS ligand,41995,0.000924877001614607,0.00210405302614461,-0.00319906692962883,0.00504882093285805,0.660256210454133
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,39590,0.0019641395711886,0.0044757510008754,-0.0068083323905272,0.0107366115329044,0.660785939135467
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,39590,0.00391366341002554,0.00892306859740532,-0.0135755510408889,0.02140287786094,0.66095956997486
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39597,-0.0024001975168092,0.00547729571755747,-0.0131356971232218,0.00833530208960344,0.661243757904175
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RLN1,Prorelaxin H1,39872,-0.00212367352100443,0.00486378753398328,-0.0116566970876116,0.0074093500456028,0.662388368198515
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,39526,0.00286199024826218,0.00656181221167667,-0.00999916168662408,0.0157231421831485,0.662730344496861
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,39675,0.00251413894140811,0.00578055854135421,-0.00881575579964614,0.0138440336824624,0.663621635417111
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CYTH3,Cytohesin-3,39500,-0.00349330626048289,0.00804583379609639,-0.0192631405008318,0.012276527979866,0.664169384567621
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRSS53,Serine protease 53,39868,0.0018037711154741,0.00420347336513495,-0.00643503668019041,0.0100425789111386,0.667848148695845
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39500,0.00277433838341877,0.00647004079507033,-0.00990694157491907,0.0154556183417566,0.668078952287389
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EDNRB,Endothelin receptor type B,39597,-0.00206753751451433,0.00482841836856826,-0.0115312375169081,0.00739616248787946,0.668512580054697
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PKD1,Polycystin-1,39895,-0.00127961130594993,0.00299306375097451,-0.00714601625785996,0.0045867936459601,0.669004710275711
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,41771,0.00241555317372506,0.00565680390054124,-0.00867178247133577,0.0135028888187859,0.669373701123211
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EFNB2,Ephrin-B2,39590,0.00270988605593021,0.00637445726638751,-0.00978405018618932,0.0152038222980497,0.670760177082786
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LY96,Lymphocyte antigen 96,41943,-0.00170494769349011,0.00401900115666741,-0.00958218996055824,0.00617229457357801,0.671410941200908
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42039,0.00158590518837467,0.0037528445199543,-0.00576967007073576,0.00894148044748511,0.672603008197775
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39858,-0.00214175856291224,0.0050738175845376,-0.0120864410286059,0.00780292390278146,0.672945680345393
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42236,0.00322992074086601,0.0077067883642135,-0.0118753844529925,0.0183352259347245,0.675149108137277
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,39696,-0.00185231663591098,0.00442697126206562,-0.0105291803095596,0.00682454703773763,0.67565091831053
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,39597,0.00093713574331193,0.00224734749323055,-0.00346766534341995,0.00534193683004381,0.676689203525021
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HDAC8,Histone deacetylase 8,39597,0.00276197890179608,0.0066316563386909,-0.0102360675220381,0.0157600253256302,0.677063985452632
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,39500,0.00141046659551803,0.00343587523327123,-0.00532384886169358,0.00814478205272964,0.681438774216131
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AHNAK2,Protein AHNAK2,39575,-0.00138926409555864,0.00341568572716495,-0.00808400812080194,0.00530547992968467,0.684213753627091
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39500,-0.00240488388414707,0.00596679167340091,-0.0140997955640128,0.00929002779571871,0.686923230708115
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41771,0.00546946876590493,0.0136405052572278,-0.0212659215382615,0.0322048590700714,0.688446806544163
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39575,0.00280266256526484,0.00702227171442702,-0.0109609899950121,0.0165663151255418,0.689819531316095
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,41943,0.0025477903185129,0.00639324670401049,-0.00998297322134766,0.0150785538583735,0.690258639239847
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,S100A11,Protein S100-A11,41954,-0.00202903331955915,0.0051016252667664,-0.0120282188424213,0.00797015220330299,0.690840794674943
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39696,0.00224941857127056,0.005674755895153,-0.00887310298322932,0.0133719401257704,0.691824693861724
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEP350,Centrosome-associated protein 350,39500,0.00159346529916282,0.00402675472915685,-0.00629897396998461,0.00948590456831024,0.692319725888088
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RNASE3,Eosinophil cationic protein,42008,0.00473865359873007,0.0119938436405745,-0.018769279936796,0.0282465871342561,0.692782389726616
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39590,0.0018057294577336,0.00458377820760181,-0.00717847582916596,0.0107899347446332,0.693633645619389
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42048,-0.00210682150599654,0.00536205751426718,-0.0126164542339602,0.00840281122196713,0.694390049848456
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,41828,-0.00258947709349475,0.00663315284215239,-0.0155904566641134,0.0104115024771239,0.696258863965403
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39696,-0.00236968427877062,0.00611096679683273,-0.0143471792005628,0.00960781064302154,0.698189486044984
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LMOD2,Leiomodin-2,39526,0.0026267534231716,0.00677776578967656,-0.0106576675245945,0.0159111743709377,0.698353317870759
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLSTN1,Calsyntenin-1,41766,0.00215991469673668,0.00559731290975009,-0.0088108186063735,0.0131306479998469,0.69958865663625
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD72,B-cell differentiation antigen CD72,39675,0.00183231468208522,0.00478282424810694,-0.00754202084420439,0.0112066502083748,0.701650691670973
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,39512,-0.00137926925565992,0.00360098054632882,-0.00843719112646441,0.00567865261514456,0.701707930535838
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL19,Interleukin-19,41686,-0.00308077011946773,0.00809565448365207,-0.0189482529074258,0.0127867126684903,0.703546225061353
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,41766,0.0022689687824715,0.00597233272285266,-0.00943680335431972,0.0139747409192627,0.704015883748279
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA5,Annexin A5,41708,0.0012745903648077,0.00335656299336594,-0.00530427310218955,0.00785345383180495,0.70415140332031
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39858,0.00200644085718531,0.0053268395471266,-0.00843416465518283,0.0124470463695535,0.706428720742584
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41766,0.002021285145853,0.00541110110103787,-0.00858447301218123,0.0126270433038872,0.708749508879054
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C1S,Complement C1s subcomponent,39917,0.000864308925393468,0.00231971439067666,-0.00368233128033279,0.00541094913111972,0.709458495138998
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,39696,-0.00161807021857941,0.00434543349369265,-0.010135119866217,0.00689897942905818,0.709631154331068
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL2,Interleukin-2,41842,-0.0013084819770013,0.00351652522077732,-0.00820087140972485,0.00558390745572225,0.709827962017767
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,39597,0.00166535632746606,0.00449351064612283,-0.00714192453893469,0.0104726371938668,0.710932461042429
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ISM2,Isthmin-2,39904,-0.00176968513849339,0.00478066706204791,-0.0111397925801073,0.00760042230312051,0.711258771715549
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39597,-0.00180318239453793,0.00487534256388619,-0.0113588538197549,0.007752489030679,0.711495733221063
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,39675,-0.00105915261354612,0.00289262618824182,-0.0067286999425001,0.00461039471540785,0.714255620406905
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,42027,0.00191904180286989,0.00524626634208156,-0.00836364022760997,0.0122017238333498,0.714526117122976
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TTN,Titin,39512,-0.00277976019782615,0.00761506585648433,-0.0177052892765354,0.0121457688808831,0.715092880653551
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,39500,0.00224383683180786,0.00618268356479407,-0.00987422295518852,0.0143618966188042,0.716669591402789
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,39526,0.00165180606311479,0.00456167304431584,-0.00728907310374425,0.0105926852299738,0.7172803336123
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTSV,Cathepsin L2,42126,-0.00159379814707149,0.00440273898380522,-0.0102231665553297,0.00703557026118674,0.717356559389246
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42013,-0.0076442295383672,0.0211358224338831,-0.049070441508778,0.0337819824320436,0.717603049523143
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,41741,-0.00212919399968184,0.00593826037779638,-0.0137681843401627,0.00950979634079906,0.719933643517934
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42221,-0.00110171448315983,0.00307327092191896,-0.007125325490121,0.00492189652380134,0.71998766170456
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLU,Clusterin,39917,0.00117136321387985,0.00329726895220869,-0.00529128393244917,0.00763401036020887,0.722407017706757
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,S100A12,Protein S100-A12,41837,-0.00286498578218212,0.00807743512699923,-0.0186967586311006,0.0129667870667364,0.722827464347385
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,41771,-0.0011480514724115,0.00328109556372557,-0.00757899877731361,0.00528289583249061,0.726420225827381
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINB5,Serpin B5,41828,-0.00186056353431585,0.00536365236916455,-0.0123733221778784,0.00865219510924667,0.728684217042678
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLK10,Kallikrein-10,42065,0.0015522981358246,0.00450086832657643,-0.0072694037842652,0.0103740000559144,0.730183514752529
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,39597,0.00232364167590551,0.00689097742888169,-0.0111826740847026,0.0158299574365136,0.735972125527133
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,39512,0.00172395903712911,0.00511537289206826,-0.00830217183132468,0.0117500899055829,0.736111832108644
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,S100A3,Protein S100-A3,39858,-0.00158040667876634,0.00470228895500908,-0.0107968930305841,0.00763607967305146,0.736806956073639
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42108,-0.00100120783271058,0.00301463083271404,-0.00690988426483009,0.00490746859940894,0.739806646890417
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDH3,Cadherin-3,42174,0.00131677593307747,0.00405249069670292,-0.00662610583246026,0.0092596576986152,0.745239034112231
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDH23,Cadherin-23,39868,-0.000950992042019133,0.00294654806202963,-0.0067262262435972,0.00482424215955894,0.746892201552092
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,39858,0.0015687975132205,0.00486271033912829,-0.00796211475147094,0.0110997097779119,0.74699060888731
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,39500,-0.00219544268686791,0.00689967902041526,-0.0157188135668818,0.011327928193146,0.750343195840076
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39904,-0.000891278675488818,0.00286800678220873,-0.00651257196861792,0.00473001461764029,0.755984333524953
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,39526,0.00237492391128364,0.00764348160857969,-0.0126063000415325,0.0173561478640998,0.756025256734326
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL3,Interleukin-3,39500,0.00208015278709008,0.00674271016166752,-0.0111355591297783,0.0152958647039584,0.757704782895933
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39575,0.00242138143423061,0.00786525680803627,-0.0129945219095205,0.0178372847779817,0.758196304823798
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTSH,Pro-cathepsin H,41794,-0.00250592208550071,0.00821028061897785,-0.0185980720986973,0.0135862279276959,0.760205248922839
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CA8,Carbonic anhydrase-related protein,39597,-0.000893062639181545,0.00293588274169144,-0.00664739281289676,0.00486126753453367,0.760989814952283
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,39512,0.00197174027105493,0.00649133286832016,-0.0107512721508526,0.0146947526929624,0.761324398460358
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39526,-0.00105907053387384,0.00349410414375132,-0.00790751465562643,0.00578937358787874,0.761817774239788
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SELENOP,Selenoprotein P,39917,-0.00073990992602655,0.00248465347559606,-0.00560983073819483,0.00413001088614173,0.765867387711178
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,39590,0.00228366344451723,0.00767435720908837,-0.012758076685296,0.0173254035743304,0.766036504577656
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,41995,-0.00119188060256536,0.00404339526805888,-0.00911693532796077,0.00673317412283005,0.768172456763011
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39575,-0.000828349618437002,0.00281597176092778,-0.00634765426985546,0.00469095503298146,0.768640294311678
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41766,0.0016425086819526,0.00562516440403404,-0.00938281354995413,0.0126678309138593,0.77029656957474
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OSTN,Osteocrin,39590,0.00130098807227962,0.00445846861069501,-0.00743761040468261,0.0100395865492418,0.770443864075769
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,39597,0.00115369392295917,0.00399854723711251,-0.00668345866178134,0.00899084650769968,0.772947830676272
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39512,0.00153995691874437,0.00533919008999867,-0.00892485565765302,0.0120047694951418,0.773026765696165
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,39526,0.00173163044164228,0.00607305583368464,-0.0101715589923796,0.0136348198756642,0.775547424433624
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,39869,0.000769270611590719,0.00270739589624029,-0.00453722534504024,0.00607576656822168,0.776310821838232
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FAM171A2,Protein FAM171A2,39872,0.00486245362609917,0.0172138420028778,-0.0288766766995413,0.0386015839517397,0.777585675402127
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HRAS,GTPase Hras,39689,0.0030539971799521,0.0109367436756098,-0.018382020424243,0.0244900147841472,0.780064391307661
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SHPK,Sedoheptulokinase,39696,-0.00121181025705695,0.00440588818142733,-0.00984735109265452,0.00742373057854062,0.783288052565772
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,39481,-0.0014642301387084,0.00532596426083161,-0.0119031200899384,0.00897465981252157,0.783380606505892
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,39904,0.000701270825058176,0.002551731542887,-0.00430012299900035,0.0057026646491167,0.78345836110037
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA7A,Semaphorin-7A,42198,-0.000860383504699282,0.00314049477135372,-0.00701575325655257,0.00529498624715401,0.784116205156017
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,39500,0.0018880964160888,0.00697053604507349,-0.0117741542322552,0.0155503470644328,0.786497547563426
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLK11,Kallikrein-11,41989,0.000952439171416565,0.00354894246404269,-0.0060034880581071,0.00790836640094023,0.788416607435225
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DBH,Dopamine beta-hydroxylase,39915,-0.00333815488362415,0.0125478426979745,-0.0279319265716541,0.0212556168044058,0.790217742335994
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL1A,Interleukin-1 alpha,41842,-0.00168705969843586,0.00637542886501284,-0.014182900273861,0.0108087808769893,0.791307089711478
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,39597,0.000890334954169498,0.00341019122746396,-0.00579363985165987,0.00757430975999887,0.794035199604124
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRR5,Proline-rich protein 5,39597,0.00135699633897048,0.00519887347432978,-0.00883279567071588,0.0115467883486568,0.794083991219644
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DKKL1,Dickkopf-like protein 1,41995,-0.00232859894334436,0.00921605870495211,-0.0203920740050505,0.0157348761183618,0.800529005267358
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAG,Myelin-associated glycoprotein,39590,0.00135280091085054,0.00535839584740268,-0.00914965495005872,0.0118552567717598,0.800687322441734
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,39500,0.00116563199909888,0.00463028611066709,-0.00790972877780861,0.0102409927760064,0.801246152898869
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42236,-0.000845453461373827,0.0034218599399366,-0.00755229894364956,0.00586139202090191,0.804854484968547
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,41842,0.00154436337788708,0.00626931157444977,-0.0107434873080345,0.0138322140638086,0.805425191950215
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HLA_A,,39872,0.000884515788405657,0.00362060531579044,-0.0062118706305436,0.00798090220735491,0.807002521448812
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,39500,0.00131454143398791,0.00538357124261338,-0.00923725820153432,0.0118663410695101,0.807098743844691
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,39696,-0.00119386143192478,0.00492009889940006,-0.0108372552747489,0.00844953241089934,0.80828111809144
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PCDH12,Protocadherin-12,39872,-0.000679701814908934,0.00281164127258571,-0.00619051870917693,0.00483111507935906,0.80898171634632
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39872,-0.00130697810430156,0.00542730395441854,-0.0119444938549619,0.00933053764635879,0.809702611412556
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,39597,0.00242480636789536,0.0100960801216357,-0.0173635106705107,0.0222131234063014,0.810200581023272
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HK2,Hexokinase-2,41828,-0.000722015215517463,0.00300757892988305,-0.00661686991808824,0.00517283948705332,0.810283385756885
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39575,-0.00066946416230953,0.00282267222959346,-0.00620190173231272,0.00486297340769366,0.812526315452835
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL21R,Interleukin-21 receptor,39597,0.00140974817398368,0.00595383165488252,-0.0102597618695861,0.0130792582175534,0.812831889436514
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39872,0.00179959416522568,0.0077256941250816,-0.0133427663199343,0.0169419546503856,0.815815143833936
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39512,0.00170913159718923,0.00753078711054491,-0.0130512111394788,0.0164694743338573,0.820464863689836
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SHH,Sonic hedgehog protein,39597,0.00106528595309457,0.00469637969024614,-0.00813961823978787,0.010270190145977,0.820559133247154
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",41995,0.000850681493297862,0.00381012069650995,-0.00661715507186164,0.00831851805845737,0.823329627674569
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41766,-0.00109298563716386,0.00494584966110327,-0.0107868509729263,0.00860087969859855,0.825103280891767
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TP53BP1,TP53-binding protein 1,39597,-0.00208323852084936,0.00946661727718326,-0.0206378083841285,0.0164713313424298,0.82582730011438
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39500,0.00130427292384597,0.00592883582902807,-0.0103162453010491,0.012924791148741,0.825884595457835
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RUVBL1,RuvB-like 1,41771,-0.002385046254618,0.0108932362031752,-0.0237357892128413,0.0189656967036053,0.826694378299245
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TSPAN15,Tetraspanin-15,39512,-0.00118548809065648,0.0055385710873315,-0.0120410874218262,0.00967011124051325,0.83051812690274
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,41766,0.000833439980602005,0.0038964163952457,-0.00680353615407957,0.00847041611528358,0.83062905026177
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,39869,-0.000615292507212126,0.00288152951450007,-0.00626309035563226,0.00503250534120801,0.830917587530112
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39500,0.000624551980874915,0.00293392098756849,-0.00512593315475933,0.00637503711650916,0.831430158035756
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATP1B4,Protein ATP1B4,39500,0.000975227266297673,0.00461134113438965,-0.00806300135710604,0.0100134558897014,0.832513164134801
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39575,-0.0017759308784429,0.0084333186039199,-0.0183052353421259,0.0147533735852401,0.833214983093741
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RBP1,Retinol-binding protein 1,39590,0.00161248260167736,0.00771987092802477,-0.0135184644172512,0.0167434296206059,0.834550241858202
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PCDHB15,Protocadherin beta-15,39858,0.000916359465682433,0.00439067808718733,-0.00768936958520472,0.00952208851656959,0.834681779815956
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39895,-0.000785957969622527,0.00377950089375448,-0.00819377972138131,0.00662186378213625,0.835269534668503
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39278,0.00118185787384301,0.00569579814112273,-0.00998190648275754,0.0123456222304436,0.835626124512646
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,39590,-0.00115820345983704,0.00559356024129955,-0.0121215815327841,0.00980517461311008,0.835966714270889
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,39597,-0.000671905184293997,0.00324969542129916,-0.00704130821004034,0.00569749784145235,0.836201566836902
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,41771,0.000734587551197543,0.00355432188682187,-0.00623188334697332,0.00770105844936841,0.836267300639062
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,39696,0.00181806706370393,0.00880760280696808,-0.0154448344379535,0.0190809685653614,0.836466486711738
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39696,0.00148917752880589,0.00722964698643474,-0.0126809305646062,0.015659285622218,0.836808709272911
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IFNL2,Interferon lambda-2,39526,0.00131028031417767,0.00644340229044787,-0.0113187881751002,0.0139393488034555,0.8388635105997
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39927,-0.000824476181440334,0.00406023990488729,-0.00878254639501943,0.00713359403213876,0.83909103883274
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42111,-0.000599228994741559,0.00298746301482811,-0.00645465650380465,0.00525619851432153,0.841029058116457
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,39526,0.000821306965701475,0.0041277951546581,-0.0072691715374284,0.00891178546883135,0.842289996826604
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,41771,0.000660822794608509,0.00336569500626468,-0.00593593941767026,0.00725758500688728,0.844346564117263
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,INSL4,Early placenta insulin-like peptide,39858,-0.00102977005103326,0.005303285128421,-0.0114242089027384,0.00936466880067189,0.846041672673849
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41842,-0.00113577811370103,0.0059288969540868,-0.0127564161437112,0.0104848599163091,0.848084712772585
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,39904,0.000632812723458257,0.00333235766945097,-0.00589860830866565,0.00716423375558216,0.849391372047518
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42072,0.000363299538489321,0.00193045107810619,-0.00342038457459882,0.00414698365157746,0.850727317548169
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MYL3,Myosin light chain 3,39575,-0.00162596067856084,0.00864768874448854,-0.0185754306177584,0.0153235092606367,0.850862433033377
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,39696,0.00126701777335437,0.00675199361154706,-0.0119668897052779,0.0145009252519866,0.851153742610555
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FOLR3,Folate receptor gamma,42060,-0.00388689333287659,0.0211597977214132,-0.0453600968668465,0.0375863102010933,0.854257564101178
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CASP8,Caspase-8,42149,-0.00122660439334173,0.00673658868736008,-0.0144303182205675,0.011977109433884,0.855521931163224
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BRD2,Bromodomain-containing protein 2,39526,-0.00068948476640224,0.00385690744845108,-0.00824902336536636,0.00687005383256188,0.858124584832782
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CNPY2,Protein canopy homolog 2,41828,-0.00119523845001393,0.00669800752512301,-0.014323333199255,0.0119328562992272,0.858374778982867
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42070,0.000681534799386276,0.00382560591037508,-0.00681665278494888,0.00817972238372143,0.858607217014257
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39512,0.000837594569479473,0.00470383252108746,-0.00838191717185195,0.0100571063108109,0.858674126881294
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42087,-0.000446273339004873,0.00251223821581476,-0.00537026024200181,0.00447771356399206,0.859008581983719
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39512,-0.00091741897741921,0.00522891377432928,-0.0111660899751046,0.00933125202026618,0.860728401017309
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SEPTIN9,Septin-9,41995,0.00055328457895601,0.00316724475735639,-0.00565451514546251,0.00676108430337453,0.861326215199553
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39858,-0.000885634417105677,0.00518882158648713,-0.0110557247266204,0.00928445589240909,0.864477494833599
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL26,C-C motif chemokine 26,42048,-0.00167911427339804,0.00988286167162917,-0.0210495231497912,0.0176912946029951,0.865090057565881
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,39526,-0.000750220930239455,0.00444164634335601,-0.00945584776321724,0.00795540590273832,0.865873668636829
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,39500,-0.000742196901377722,0.0043991501266445,-0.00936453114960094,0.00788013734684549,0.866024971481662
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42174,0.000865196104346435,0.00515070903038742,-0.00923019359521291,0.0109605858039058,0.866604570211115
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SAG,S-arrestin,39526,0.000934737716972153,0.00576044158125068,-0.0103557277822792,0.0122252032162235,0.871097487963062
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39696,0.0012055327324066,0.00760498813385839,-0.0137002440099558,0.016111309474769,0.874050981625393
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",39526,-0.00143490356180955,0.00906361435572103,-0.0191995876990228,0.0163297805754037,0.874211735943311
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HSPB6,Heat shock protein beta-6,42187,-0.000696023976267882,0.00447433385392208,-0.00946571832995517,0.0080736703774194,0.876382765945286
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,39512,0.000554201174199454,0.00361479213705482,-0.006530791414428,0.00763919376282691,0.87815285599071
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KHDC3L,KH domain-containing protein 3,39500,0.00113000666806226,0.00738867710888005,-0.0133518004653426,0.0156118138014671,0.878450301858506
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39597,0.000518397794963907,0.00342641407211394,-0.00619737378637942,0.00723416937630723,0.879746138831144
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,41766,-0.00055534481219004,0.00370834218678474,-0.00782369549828814,0.00671300587390806,0.880959776063918
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CORO6,Coronin-6,39526,-0.000633545898483263,0.00430125392267054,-0.00906400358691753,0.007796911789951,0.882903235779006
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41766,0.00122012630450031,0.00835166450274184,-0.0151491361208737,0.0175893887298743,0.883849586762229
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39512,-0.000796667118582707,0.00548255814642428,-0.0115424810855743,0.00994914684840888,0.884469293918073
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,39491,-0.00130997825266351,0.00909157521996772,-0.0191294656838002,0.0165095091784732,0.885434396595558
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRL,Prolactin,42174,-0.00115776439924315,0.00811312624188318,-0.0170594918333342,0.0147439630348479,0.886527162733761
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,39575,0.000633650551955383,0.00454236199676291,-0.00826937896169992,0.00953668006561069,0.889059171893462
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,41828,-0.000879935346040506,0.00642683708343806,-0.0134765360295791,0.0117166653374981,0.891099457480601
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PGM2,Phosphoglucomutase-2,39590,0.000900868422159991,0.00667899404709466,-0.0121899599101455,0.0139916967544655,0.892708547412971
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLINT1,Clathrin interactor 1,39500,-0.000740213161818994,0.00550860494332104,-0.0115370788507282,0.0100566525270902,0.893109338139082
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,39526,-0.00104595412265917,0.00781672508538774,-0.0163667352900191,0.0142748270447008,0.893555472180724
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LUZP2,Leucine zipper protein 2,39858,0.000634796407829518,0.00494591432536808,-0.00905919566989191,0.0103287884855509,0.897876161881565
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MMP12,Macrophage metalloelastase,42071,0.000763487249936891,0.00602125983901208,-0.0110381820345268,0.0125651565344006,0.899101705214766
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39500,-0.000600516660894739,0.00484478727556975,-0.0100962997210115,0.00889526639922198,0.901356286807233
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,39590,-0.00142110629489092,0.0116026306330357,-0.0241622623356409,0.021320049745859,0.902520025407822
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,H2AP,Huntingtin-interacting protein M,39500,0.000670447142540834,0.00550893257011572,-0.010127060694886,0.0114679549799677,0.903137412009337
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42072,-0.000443000307529389,0.00365675819893558,-0.00761024637744312,0.00672424576238434,0.903577487635983
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PCDH17,Protocadherin-17,42072,0.000496899779728737,0.00412228984964229,-0.00758278832557014,0.00857658788502762,0.904057392370402
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CHGA,Chromogranin-A,39904,0.00107327028630563,0.00935873928678889,-0.0172698587158006,0.0194163992884119,0.90869995137208
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,39221,-0.00137213020820673,0.0121839681551185,-0.0252527077922389,0.0225084473758254,0.910335797134039
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,39858,0.00042921821313911,0.00381643116498051,-0.00705098687022269,0.00790942329650091,0.910456042883644
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,39500,-0.000611732691510998,0.00573412492220526,-0.0118506175390333,0.0106271521560113,0.915042565449851
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NENF,Neudesin,39858,-0.00124379151842157,0.0123464993539131,-0.0254429302520913,0.0229553472152482,0.919758318727685
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39512,-0.000447185410948973,0.00447328781334974,-0.00921482952511446,0.00832045870321652,0.920371606867155
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NECTIN1,Nectin-1,39597,-0.000361432747969282,0.00363081335741163,-0.00747782692849607,0.0067549614325575,0.920706624427821
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],41995,-0.000585265436984962,0.00623120094152561,-0.0127984192823752,0.0116278884084052,0.925170153497179
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FRMD7,FERM domain-containing protein 7,39590,-0.00034715853431012,0.00374407638305419,-0.00768554824509633,0.00699123117647609,0.926126048680066
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UNG,Uracil-DNA glycosylase,39858,0.000350503532786991,0.00388206891068413,-0.00725835153215389,0.00795935859772788,0.928060106327403
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TBR1,T-box brain protein 1,39590,0.000477151111757459,0.00528840903415419,-0.00988813059518476,0.0108424328186997,0.928109400294755
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,39696,-0.000525354141606752,0.00584299848520441,-0.0119776311726074,0.0109269228893939,0.928358977161445
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,39526,-0.00106383042764652,0.0119531915130469,-0.0244920857932185,0.0223644249379254,0.929083781811469
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGF12,Fibroblast growth factor 12,39597,-0.00043937787431956,0.00499514013928491,-0.010229852547318,0.00935109679867886,0.929909218964622
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPM1B,Protein phosphatase 1B,39597,-0.000584927664874566,0.00679992274278658,-0.0139127762407363,0.0127429209109871,0.93145228196496
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FOS,Proto-oncogene c-Fos,39479,0.000334590955019408,0.00396860949920028,-0.00744388366341314,0.00811306557345196,0.93281201637186
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,39597,0.000805307936185599,0.00977181360016219,-0.0183474467201323,0.0199580625925035,0.934321144357887
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,41771,-0.000418014458833339,0.00509034318249964,-0.0103950870965326,0.00955905817886595,0.93455324358814
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TAP1,Antigen peptide transporter 1,39696,0.000516948287572879,0.0064238318597449,-0.0120737621575271,0.0131076587326729,0.935862116370983
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,39512,0.000377145242859796,0.00513573152452782,-0.00968888854521474,0.0104431790309343,0.94146087920766
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DLL4,Delta-like protein 4,39575,-0.000710178638432935,0.00973369751050124,-0.0197882257590154,0.0183678684821495,0.941838617989863
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPRING1,SREBP regulating gene protein,39500,0.000484416503401735,0.00681410553233842,-0.0128712303399816,0.013840063346785,0.943327227740867
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTSL,Cathepsin L1,42072,-0.000187943784569464,0.0026940350839516,-0.00546825254911461,0.00509236497997568,0.944383387202818
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APOB,Apolipoprotein B-100,39927,0.000161895935050112,0.00251275624739367,-0.00476310630984148,0.00508689817994171,0.948629281077767
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NRN1,Neuritin,39872,0.000241869609235599,0.00383855532617323,-0.00728169883006394,0.00776543804853513,0.949759194240685
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TMEM25,Transmembrane protein 25,39872,0.000322743785990441,0.0051706387154586,-0.00981170809630842,0.0104571956682893,0.950230627421778
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,39590,-0.000266394223131599,0.00445906725208108,-0.00900616603721052,0.00847337759094732,0.952362094487743
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,41766,-0.000307979486266942,0.0052279892340356,-0.0105548383849767,0.00993887941244283,0.953024894210601
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,39526,-0.000271163922843209,0.00481177620686379,-0.00970224528829625,0.00915991744260983,0.955060651944275
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39895,-0.000309633432776694,0.00579005507912603,-0.0116581413878637,0.0110388745223103,0.957352986268101
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,39575,-0.000183393122843429,0.00351325700246285,-0.00706937684767061,0.00670259060198375,0.958370031821173
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PCDH9,Protocadherin-9,39869,-0.000186588631679069,0.00372265020896143,-0.00748298304124347,0.00710980577788534,0.960025637504144
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,39575,-0.00140106721929867,0.02935068980353,-0.0589284192342175,0.0561262847956202,0.961927981519625
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39526,-0.000291770702804381,0.00648161785272147,-0.0129957416941385,0.0124122002885297,0.964096092417587
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,39869,-0.000114788337713914,0.00326040304083886,-0.00650517829775808,0.00627560162233025,0.971915468455389
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42063,0.000131523922990664,0.00406020237860688,-0.00782647273907881,0.00808952058506014,0.974158773895138
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD83,CD83 antigen,42048,-0.000119941758326591,0.00379665971063077,-0.0075613947911629,0.00732151127450972,0.974798378416902
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NPTN,Neuroplastin,41771,0.000255689307338397,0.0086430767854796,-0.0166847411922016,0.0171961198068784,0.976399963969613
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,41995,-6.87281003642737e-05,0.0023594812302122,-0.00469331131158018,0.00455585511085164,0.976762556114633
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,39500,0.000268708705930083,0.0100769659071131,-0.0194821444720116,0.0200195618838718,0.978726909946858
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TEF,Thyrotroph embryonic factor,39512,0.000121724428169422,0.0047271532847338,-0.00914349600990883,0.00938694486624768,0.979457174697511
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,39590,0.000195854714693639,0.00762072177514351,-0.0147407599645876,0.0151324693939749,0.979496863866208
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RCC1,Regulator of chromosome condensation,39858,0.000143537817819434,0.00573899178123481,-0.0111048860734008,0.0113919617090397,0.980046647585024
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLK12,Kallikrein-12,41771,-0.000330882752392871,0.0147025706498113,-0.029147921226023,0.0284861557212373,0.982045388552388
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,39500,5.85003292501975e-05,0.00279545577134532,-0.00542059298258663,0.00553759364108703,0.983304321057184
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,41842,-6.21410815791542e-05,0.00345716896166032,-0.00683819224643338,0.00671391008327508,0.985659421270862
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,39904,-4.43246097789488e-05,0.00312761353379831,-0.00617444713602363,0.00608579791646573,0.988692990555628
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MYH7B,Myosin-7B,39500,-6.51225508111106e-05,0.00472314424236783,-0.00932248526585206,0.00919224016422983,0.988999395944759
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,39512,-7.07621697111923e-05,0.00549719132948102,-0.010845257175494,0.0107037328360716,0.989729811734433
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,39689,-0.000105485894893201,0.0110630964901744,-0.021789155015635,0.0215781832258486,0.992392510168787
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,39895,3.56005217330612e-05,0.00376894479937944,-0.00735153128505064,0.00742273232851676,0.992463658387292
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MTPN,Myotrophin,41828,-3.22425906018303e-05,0.00358073299739232,-0.00705047926549078,0.00698599408428712,0.992815708011631
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PI3,Elafin,41894,4.12386950334969e-05,0.0061908406855569,-0.012092809048658,0.012175286438725,0.994685236200565
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,39526,2.06222405137413e-05,0.00534473557660429,-0.0104550594896307,0.0104963039706582,0.996921503456424
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,39597,2.17441442464125e-05,0.00615911535343093,-0.0120501219484782,0.012093610236971,0.997183217793646
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NXPH1,Neurexophilin-1,41766,1.24293999354809e-05,0.00428307979823341,-0.00838240700460201,0.00840726580447297,0.997684604409481
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,41766,1.16784703255341e-05,0.00427920014033976,-0.0083755538047404,0.00839891074539147,0.99782251767606
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MMP15,Matrix metalloproteinase-15,39895,-1.31090625902169e-05,0.0053476741373531,-0.0104945503718023,0.0104683322466219,0.998044144725843
